👪

Inheritance

2

Predominantly sporadic 4p deletion HP:0003745

WHS is usually sporadic. About 50%-60% of affected individuals have a de novo pure 4p deletion, while about 40%-45% have an unbalanced translocation that may be de novo or inherited from a parent carrying a balanced rearrangement in the historical GeneReviews summary; cohort proportions vary with ascertainment. Ring chromosome 4 and other complex rearrangements account for the remainder.

Sporadic

Show evidence (2 references)

PMID:20301362 SUPPORT Human Clinical

"About 50%-60% of individuals with WHS have a de novo pure deletion of 4p16 and about 40%-45% have an unbalanced translocation with both a deletion of 4p and a partial trisomy of a different chromosome arm."

The retired GeneReviews chapter supplies the historical distribution of pure deletions and unbalanced translocations; newer cohort evidence is used elsewhere in this entry to cross-check the chromosomal mechanisms.

PMID:18932224 SUPPORT Human Clinical

"Sixty-five of 87 patients had an apparent pure, de novo, terminal deletion"

Demonstrates a higher pure-deletion proportion in one later cohort and therefore cautions against treating the historical percentages as fixed.

Rearrangement-dependent recurrence risk

Recurrence risk cannot be assigned from the WHS diagnosis alone. It is low after a confirmed de novo deletion but can be substantially higher when an unbalanced 4p deletion is inherited from a parent with a balanced rearrangement. Parental chromosome studies therefore determine counseling and prenatal-testing options.

Show evidence (2 references)

PMID:20301362 SUPPORT Human Clinical

"These unbalanced translocations may be de novo or inherited from a parent with a balanced rearrangement."

Documents the inherited balanced-rearrangement mechanism that changes recurrence risk.

PMID:20301362 SUPPORT Human Clinical

"Risks to family members depend on the mechanism of origin of the deletion."

Directly supports mechanism-specific rather than universal recurrence counseling.

?

Discussions and Knowledge Gaps

2

Which distal 4p genes and gene combinations are necessary for each major WHS phenotype, and how do deletion size, breakpoint, and additional duplicated material alter penetrance?

KNOWLEDGE GAP OPEN gap_whs_deletion_resolved_causality

Attached to

pathophysiology#4p16.3 Contiguous Gene Deletion pathophysiology#NSD2 (WHSC1) Haploinsufficiency pathophysiology#Telomeric 4p Seizure-Susceptibility Region Haploinsufficiency pathophysiology#Candidate Multigene Neuronal-Communication Dysfunction

Human deletion mapping supports a multigene syndrome and identifies candidate intervals, but most individual-gene assignments remain correlational or extrapolated. Resolving this gap is necessary for genotype-specific prognosis and for distinguishing causal drivers from passengers in differently sized deletions.

Proposed experiments

Isogenic distal-4p deletion and gene-restoration series

exp_whs_isogenic_4p_dosage_series

Engineer matched human iPSC lines carrying nested heterozygous distal-4p deletions, then restore NSD2, LETM1, PIGG, or defined gene combinations. Differentiate cortical, neural-crest, cardiac, renal, and cochlear lineages and compare chromatin, mitochondrial, electrophysiologic, migration, and morphogenesis readouts.

Decision criterion

Reproducible rescue by one restored gene would assign that dosage component to the affected lineage; rescue only after defined multigene restoration would support a synergistic contiguous-deletion mechanism.

Show evidence (1 reference)

PMID:26239400 SUPPORT Other

"Thus, the next step is to determine the precise effects of specific gene deletions."

Motivates an isogenic experiment that separates the effects of specific deleted genes.

Show evidence (2 references)

PMID:26239400 SUPPORT Other

"Thus, the next step is to determine the precise effects of specific gene deletions."

The review explicitly identifies gene-resolved dosage effects as the next mechanistic task.

PMID:26239400 SUPPORT Other

"our focus will continue to be on the establishment of robust genotype-phenotype correlations and the penetrance of these phenotypes."

Supports the need for deletion-resolved penetrance estimates.

How faithfully do current NSD2 developmental models and LETM1 seizure-susceptibility models represent a human heterozygous multigene 4p deletion?

HUMAN MODEL MISMATCH OPEN gap_whs_human_model_translation

Attached to

pathophysiology#Impaired H3K36 Dimethylation and Developmental Gene Mis-regulation pathophysiology#LETM1 Haploinsufficiency and Mitochondrial Ion Dyshomeostasis pathophysiology#Candidate FGFR3-Dependent Neural-Crest Signaling Defect pathophysiology#Humoral Antibody Deficiency

Existing models establish important NSD2- and LETM1-dependent biology but perturb one gene; some use homozygous deficiency, transient knockdown, or pharmacologically triggered seizures. They cannot by themselves validate the human effects of heterozygous dosage loss across multiple neighboring genes or interactions with unbalanced-translocation trisomic material.

Proposed experiments

Cross-model benchmark against deletion-resolved human cells

exp_whs_model_benchmark

Compare matched molecular and developmental readouts across nested-deletion human iPSC lineages, stable heterozygous Nsd2 mouse cells, and stable heterozygous zebrafish mutants. In a parallel neuronal/seizure arm, compare human deletion-derived neurons with heterozygous Letm1 mice and lentiviral-mediated Letm1-knockdown rats at baseline and under matched kainic-acid or pilocarpine challenge. Separate conserved single-gene effects from phenotypes that require additional 4p dosage loss.

Decision criterion

Translational conservation requires concordant lineage-specific NSD2 signatures across heterozygous human and animal models and concordant LETM1-related neuronal or seizure-threshold effects across human cells, heterozygous mice, and rat knockdown. Effects confined to homozygous, morpholino, knockdown, or provoked-seizure conditions would limit their relevance to human WHS haploinsufficiency.

Show evidence (2 references)

PMID:26239400 SUPPORT Other

"New animal models will also be developed to further our understanding of the effects of hemizygosity as well as to serve as models for treatment development."

Motivates a cross-model benchmark centered on human hemizygosity.

PMID:26747863 SUPPORT Model Organism

"heterozygous Letm1± mice, as well as rats with a lentiviral-mediated Letm1 knockdown, demonstrate increased seizure susceptibility in response to kainic acid or pilocarpine seizure induction."

Supplies the permitted evidence for the explicit LETM1 mouse/rat comparison arm while underscoring that the existing endpoint is challenge-induced seizure susceptibility.

Show evidence (1 reference)

PMID:26239400 SUPPORT Other

"New animal models will also be developed to further our understanding of the effects of hemizygosity as well as to serve as models for treatment development."

The review explicitly calls for models that address hemizygosity and treatment translation.

⚙

Pathophysiology

10

4p16.3 Contiguous Gene Deletion

Wolf-Hirschhorn syndrome is a contiguous gene deletion disorder caused by hemizygous loss of distal chromosome 4 (4p16.3). Two adjacent "critical regions" lie ~1.8-2.0 Mb from the 4p telomere: WHSCR (a ~165 kb interval encompassing parts of WHSC1/NSD2 and WHSC2/NELFA) and WHSCR-2 (a ~300-600 kb interval that includes the 5' end of WHSC1/NSD2 and all of LETM1). A separate ~197 kb terminal seizure susceptibility region (containing PIGG, ZNF721 and ABCA11P) lies ~368 kb from the 4p telomere. Phenotypic severity scales broadly with deletion size, but individual features track more tightly with which dosage-sensitive genes are removed.

Downstream

NSD2 (WHSC1) Haploinsufficiency Loss of one copy of NSD2/WHSC1 within WHSCR/WHSCR-2 reduces H3K36 dimethyltransferase dosage.

LETM1 Haploinsufficiency and Mitochondrial Ion Dyshomeostasis Loss of LETM1, located in WHSCR-2, halves the mitochondrial K+/H+ and Ca2+/H+ exchanger.

Telomeric 4p Seizure-Susceptibility Region Haploinsufficiency Most WHS deletions extend to the 4p terminus, removing the ~197 kb terminal region containing PIGG and ZNF721.

Candidate Multigene Neuronal-Communication Dysfunction Depending on the breakpoint, the 4p deletion can remove several candidate epilepsy contributors nominated by computational network analysis, including PIGG, CPLX1, CTBP1, and LETM1.

Candidate MSX1-Dependent Odontogenesis Defect Larger 4p deletions remove MSX1, a craniofacial/odontogenic transcription factor.

Candidate FGFR3-Dependent Neural-Crest Signaling Defect FGFR3 lies near the WHS critical regions and may be co-deleted depending on the breakpoint.

Microcephaly Distal 4p gene loss can produce microcephaly through unresolved multigene developmental mechanisms.

Hypotonia Hypotonia is associated with the distal 4p deletion syndrome, but its gene-level mechanism remains unresolved.

Status Epilepticus WHS-associated epilepsy can include status epilepticus, but available cohort evidence does not assign that complication to a particular distal interval or deleted gene.

Corpus Callosum Abnormalities Structural brain abnormalities can accompany distal 4p deletion, but the responsible dosage-sensitive genes are unresolved.

Renal Anomalies Kidney and urinary-tract anomalies occur in the deletion syndrome without a securely mapped single-gene mechanism.

Feeding Difficulties Feeding impairment is a variable multisystem consequence of the deletion syndrome.

Hearing Loss Hearing loss is a recurrent manifestation with conductive and sensorineural components and incompletely resolved gene attribution.

Ophthalmologic Abnormalities Ocular abnormalities occur in the distal 4p deletion syndrome, with the responsible gene-level mechanisms unresolved.

Hepatic Neoplasia Rare reported hepatic neoplasms may be associated with the distal 4p deletion, but penetrance and gene attribution are unresolved.

Show evidence (5 references)

PMID:32914558 SUPPORT Human Clinical

"The syndrome is caused by deletion of a critical region (Wolf-Hirschhorn Syndrome Critical region-WHSCR) on chromosome 4p16.3."

This establishes the genetic basis of Wolf-Hirschhorn syndrome as a deletion of the critical region on 4p16.3.

PMID:26747863 SUPPORT Human Clinical

"Wolf-Hirschhorn syndrome (WHS) is a contiguous gene deletion syndrome involving variable size deletions of the 4p16.3 region."

Establishes WHS as a contiguous gene deletion syndrome of variable size.

PMID:26747863 SUPPORT Human Clinical

"Two adjacent regions, located approximately 1.8–2.0 Mbp from the 4p terminus, are each proposed to be the minimal region of deletion necessary to observe the core WHS features."

Defines WHSCR/WHSCR-2 as the historically recognized critical regions for the core WHS phenotype.

+ 2 more references

NSD2 (WHSC1) Haploinsufficiency

NSD2 (also called WHSC1 or MMSET) encodes a SET-domain histone methyltransferase that dimethylates lysine 36 of histone H3 (H3K36me2). NSD2 partners with cell-type-specific transcription factors (e.g., Sall1/Sall4/Nanog in embryonic stem cells, Nkx2-5 in embryonic heart) to deposit H3K36 marks at developmental gene loci, preventing inappropriate transcription. Hemizygous loss of NSD2 is included in essentially all classic WHS deletions and is a well-supported contributor to the craniofacial, growth, neurodevelopmental and cardiovascular phenotypes. NSD2 loss alone has not been shown to reproduce the full human contiguous-deletion syndrome.

NSD2 hgnc:12766

chromatin remodeling GO:0006338 ↓ DECREASED regulation of transcription by RNA polymerase II GO:0006357 ↓ DECREASED

histone methyltransferase activity GO:0042054 ↓ DECREASED histone H3K36 dimethyltransferase activity GO:0140954 ↓ DECREASED

Downstream

Impaired H3K36 Dimethylation and Developmental Gene Mis-regulation DrWhsc1 suppression or SET-domain disruption impairs embryonic H3K36 dimethylation in zebrafish; the magnitude of the effect from heterozygous human NSD2 loss is not quantified by this evidence.

Cranial Neural Crest Cell Migration Defect WHSC1/NSD2 is expressed in jaw, face and CNS tissues that depend on cranial neural crest, and its dysregulation has been linked to defective neural crest migration.

Sensorineural Hearing Loss Whsc1-deficient mice develop abnormal cochlear hair-bundle morphology, supporting an NSD2 contribution to the sensorineural component of WHS hearing loss.

Humoral Antibody Deficiency Mouse B-cell studies make impaired NSD2-dependent class switching a candidate mechanism for the human antibody deficiencies observed in WHS.

Show evidence (3 references)

PMID:25942451 SUPPORT Other

"NSD2 haploinsufficiency causes Wolf-Hirschhorn syndrome"

Cancer-biology review shorthand linking NSD2 haploinsufficiency to WHS; it supports a contributory role but does not establish single-gene sufficiency for the full contiguous-deletion syndrome.

PMID:26092122 SUPPORT Model Organism

"WHSC1 is a histone methyltransferase (HMT) that catalyses the addition of methyl groups to lysine 36 on histone 3. In humans, WHSC1 haploinsufficiency is associated with all known cases of Wolf-Hirschhorn syndrome (WHS)."

Names WHSC1/NSD2 as the histone methyltransferase whose haploinsufficiency underlies WHS.

PMID:19483677 SUPPORT Model Organism

"the H3K36me3-specific histone methyltransferase (HMTase) Wolf-Hirschhorn syndrome candidate 1 (WHSC1, also known as NSD2 or MMSET) functions in transcriptional regulation together with developmental transcription factors whose defects overlap with the human disease Wolf-Hirschhorn syndrome (WHS)"

Identifies WHSC1/NSD2 as the H3K36 methyltransferase that partners with developmental transcription factors implicated in WHS.

Impaired H3K36 Dimethylation and Developmental Gene Mis-regulation

NSD2 is an H3K36 methyltransferase that cooperates with developmental transcription factors such as Nkx2-5. In zebrafish, DrWhsc1 suppression or SET-domain disruption impairs H3K36 dimethylation during early embryogenesis and produces brain, cartilage, bone, and motor-neuron abnormalities. Whsc1-deficient mice show growth, midline, and cardiovascular defects that are aggravated by Nkx2-5 heterozygosity. These models support a developmental chromatin mechanism, but the magnitude or global distribution of H3K36me2 change in human heterozygous 4p deletions is not established by the cited evidence.

regulation of transcription by RNA polymerase II GO:0006357 ↕ DYSREGULATED chromatin remodeling GO:0006338 ↓ DECREASED

histone H3K36 dimethyltransferase activity GO:0140954 ↓ DECREASED

Downstream

Global Developmental Delay Loss of H3K36 methylation at neurodevelopmental targets is a candidate contributor to developmental delay.

Intellectual Disability Mis-regulation of neuronal differentiation and transcription is a candidate contributor to cognitive impairment.

Intrauterine Growth Retardation Whsc1-deficient mice show growth retardation phenocopying prenatal growth deficiency in WHS.

Postnatal Growth Retardation Persistent NSD2-dependent transcriptional defects may contribute to ongoing growth failure after birth.

Congenital Heart Defects Altered H3K36 methylation at Nkx2-5 cardiac targets is a model-supported contributor to cardiovascular malformation.

Skeletal Anomalies Reduced Whsc1 activity and H3K36 dimethylation impair cartilage and bone formation in zebrafish, supporting a candidate skeletal contribution.

Show evidence (4 references)

PMID:19483677 SUPPORT Model Organism

"Whsc1-deficient mice showed growth retardation and various WHS-like midline defects, including congenital cardiovascular anomalies."

Mouse Whsc1 deficiency recapitulates growth retardation and midline/cardiac defects of WHS.

PMID:19483677 SUPPORT Model Organism

"The effects of Whsc1 haploinsufficiency were increased in Nkx2-5 heterozygous mutant hearts, indicating their functional link."

Establishes the NSD2/WHSC1-Nkx2-5 transcriptional axis as a driver of WHS cardiac phenotypes.

PMID:20946879 SUPPORT Model Organism

"Morpholino oligonucleotides for the DrWhsc1 gene affected early embryogenesis in zebrafish, such as endbrain enlargement, abnormal cartilage, marked reduction of bone, and incomplete motor neuron formation."

Zebrafish Whsc1 knockdown produces brain, skeletal and motor neuron phenotypes that mirror WHS features.

+ 1 more reference

LETM1 Haploinsufficiency and Mitochondrial Ion Dyshomeostasis

LETM1 lies in WHSCR-2 and encodes an inner-mitochondrial-membrane protein that catalyses K+/H+ exchange and Ca2+/H+ antiport, and controls mitochondrial volume, membrane potential and OXPHOS protein integrity. Hemizygous loss in WHS halves LETM1 dosage, producing impaired mitochondrial K+ efflux and perturbed Ca2+ handling. Heterozygous mouse and knockdown-rat models show increased chemically induced seizure susceptibility. LETM1 has long been treated as a major candidate gene for WHS-associated seizures. Human deletion mapping shows seizures both when LETM1 is spared and absent seizures when it is deleted, indicating that LETM1 haploinsufficiency is neither necessary nor sufficient.

LETM1 hgnc:6556

mitochondrial calcium ion homeostasis GO:0051560 ↓ DECREASED potassium ion homeostasis GO:0055075 ↓ DECREASED

mitochondrial inner membrane GO:0005743

Downstream

Seizures Mitochondrial K+/H+ and Ca2+ dyshomeostasis may lower neuronal seizure threshold, but LETM1 loss is not sufficient or necessary in human deletion mapping.

Show evidence (4 references)

PMID:24738919 SUPPORT Human Clinical

"LETM1, encoding a mitochondrial protein playing a role in K(+) /H(+) exchange and in Ca(2+) homeostasis, is currently considered the major candidate gene."

Establishes LETM1 as the historically major candidate gene for WHS seizures and its mitochondrial K+/H+ and Ca2+ functions.

PMID:36055214 SUPPORT Human Clinical

"Leucine zipper-EF-hand containing transmembrane protein 1 (LETM1) encodes an inner mitochondrial membrane protein with an osmoregulatory function controlling mitochondrial volume and ion homeostasis."

Defines LETM1's molecular function as the inner-mitochondrial-membrane osmoregulator.

PMID:36055214 SUPPORT Human Clinical

"bi-allelic LETM1 variants are associated with defective mitochondrial K+ efflux, swollen mitochondrial matrix structures, and loss of important mitochondrial oxidative phosphorylation protein components"

Bi-allelic loss-of-function LETM1 variants confirm the cellular consequences of LETM1 loss that are partially recapitulated in WHS heterozygotes.

+ 1 more reference

Telomeric 4p Seizure-Susceptibility Region Haploinsufficiency

High-resolution chromosomal microarray mapping (n=48) proposed an independent seizure-susceptibility region to a ~197 kb interval starting ~368 kb from the 4p telomere, distal to LETM1 and containing PIGG, ZNF721 and the pseudogene ABCA11P. Patients with interstitial deletions whose distal breakpoint preserves the terminal 751 kb (and thus this region) lacked seizures in the mapped cohort, while deletion of the interval tracked with seizures in that cohort. This is evidence for susceptibility, not proof of a universally deterministic interval.

PIGG hgnc:25985

Downstream

Seizures Deletion of the mapped distal interval was associated with seizures in the high-resolution mapping cohort.

Show evidence (3 references)

PMID:26747863 SUPPORT Human Clinical

"We identify a small terminal region of chromosome 4p that represents a seizure susceptibility region. Deletion of this region in the context of WHS is sufficient for seizure occurrence."

Defines the terminal interval associated with seizures in the mapping cohort; it is retained as a susceptibility region rather than treated as a universally deterministic locus.

PMID:26747863 SUPPORT Human Clinical

"Some of these deletions suggest that LETM1 deletion is neither necessary nor sufficient for the expression of a seizure phenotype in individuals with WHS"

Refutes a single-gene LETM1 model and motivates the search for additional seizure-susceptibility genes.

PMID:24738919 SUPPORT Human Clinical

"haploinsufficiency not limited to LETM1 but including other genes acts as a risk factor for the WHS-associated seizure disorder, according to a comorbidity model of pathogenesis"

Supports a comorbidity/synergistic model of WHS seizures involving LETM1 and additional genes.

Candidate Multigene Neuronal-Communication Dysfunction

Computational network analysis nominates PIGG, CPLX1, CTBP1, and LETM1 as haploinsufficient candidate genes acting through multiple cellular networks that converge on impaired neuronal communication in WHS-associated seizures. This is a candidate multigene model rather than proof that any one gene, or the four-gene set, is necessary or sufficient.

PIGG hgnc:25985 CPLX1 hgnc:2309 CTBP1 hgnc:2494 LETM1 hgnc:6556

trans-synaptic signaling GO:0099537 ↓ DECREASED

Downstream

Seizures Candidate multigene network dysfunction may disturb neuronal communication and contribute to seizure susceptibility.

Show evidence (1 reference)

PMID:35278209 SUPPORT Computational

"The proximity among the previous reported haploinsufficient candidate genes (PIGG, CPLX1, CTBP1, LETM1) and disease genes associated with epilepsy suggests not just one, but different impaired mechanisms in cellular networks responsible for the balance of neuronal activity in WHS patients, from..."

Supports a candidate multigene network converging on neuronal communication, while remaining computational rather than experimental causal evidence.

Cranial Neural Crest Cell Migration Defect

Most of the WHS-affected midline structures (Greek-warrior-helmet facies, palatal clefts, cardiac outflow tract, mandibular and auricular cartilage, dental papilla) derive from cranial neural crest cells. Multiple WHS-region genes (NSD2/WHSC1, LETM1, TACC3, FGFR3) are enriched in migratory neural crest, and their combined haploinsufficiency is proposed to perturb neural crest cell motility, epithelial-to-mesenchymal transition (via NSD2-Twist regulation) and chemotactic responses to FGF8 (via FGFR1/3). This proposed mechanism could reduce delivery and patterning of neural crest derivatives at the face, ear, jaw and conotruncal heart.

migratory neural crest cell CL:0000333 migratory cardiac neural crest cell CL:2000073

neural crest cell migration GO:0001755 ↓ DECREASED

cranial neural crest UBERON:0003099 embryonic head UBERON:0008816

Downstream

Characteristic Facial Features Defective migration of cranial neural crest into the frontonasal and maxillary processes is proposed to shape the Greek-warrior-helmet facies.

Hypertelorism Aberrant cranial-neural-crest patterning is a proposed contributor to hypertelorism.

Cleft Lip or Palate Disrupted neural crest delivery to the palatal shelves is a proposed contributor to cleft palate.

Congenital Heart Defects Reduced cardiac neural crest migration is a proposed contributor to septal and conotruncal defects.

Show evidence (2 references)

PMID:27777068 SUPPORT Other

"we propose a novel characterization for WHS as a pathophysiology owing in part to defects in neural crest cell motility and migration during development."

Review proposes defective cranial neural crest migration as a unifying mechanism for WHS midline phenotypes.

PMID:27777068 SUPPORT Other

"the formation of structures of the face and jaw, as well as certain glial cell populations in the brain, depend on neural crest cell migration"

Establishes the developmental dependence of WHS-affected craniofacial structures on cranial neural crest migration.

Candidate FGFR3-Dependent Neural-Crest Signaling Defect

FGFR3 lies just distal to the WHSC1/LETM1 critical regions in 4p16.3 and is co-deleted in many WHS deletions. Together with FGFR1, FGFR3 participates in cardiac-neural-crest chemotaxis to FGF8 in chick embryos. Its specific contribution to human WHS remains a candidate mechanism rather than an established explanation for skeletal or hearing phenotypes; the available WHS cochlear model instead directly tests Whsc1/NSD2 deficiency.

migratory cardiac neural crest cell CL:2000073

FGFR3 hgnc:3690

fibroblast growth factor receptor signaling pathway GO:0008543 ↓ DECREASED

Downstream

Congenital Heart Defects Reduced FGFR3-dependent neural-crest chemotaxis is a proposed, not yet human-validated, contributor to cardiac malformation risk.

Show evidence (1 reference)

PMID:27777068 SUPPORT Other

"FGFRs 1 and 3 have recently been implicated in the chemotactic response of cardiac neural crest cells to FGF8 in the pharyngeal ecto-and endoderm in chick embryos, operating upstream of the MAPK/ERK pathway"

Provides mechanism by which FGFR3 haploinsufficiency may compromise cardiac neural-crest chemotaxis.

Candidate MSX1-Dependent Odontogenesis Defect

Larger 4p deletions extend proximally to encompass MSX1, a homeobox transcription factor involved in odontogenesis. Heterozygous MSX1 variants cause non-syndromic tooth agenesis; applying that evidence to WHS makes MSX1 haploinsufficiency a plausible contributor to hypodontia and abnormal tooth morphology, but the WHS-specific attribution remains extrapolative.

odontoblast CL:0000060

MSX1 hgnc:7391

odontogenesis GO:0042476 ↕ DYSREGULATED

Downstream

Tooth Abnormalities MSX1 haploinsufficiency is a candidate contributor to hypodontia and abnormal dental morphology in WHS.

Show evidence (1 reference)

PMID:29628999 SUPPORT Other

"Mutation of candidate genes PAX9 and MSX1 have been identified as the main causes of hypodontia and oligodontia"

Identifies MSX1 as a primary disease gene for tooth agenesis. Evidence is extrapolated from non-syndromic tooth agenesis literature; no WHS-specific MSX1 publication is cited here.

Humoral Antibody Deficiency

A selected series of infection-prone children with WHS documented common variable immunodeficiency, IgA or IgG2 subclass deficiency, and impaired polysaccharide responsiveness with normal T-cell immunity. NSD2-dependent B-cell class switching and B1-cell development in mice provide a plausible deleted-gene mechanism, but that attribution has not been established directly in human WHS.

B cell CL:0000236

NSD2 hgnc:12766

histone H3K36 dimethyltransferase activity GO:0140954 ↓ DECREASED

Downstream

Immunodeficiency Documented antibody-production defects constitute a humoral immunodeficiency phenotype in a subset of WHS patients.

Recurrent Infections Impaired antibody quantity or vaccine-polysaccharide responsiveness increases susceptibility to recurrent infection.

Show evidence (4 references)

PMID:9672528 SUPPORT Human Clinical

"We identified antibody deficiencies in 9 of 13 infection-prone children with Wolf-Hirschhorn syndrome (4p-monosomy)."

Directly documents humoral antibody defects in a selected infection-prone WHS cohort; the selected denominator is not used as a population frequency.

PMID:9672528 SUPPORT Human Clinical

"Two of the children had common variable immunodeficiency, one had IgA and IgG2 subclass deficiency, three had IgA deficiency, and three had impaired polysaccharide responsiveness."

Defines the spectrum of antibody defects observed in that cohort.

PMID:32862441 SUPPORT Model Organism

"NSD2 is required for B cell class switch recombination"

NSD2 is required for normal B-cell class switching, providing a mechanism for WHS-associated humoral immunodeficiency.

+ 1 more reference

⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.

●

Phenotypes

23

Cardiovascular 1

Congenital Heart Defects FREQUENT Abnormal heart morphology HP:0001627

Congenital heart defects occur in a substantial proportion of patients.

Show evidence (3 references)

PMID:29199884 SUPPORT Human Clinical

"Wolf-Hirschhorn syndrome is a rare genetic syndrome caused by a heterozygous deletion on chromosome 4p16.3 and is characterized by a "Greek warrior helmet" facies, hypotonia, developmental delay, seizures, structural central nervous system defects, intrauterine growth restriction, sketelal..."

This identifies cardiac defects as one of the characteristic features of Wolf-Hirschhorn syndrome.

PMID:33599186 SUPPORT Human Clinical

"The infant had multiple congenital anomalies; a cleft palate, microcephalia, micrognathia, renal pelvicalyceal ectasia, atrial septal defect, transvers arcus hypoplasia, patent ductus arteriosus, hypospadias and undescended testicle."

This case report documents specific cardiac defects (atrial septal defect, patent ductus arteriosus) in Wolf-Hirschhorn syndrome.

PMID:18932224 SUPPORT Human Clinical

"60% had skeletal anomalies; 50% had heart lesions; 50% had abnormal tooth development"

Quantitatively supports the frequent congenital-heart-defect annotation.

Digestive 2

Hepatic Neoplasia Neoplasm of the liver HP:0002896

Hepatocellular neoplasia has been proposed as a rare WHS manifestation from seven cumulative reported cases. No population frequency or causal deleted gene has been established.

Show evidence (1 reference)

PMID:30289612 SUPPORT Human Clinical

"We propose that, in the context of the rarity of WHS, these seven cases suggest that hepatocellular neoplasia may be a feature of WHS."

Supports a proposed association while avoiding a frequency assignment from a small cumulative case series.

Feeding Difficulties HP:0011968

Feeding difficulties are highly variable and may require special feeding techniques, gavage feeding, or gastrostomy, while contributing to postnatal growth failure. No quantitative frequency is assigned from the available evidence.

Show evidence (1 reference)

PMID:26747863 SUPPORT Human Clinical

"additional highly variable clinical features of WHS include, but are not limited to, feeding difficulties, congenital heart defects, hearing loss, skeletal anomalies, kidney and urinary tract malformations, and ophthalmological and dental abnormalities."

WHS clinical-genetic literature lists feeding difficulties among the recurrent variable features.

Ear 2

Hearing Loss FREQUENT Hearing impairment HP:0000365

Hearing loss affects about 40% or more of reported cohorts and is predominantly conductive, although a sensorineural component is also recognized.

Show evidence (2 references)

PMID:18932224 SUPPORT Human Clinical

"50% had abnormal tooth development; and 40% had hearing loss."

Quantitatively supports the frequent hearing-loss annotation.

PMID:20301362 SUPPORT Human Clinical

"hearing loss (mostly conductive) (>40%)"

Supports both the frequency range and predominant conductive type.

Sensorineural Hearing Loss OCCASIONAL Sensorineural hearing impairment HP:0000407

Sensorineural hearing loss is reported in approximately 15% of individuals with WHS. Whsc1-deficient mice provide a candidate cochlear hair-cell mechanism; the model does not establish that all human sensorineural loss has this cause.

Show evidence (1 reference)

PMID:26092122 SUPPORT Other

"The cardinal feature of WHS is a craniofacial dysmorphism, which is accompanied by sensorineural hearing loss in 15% of individuals with WHS."

Quantitatively supports the occasional sensorineural-hearing-loss annotation; model findings are curated separately.

Eye 1

Hypertelorism HP:0000316

Widely spaced eyes are a characteristic feature contributing to the distinctive facial appearance.

Show evidence (2 references)

PMID:9774859 SUPPORT Human Clinical

"At the autopsy, the propositus showed microcephaly, prominent glabella, broad bridge of the nose, ocular hypertelorism, poorly differentiated and low-set ears, bilateral palatoschisis, and micrognathia."

This case report confirms ocular hypertelorism as a characteristic craniofacial feature of Wolf-Hirschhorn syndrome.

PMID:29199884 SUPPORT Human Clinical

"Ocular findings included normal intraocular pressures and corneal diameters, large-angle exotropia, downward slanting of the palpebral fissures, absent eyelid creases, upper and lower eyelid retraction with shortage of the anterior eyelid lamellae, euryblepharon, lagophthalmos with poor Bell's..."

This documents hypertelorism as one of the ocular findings in Wolf-Hirschhorn syndrome.

Genitourinary 1

Renal Anomalies OCCASIONAL Abnormality of the kidney HP:0000077

Renal/urological anomalies including renal hypoplasia and oligomeganephronia occur in a minority of WHS patients and warrant routine renal surveillance. The archival GeneReviews summary reports urinary-tract malformations in 25%.

Show evidence (4 references)

PMID:34572183 SUPPORT Human Clinical

"In some cases, we observed seizures, structural brain abnormalities, immunodeficiencies, and renal anomalies."

This study identifies renal anomalies as a manifestation in some cases of Wolf-Hirschhorn syndrome.

PMID:41225980 SUPPORT Human Clinical

"It is characterized by intrauterine growth restriction (IUGR), developmental delay, epilepsy, distinctive facial features, and urinary tract anomalies, particularly renal hypoplasia."

This identifies renal hypoplasia as a characteristic urinary tract anomaly in Wolf-Hirschhorn syndrome.

PMID:29199884 SUPPORT Human Clinical

"Systemic findings included "Greek warrior helmet" facies, hypotonia, cleft palate, neonatal tooth eruption, talipes equinovarus, bilateral clinodactyly, clitoromegaly, partial agenesis of the corpus callosum, bilateral renal hypoplasia, and two atrial septal defects."

This case report documents bilateral renal hypoplasia as a systemic finding in Wolf-Hirschhorn syndrome.

+ 1 more reference

Head and Neck 4

Characteristic Facial Features Abnormal facial shape HP:0001999

The distinctive facies includes broad nasal bridge continuing to the forehead (Greek warrior helmet appearance), microcephaly, high forehead with prominent glabella, hypertelorism, and micrognathia.

Show evidence (2 references)

PMID:25137600 SUPPORT Human Clinical

"The major features of this disorder include a characteristic facial appearance known as the "Greek helmet," delayed growth and development; prenatally and postnatally, intellectual disabilities, and seizures."

This establishes the characteristic Greek helmet facial appearance as a major diagnostic feature.

PMID:32914558 SUPPORT Human Clinical

"Its core features are typical facial gestalt, growth retardation, intellectual disability, or developmental delay and seizures."

This identifies the typical facial gestalt as one of the core features of Wolf-Hirschhorn syndrome.

Microcephaly HP:0000252

Microcephaly is characteristic but not universal and can be absent in some individuals with smaller or cryptic unbalanced rearrangements.

Show evidence (1 reference)

PMID:18474167 SUPPORT Human Clinical

"It was characterized by well-described facial appearance, seizures, microcephaly and midline closure defects along with growth and mental retardation."

This establishes microcephaly as a characteristic feature of Wolf-Hirschhorn syndrome.

Cleft Lip or Palate Cleft palate HP:0000175

Cleft lip/palate may occur in some cases.

Show evidence (1 reference)

PMID:33599186 SUPPORT Human Clinical

"The infant had multiple congenital anomalies; a cleft palate, microcephalia, micrognathia, renal pelvicalyceal ectasia, atrial septal defect, transvers arcus hypoplasia, patent ductus arteriosus, hypospadias and undescended testicle."

This case report documents cleft palate as one of the congenital anomalies in Wolf-Hirschhorn syndrome.

Tooth Abnormalities FREQUENT Abnormality of the dentition HP:0000164

Dental abnormalities including hypodontia, abnormal tooth morphology, delayed eruption and neonatal teeth are recurrent in WHS, consistent with co-deletion of MSX1 in larger 4p deletions and broader cranial neural-crest dysfunction.

Show evidence (3 references)

PMID:29199884 SUPPORT Human Clinical

"Wolf-Hirschhorn syndrome is a rare genetic syndrome caused by a heterozygous deletion on chromosome 4p16.3 and is characterized by a "Greek warrior helmet" facies, hypotonia, developmental delay, seizures, structural central nervous system defects, intrauterine growth restriction, sketelal..."

Lists abnormal tooth development among the characteristic WHS features.

PMID:29199884 SUPPORT Human Clinical

"Systemic findings included "Greek warrior helmet" facies, hypotonia, cleft palate, neonatal tooth eruption, talipes equinovarus, bilateral clinodactyly, clitoromegaly, partial agenesis of the corpus callosum, bilateral renal hypoplasia, and two atrial septal defects."

Documents neonatal tooth eruption as a specific dental abnormality observed in WHS.

PMID:18932224 SUPPORT Human Clinical

"50% had abnormal tooth development"

Quantitatively supports the frequent dental-abnormality annotation.

Immune 2

Immunodeficiency HP:0002721

Humoral immune defects include common variable immunodeficiency, IgA or IgG2 subclass deficiency, and impaired polysaccharide responsiveness. The available 9/13 proportion comes from a selected infection-prone cohort and is not treated as a population frequency.

Show evidence (2 references)

PMID:34572183 SUPPORT Human Clinical

"In some cases, we observed seizures, structural brain abnormalities, immunodeficiencies, and renal anomalies."

This study identifies immunodeficiencies as a rare manifestation that should be looked for in Wolf-Hirschhorn syndrome.

PMID:9672528 SUPPORT Human Clinical

"We identified antibody deficiencies in 9 of 13 infection-prone children with Wolf-Hirschhorn syndrome (4p-monosomy)."

Establishes antibody deficiency in a clinically selected WHS subgroup without supporting a syndrome-wide frequency estimate.

Recurrent Infections HP:0002719

Recurrent or clinically important infections should prompt evaluation for humoral antibody deficiency; published immune testing focused specifically on infection-prone children.

Show evidence (1 reference)

PMID:9672528 SUPPORT Human Clinical

"We identified antibody deficiencies in 9 of 13 infection-prone children with Wolf-Hirschhorn syndrome (4p-monosomy)."

The infection-prone ascertainment documents the clinically relevant infection phenotype while precluding a population frequency estimate.

Musculoskeletal 2

Hypotonia VERY_FREQUENT HP:0001252

Hypotonia with muscle underdevelopment is a characteristic feature.

Show evidence (2 references)

PMID:29199884 SUPPORT Human Clinical

"Wolf-Hirschhorn syndrome is a rare genetic syndrome caused by a heterozygous deletion on chromosome 4p16.3 and is characterized by a "Greek warrior helmet" facies, hypotonia, developmental delay, seizures, structural central nervous system defects, intrauterine growth restriction, sketelal..."

This establishes hypotonia as one of the characteristic features of Wolf-Hirschhorn syndrome.

PMID:18932224 SUPPORT Human Clinical

"Hypotonia was present in virtually all patients."

Quantitatively supports the very-frequent hypotonia annotation.

Skeletal Anomalies FREQUENT Abnormality of the skeletal system HP:0000924

Skeletal anomalies may include kyphosis, scoliosis, vertebral malformations, and limb abnormalities.

Show evidence (3 references)

PMID:29199884 SUPPORT Human Clinical

"Wolf-Hirschhorn syndrome is a rare genetic syndrome caused by a heterozygous deletion on chromosome 4p16.3 and is characterized by a "Greek warrior helmet" facies, hypotonia, developmental delay, seizures, structural central nervous system defects, intrauterine growth restriction, sketelal..."

This identifies skeletal anomalies as one of the characteristic features of Wolf-Hirschhorn syndrome.

PMID:9774859 SUPPORT Human Clinical

"Midline closure defects of the cervical spine bodies, lower jaw, and skull base were seen at postmortem radiography."

This case report documents specific skeletal abnormalities including cervical spine defects in Wolf-Hirschhorn syndrome.

PMID:18932224 SUPPORT Human Clinical

"slow weight gain; 60% had skeletal anomalies; 50% had heart lesions"

Quantitatively supports the frequent skeletal-anomaly annotation.

Nervous System 4

Intellectual Disability VERY_FREQUENT HP:0001249

Intellectual disability is moderate to severe in most cases, rarely mild.

Show evidence (4 references)

PMID:32914558 SUPPORT Human Clinical

"Its core features are typical facial gestalt, growth retardation, intellectual disability, or developmental delay and seizures."

This identifies intellectual disability as one of the core features of Wolf-Hirschhorn syndrome.

PMID:25137600 SUPPORT Human Clinical

"The major features of this disorder include a characteristic facial appearance known as the "Greek helmet," delayed growth and development; prenatally and postnatally, intellectual disabilities, and seizures."

This establishes intellectual disabilities as a major feature of the disorder.

PMID:18474167 SUPPORT Human Clinical

"It was characterized by well-described facial appearance, seizures, microcephaly and midline closure defects along with growth and mental retardation."

This confirms mental retardation (intellectual disability) as a characteristic feature.

+ 1 more reference

Global Developmental Delay VERY_FREQUENT HP:0001263

Global developmental delay is present in nearly all affected individuals, with severity varying across motor, speech, and adaptive domains.

Show evidence (3 references)

PMID:29199884 SUPPORT Human Clinical

"Wolf-Hirschhorn syndrome is a rare genetic syndrome caused by a heterozygous deletion on chromosome 4p16.3 and is characterized by a "Greek warrior helmet" facies, hypotonia, developmental delay, seizures, structural central nervous system defects, intrauterine growth restriction, sketelal..."

This identifies developmental delay as one of the characteristic features of Wolf-Hirschhorn syndrome.

PMID:40404199 SUPPORT Human Clinical

"Wolf-Hirschhorn syndrome (WHS) is associated with intellectual disability and multiple congenital anomalies."

This confirms the association of Wolf-Hirschhorn syndrome with intellectual disability and developmental impairment.

PMID:18932224 SUPPORT Human Clinical

"Global developmental delay of varying degrees was present in all patients."

Directly supports the very-frequent global-developmental-delay annotation.

Seizures VERY_FREQUENT HP:0001250

Seizures are a very frequent feature, occurring in the majority of patients with Wolf-Hirschhorn syndrome.

Show evidence (4 references)

PMID:32914558 SUPPORT Human Clinical

"Its core features are typical facial gestalt, growth retardation, intellectual disability, or developmental delay and seizures."

This identifies seizures as one of the core features of Wolf-Hirschhorn syndrome.

PMID:25137600 SUPPORT Human Clinical

"The major features of this disorder include a characteristic facial appearance known as the "Greek helmet," delayed growth and development; prenatally and postnatally, intellectual disabilities, and seizures."

This establishes seizures as a major feature of the disorder.

PMID:18474167 SUPPORT Human Clinical

"It was characterized by well-described facial appearance, seizures, microcephaly and midline closure defects along with growth and mental retardation."

This confirms seizures as a characteristic feature of Wolf-Hirschhorn syndrome.

+ 1 more reference

Corpus Callosum Abnormalities Abnormal corpus callosum morphology HP:0001273

Structural central nervous system defects including corpus callosum abnormalities may occur.

Show evidence (2 references)

PMID:29199884 SUPPORT Human Clinical

"Systemic findings included "Greek warrior helmet" facies, hypotonia, cleft palate, neonatal tooth eruption, talipes equinovarus, bilateral clinodactyly, clitoromegaly, partial agenesis of the corpus callosum, bilateral renal hypoplasia, and two atrial septal defects."

This case report documents partial agenesis of the corpus callosum as a structural CNS abnormality in Wolf-Hirschhorn syndrome.

PMID:34572183 SUPPORT Human Clinical

"In some cases, we observed seizures, structural brain abnormalities, immunodeficiencies, and renal anomalies."

This study identifies structural brain abnormalities as a manifestation in some cases of Wolf-Hirschhorn syndrome.

Growth 2

Intrauterine Growth Retardation VERY_FREQUENT HP:0001511

Marked intrauterine growth retardation is a consistent prenatal finding in Wolf-Hirschhorn syndrome.

Show evidence (2 references)

PMID:25137600 SUPPORT Human Clinical

"The major features of this disorder include a characteristic facial appearance known as the "Greek helmet," delayed growth and development; prenatally and postnatally, intellectual disabilities, and seizures."

This describes delayed growth and development both prenatally and postnatally as major features.

PMID:20301362 SUPPORT Human Clinical

"All affected individuals have prenatal-onset growth deficiency followed by postnatal growth retardation and hypotonia with muscle underdevelopment."

Supports the very-frequent prenatal growth-deficiency annotation.

Postnatal Growth Retardation VERY_FREQUENT HP:0008897

Slow postnatal weight gain and continued growth impairment are characteristic.

Show evidence (2 references)

PMID:30289612 SUPPORT Human Clinical

"Wolf-Hirschhorn syndrome (WHS) is a rare contiguous gene deletion disorder characterized by distinctive craniofacial features, prenatal/postnatal growth deficiency, intellectual disability, and seizures."

This establishes prenatal/postnatal growth deficiency as a characteristic feature of Wolf-Hirschhorn syndrome.

PMID:20301362 SUPPORT Human Clinical

"All affected individuals have prenatal-onset growth deficiency followed by postnatal growth retardation and hypotonia with muscle underdevelopment."

Supports the very-frequent postnatal growth-retardation annotation.

Other 2

Ophthalmologic Abnormalities Abnormality of the eye HP:0000478

Ocular manifestations are heterogeneous and may include strabismus, eyelid abnormalities, anterior-segment anomalies, exposure keratopathy, and optic-disc anomalies. The reported "up to 40%" figure is an upper bound, not a representative prevalence estimate, so no frequency band is assigned.

Show evidence (2 references)

PMID:29199884 SUPPORT Human Clinical

"A variety of ocular manifestations may occur in up to 40% of patients."

Documents a reported upper bound for ocular manifestations but does not establish a representative frequency band.

PMID:29199884 SUPPORT Human Clinical

"Ocular findings included normal intraocular pressures and corneal diameters, large-angle exotropia, downward slanting of the palpebral fissures, absent eyelid creases, upper and lower eyelid retraction with shortage of the anterior eyelid lamellae, euryblepharon, lagophthalmos with poor Bell's..."

Documents the heterogeneous ocular phenotype in an affected individual.

Status Epilepticus FREQUENT HP:0002133

Status epilepticus is a frequent and clinically significant complication of WHS-associated epilepsy, occurring in roughly 58% of patients in pediatric cohorts and contributing to neurological morbidity.

Show evidence (1 reference)

PMID:41303083 SUPPORT Human Clinical

"Status epilepticus occurred in 58% of cases, with a high proportion requiring multiple ASMs."

Pediatric WHS cohort directly quantifies status epilepticus prevalence at 58%.

🧬

Genetic Associations

8

Chromosome 4p16.3 Deletion (Causal)

Show evidence (4 references)

PMID:32914558 SUPPORT Human Clinical

"Less than half of the patients can be identified by conventional cytogenetics and molecular cytogenetic testing should be offered for diagnosis. Karyotyping of the parents should always be offered in a child with WHS."

This provides important diagnostic guidance regarding the need for molecular cytogenetic testing and parental karyotyping.

PMID:11584045 SUPPORT Human Clinical

"Cases with large de novo deletions (proximal to and including p15.2) were more likely to have died than those with smaller deletions (odds ratio=5.7, 95% CI=1.7-19.9) after adjusting for age."

Larger 4p deletions carry a 5.7-fold increased mortality, consistent with the contiguous-gene-deletion model where more haploinsufficient genes drive worse outcomes.

PMID:41303083 SUPPORT Human Clinical

"Patients with more severe epilepsy tended to have larger deletions (>9 Mb) and poorer developmental outcomes."

Records a cohort-level association between deletions above 9 Mb, epilepsy severity, and developmental outcome without treating the threshold as deterministically predictive for an individual.

+ 1 more reference

NSD2 (WHSC1) Haploinsufficiency (Contributory)

Gene: NSD2 hgnc:12766 relationship_type: SUSCEPTIBILITY

Show evidence (1 reference)

PMID:25942451 SUPPORT Other

"NSD2 haploinsufficiency causes Wolf-Hirschhorn syndrome"

Cancer-biology review shorthand linking NSD2 haploinsufficiency to WHS; the evidence supports this contributory genetic entry but not single-gene sufficiency for the full syndrome.

LETM1 Haploinsufficiency (Contributory)

Gene: LETM1 hgnc:6556 relationship_type: SUSCEPTIBILITY

Show evidence (1 reference)

PMID:24738919 SUPPORT Human Clinical

"LETM1, encoding a mitochondrial protein playing a role in K(+) /H(+) exchange and in Ca(2+) homeostasis, is currently considered the major candidate gene."

Establishes LETM1 as the historical major candidate seizure gene.

PIGG Haploinsufficiency (Candidate contributor)

Gene: PIGG hgnc:25985 relationship_type: SUSCEPTIBILITY

Show evidence (1 reference)

PMID:26747863 SUPPORT Human Clinical

"We identify a small terminal region of chromosome 4p that represents a seizure susceptibility region. Deletion of this region in the context of WHS is sufficient for seizure occurrence."

Supports the candidate interval containing PIGG but does not isolate PIGG from ZNF721 or other co-deleted genes.

CPLX1 Haploinsufficiency (Candidate contributor)

Gene: CPLX1 hgnc:2309 relationship_type: SUSCEPTIBILITY

Show evidence (1 reference)

PMID:35278209 SUPPORT Computational

"The proximity among the previous reported haploinsufficient candidate genes (PIGG, CPLX1, CTBP1, LETM1) and disease genes associated with epilepsy suggests not just one, but different impaired mechanisms in cellular networks responsible for the balance of neuronal activity in WHS patients, from..."

Network analysis groups CPLX1 with PIGG/CTBP1/LETM1 as a synergistic seizure-susceptibility module.

CTBP1 Haploinsufficiency (Candidate contributor)

Gene: CTBP1 hgnc:2494 relationship_type: SUSCEPTIBILITY

Show evidence (1 reference)

PMID:35278209 SUPPORT Computational

"CTBP1 obtained the largest number of drug associations, reinforcing its importance for adaptations of brain circuits and its putative use as a pharmacological target for treating seizures/epilepsy in patients with WHS."

Identifies CTBP1 as a candidate drug-targetable haploinsufficient gene in WHS.

FGFR3 Haploinsufficiency (Candidate contributor)

Gene: FGFR3 hgnc:3690 relationship_type: SUSCEPTIBILITY

Show evidence (1 reference)

PMID:27777068 SUPPORT Other

"FGFRs 1 and 3 have recently been implicated in the chemotactic response of cardiac neural crest cells to FGF8 in the pharyngeal ecto-and endoderm in chick embryos, operating upstream of the MAPK/ERK pathway"

FGFR3 haploinsufficiency may compromise cardiac neural-crest chemotaxis upstream of MAPK/ERK.

MSX1 Haploinsufficiency (Candidate contributor)

Gene: MSX1 hgnc:7391 relationship_type: SUSCEPTIBILITY

Show evidence (1 reference)

PMID:29628999 SUPPORT Other

"Mutation of candidate genes PAX9 and MSX1 have been identified as the main causes of hypodontia and oligodontia"

Identifies MSX1 as a primary tooth-agenesis disease gene; mechanistic role in WHS dental phenotypes is extrapolated from this non-syndromic literature.

💊

Medical Actions

9

Seizure Management with Levetiracetam

Category: Therapeutic Action: Pharmacotherapy NCIT:C15986

Agent: levetiracetam CHEBI:6437

Platform: Small molecule

Levetiracetam is commonly used for WHS-associated epilepsy and was rated the most effective antiseizure medication in one retrospective study.

Target Phenotypes: Seizure HP:0001250

Show evidence (2 references)

PMID:37075791 SUPPORT Human Clinical

"The most effective ASM was levetiracetam. Although WHS-associated epilepsy is intractable with frequent SE occurrence during infancy, improvement in seizure control is expected with age. Levetiracetam may be a novel ASM for WHS."

This study found levetiracetam to be the most effective antiseizure medication for Wolf-Hirschhorn syndrome.

PMID:41303083 SUPPORT Human Clinical

"Valproic acid and levetiracetam were the most commonly used treatments."

This cohort study confirms that levetiracetam is one of the most commonly used antiseizure medications for WHS.

Seizure Management with Valproic Acid

Category: Therapeutic Action: Pharmacotherapy NCIT:C15986

Agent: valproic acid CHEBI:39867

Platform: Small molecule

Valproic acid is commonly used for WHS-associated epilepsy and the archival GeneReviews chapter specifically recommends it for atypical absence seizures. Carbamazepine may worsen atypical absence seizures and should be avoided for that seizure type.

Target Phenotypes: Seizure HP:0001250

Show evidence (3 references)

PMID:41303083 SUPPORT Human Clinical

"Valproic acid and levetiracetam were the most commonly used treatments."

This large cohort study indicates valproic acid is one of the most frequently prescribed antiseizure medications for WHS.

PMID:20301362 SUPPORT Human Clinical

"valproic acid for atypical absence seizures; benzodiazepines for status epilepticus"

Supplies the archival seizure-type-specific valproate recommendation and is retained only with the chapter's retirement caveat.

PMID:20301362 SUPPORT Human Clinical

"Agents/circumstances to avoid: Carbamazepine may worsen atypical absence seizures."

Records the seizure-type-specific medication-safety warning.

Growth Hormone Therapy

Category: Therapeutic Action: Pharmacotherapy NCIT:C15986

Recombinant human growth hormone may be considered only for an individual with documented growth hormone deficiency. The available WHS evidence is a single long-term case and does not support routine use for syndrome-related growth failure alone.

Target Phenotypes: Postnatal growth retardation HP:0008897

Show evidence (1 reference)

PMID:41017003 SUPPORT Human Clinical

"Across 11 years of rhGH, height improved from ~ - 4.2 to ~ - 1.3 SDS with normalized height velocity and a prolonged but uneventful pubertal course. No major adverse effects were observed. Muscle tone improvement was also noted with treatment initiation."

Single-case evidence supports a possible response in the specific context of confirmed growth hormone deficiency, not a general WHS indication.

Benzodiazepines for Status Epilepticus

Category: Therapeutic Action: Pharmacotherapy NCIT:C15986

Platform: Small molecule

Acute status epilepticus requires prompt protocol-based treatment; the archival GeneReviews chapter specifically lists benzodiazepines for status epilepticus in WHS.

Target Phenotypes: Status epilepticus HP:0002133

Show evidence (1 reference)

PMID:20301362 SUPPORT Human Clinical

"valproic acid for atypical absence seizures; benzodiazepines for status epilepticus"

Directly supports benzodiazepine use for this acute complication.

Multidisciplinary Rehabilitation Therapy

Category: Therapeutic Action: physical therapy Ontology label: Physical Therapy NCIT:C15302

Platform: Behavioral / lifestyle

Multidisciplinary rehabilitation including physical therapy, speech and communication therapy, sign language, and occupational therapy is the standard of care to address the developmental delay, hypotonia, and motor/communication impairments seen in WHS.

Target Phenotypes: Global developmental delay HP:0001263 Hypotonia HP:0001252

Show evidence (1 reference)

PMID:20301362 SUPPORT Human Clinical

"Treatment includes: rehabilitation, speech/communication therapy and sign language"

GeneReviews lists rehabilitation and speech/communication therapy as core management for WHS.

Feeding Support

Category: Therapeutic Action: dietary intervention Ontology label: Dietary Intervention NCIT:C15447

Platform: Behavioral / lifestyle

Special feeding techniques, gavage feeding, and gastrostomy placement are recommended for the feeding difficulties common in WHS, which contribute to postnatal growth deficiency.

Target Phenotypes: Feeding difficulties HP:0011968

Show evidence (1 reference)

PMID:20301362 SUPPORT Human Clinical

"special feeding techniques, gavage feeding, and/or gastrostomy for feeding difficulties"

GeneReviews recommends graduated feeding support for the WHS feeding-difficulty phenotype.

Genetic Counseling

Category: Counseling / Informational Action: Genetic Counseling NCIT:C15240

Genetic counseling incorporates the proband's deletion mechanism and parental chromosome findings. A confirmed parental balanced rearrangement changes recurrence risk and enables targeted prenatal testing.

Show evidence (1 reference)

PMID:20301362 SUPPORT Human Clinical

"Risks to family members depend on the mechanism of origin of the deletion. Prenatal testing is possible for families in which one parent is known to be a carrier of a chromosome rearrangement involving 4p16.3."

GeneReviews establishes the indication for genetic counseling and prenatal testing in WHS families.

Immunoglobulin Replacement for Documented Antibody Deficiency

Category: Therapeutic Action: intravenous immunoglobulin therapy Ontology label: Immunoglobulin Therapy NCIT:C62710

IVIG may be used for selected individuals with documented antibody deficiency and clinically important infections; continuous antibiotic prophylaxis is another option described in the archival management summary. This is not universal treatment for all individuals with WHS.

Target Phenotypes: Immunodeficiency HP:0002721 Recurrent infections HP:0002719

Show evidence (1 reference)

PMID:20301362 SUPPORT Human Clinical

"IVIG infusions or continuous antibiotics for those with antibody deficiencies."

Bounds immune-directed management to patients with documented antibody deficiency.

Multisystem Surveillance

Category: Monitoring Action: Supportive Care NCIT:C15747

Longitudinal follow-up should monitor developmental therapies and known complications. The archival GeneReviews summary specifies annual complete blood count and renal-function testing and consideration of routine liver ultrasonography, with standard specialty care for skeletal, ophthalmologic, cardiac, hearing, sleep, and hepatic manifestations. Because the chapter is retired, schedules should be individualized with current specialist input.

Show evidence (2 references)

PMID:20301362 SUPPORT Human Clinical

"Surveillance: Systematic follow up to monitor rehabilitation and treatment as needed; annual complete blood count and renal function testing; consideration of routine liver ultrasounds."

Provides the explicit historical surveillance schedule, retained with a retirement caveat.

PMID:20301362 SUPPORT Human Clinical

"Standard care is recommended for skeletal anomalies, ophthalmologic abnormalities, congenital heart defects, hearing loss, sleep disturbance, and hepatic adenomas."

Supports coordinated specialty follow-up across recurrent WHS complications.

🔬

Diagnosis

2

Chromosomal microarray confirmation and deletion definition

Chromosomal microarray is used to establish the distal 4p deletion, define its breakpoints and gene content, and detect additional copy-number changes from an unbalanced translocation. A heterozygous deletion including the WHS critical region establishes the molecular diagnosis in the appropriate clinical setting.

chromosomal microarray analysis NCIT:C18477

Results: Heterozygous distal 4p16.3 deletion including the WHS critical region.

Show evidence (2 references)

PMID:20301362 SUPPORT Human Clinical

"The diagnosis of WHS is established by the finding of a heterozygous deletion of the Wolf-Hirschhorn syndrome critical region (WHSCR) on chromosome 4p16.3 by chromosomal microarray (CMA), conventional G-banded cytogenetic analysis, or fluorescence in situ hybridization (FISH)."

Defines the diagnostic lesion and accepted cytogenetic methods.

PMID:18932224 SUPPORT Human Clinical

"Array-CGH analysis at 1 Mb resolution was performed in 34/87 patients, and, in 15/34 (44%), showed an unbalanced translocation leading to both a 4p monosomy and a partial trisomy for another chromosome arm."

Shows why genome-wide copy-number definition matters beyond a targeted deletion call.

Karyotype and targeted FISH assessment

Conventional karyotyping can identify larger 4p deletions, rings, and translocations, while targeted FISH can confirm a suspected deletion not visible by routine chromosome analysis. Once WHS is diagnosed, parental karyotyping is important to determine whether a balanced rearrangement changes recurrence risk.

karyotyping NCIT:C16768

Results: Defines visible structural rearrangements and parental balanced-rearrangement status.

Show evidence (2 references)

PMID:18932224 SUPPORT Human Clinical

"Deletion was detected by standard cytogenetics in 44/87 (50.5%) patients, whereas FISH was necessary in the other 43 (49.5%)."

Documents complementary diagnostic yield of standard cytogenetics and targeted FISH in the cohort.

PMID:32914558 SUPPORT Human Clinical

"Karyotyping of the parents should always be offered in a child with WHS."

Supports parental chromosome analysis for recurrence-risk assessment.

📈

Progression

4

Onset

Age: Antenatal-Neonatal

Prenatal growth deficiency is a defining early manifestation.

Show evidence (1 reference)

PMID:20301362 SUPPORT Human Clinical

"All affected individuals have prenatal-onset growth deficiency followed by postnatal growth retardation and hypotonia with muscle underdevelopment."

Establishes prenatal onset and persistence after birth.

Infantile epilepsy

Age: First year of life

Epilepsy usually begins before 12 months; status epilepticus is a major infantile complication.

Show evidence (1 reference)

PMID:41303083 SUPPORT Human Clinical

"Epilepsy was observed in 92% of patients, typically beginning before 12 months of age."

Quantifies the epilepsy burden and typical first-year onset.

Childhood and later course

Age: Childhood-Adulthood

Developmental gains and improved seizure control may occur over time, but multisystem disability persists and outcome varies with deletion size and complications.

Show evidence (2 references)

PMID:18932224 SUPPORT Human Clinical

"A global improvement was observed in all individuals, over time."

Longitudinal cohort documents developmental improvement rather than uniform regression.

PMID:41303083 SUPPORT Human Clinical

"ASM discontinuation was significantly associated with older age at evaluation, supporting improved seizure control over time."

Supports age-related improvement in seizure control for some patients.

Early mortality risk

Age: Infancy-Early childhood

Mortality is concentrated in early life but is lower than historically reported; larger de novo deletions carry higher overall mortality risk.

Show evidence (2 references)

PMID:11584045 SUPPORT Human Clinical

"The crude infant mortality rate was 17% (23/132) and in the first two years of life the mortality rate was 21% (28/132)."

Quantifies early mortality in the UK epidemiologic cohort.

PMID:11584045 SUPPORT Human Clinical

"The mortality rate is lower than previously reported. There is a statistically significant relationship between deletion size and overall risk of death in de novo deletion cases."

Directly supports the comparison with historical mortality estimates and the deletion-size association stated in this progression phase.

📊

Prevalence

1

Global

Birth Prevalence 2.0–5.0 per 100,000 1–9 per 100,000 (births)

Show evidence (1 reference)

PMID:18932224 SUPPORT Human Clinical

"Its frequency is estimated as 1/50,000-1/20,000 births, with a female predilection of 2:1."

Directly supports the curated range of 2-5 affected births per 100,000.

🔀

Differential Diagnoses

2

Conditions with similar clinical presentations that must be differentiated from Wolf-Hirschhorn_Syndrome:

Cri-du-chat syndrome MONDO:0007404

Overlapping Features Cri-du-chat syndrome is another terminal autosomal deletion disorder with prenatal or postnatal growth impairment, microcephaly, craniofacial dysmorphism, developmental delay, and possible cardiac, neurologic, and renal malformations. Cytogenetic testing distinguishes its 5p deletion from the distal 4p deletion of WHS.

Distinguishing Features

A high-pitched monochromatic cat-like cry and a chromosome 5p deletion favor Cri-du-chat syndrome.
A Greek-warrior-helmet facial gestalt with a distal 4p16.3 deletion favors Wolf-Hirschhorn syndrome.

Show evidence (2 references)

PMID:16953888 SUPPORT Human Clinical

"The Cri du Chat syndrome (CdCS) is a genetic disease resulting from a deletion of variable size occurring on the short arm of chromosome 5 (5p-)."

Establishes the alternative chromosomal lesion.

PMID:16953888 SUPPORT Human Clinical

"The main clinical features are a high-pitched monochromatic cry, microcephaly, broad nasal bridge, epicanthal folds, micrognathia, abnormal dermatoglyphics, and severe psychomotor and mental retardation."

Documents the overlapping phenotype and the characteristic cry that helps distinguish Cri-du-chat syndrome.

Dravet syndrome MONDO:0100135

Overlapping Features WHS epilepsy can resemble Dravet syndrome through infantile onset, fever-associated prolonged clonic or tonic-clonic seizures, atypical absences, and later developmental impairment. Children with subtle WHS dysmorphism may initially undergo SCN1A testing. Chromosomal microarray showing distal 4p deletion favors WHS, whereas a pathogenic SCN1A variant without the WHS deletion supports Dravet syndrome.

Distinguishing Features

The characteristic WHS facial gestalt, congenital anomalies, and distal 4p deletion favor Wolf-Hirschhorn syndrome.
A pathogenic SCN1A variant in the appropriate electroclinical setting favors Dravet syndrome.

Show evidence (2 references)

PMID:26747863 SUPPORT Human Clinical

"Individuals with WHS display a distinctive electroclinical pattern resembling the severe myoclonic epilepsy of infancy or Dravet syndrome."

Directly establishes the electroclinical overlap.

PMID:26747863 SUPPORT Human Clinical

"some patients with a milder presentation of WHS-related dysmorphologies are sometimes first suspected of having Dravet syndrome"

Documents the real-world diagnostic confusion in mildly dysmorphic WHS.

🐁

Animal Models

4

Whsc1/Nsd2 deficiency, including haploinsufficient and deficient mouse embryos Mus musculus

Whsc1-deficient mice model one deleted gene rather than the full human 4p contiguous deletion. They show growth retardation and WHS-like midline and cardiovascular defects, with genetic interaction between Whsc1 and Nkx2-5. A complementary cochlear study found disorganized hair cells and abnormal stereocilia bundles, supporting an NSD2-dependent sensorineural-hearing mechanism. The single-gene model cannot assign the remaining human deletion phenotypes.

Species

Mus musculus

Genotype

Whsc1/Nsd2 deficiency, including haploinsufficient and deficient mouse embryos

Genes

NSD2 hgnc:12766

Show evidence (3 references)

PMID:19483677 SUPPORT Model Organism

"Whsc1-deficient mice showed growth retardation and various WHS-like midline defects, including congenital cardiovascular anomalies."

Documents WHS-relevant growth, midline, and cardiac phenotypes in the mouse model.

PMID:19483677 SUPPORT Model Organism

"The effects of Whsc1 haploinsufficiency were increased in Nkx2-5 heterozygous mutant hearts, indicating their functional link."

Supports a Whsc1-Nkx2-5 developmental interaction in the cardiac phenotype.

PMID:26092122 SUPPORT Model Organism

"Although auditory hair cells are specified normally, their stereocilia hair bundles required for sound perception fail to develop the appropriate morphology."

Documents the cochlear hair-bundle phenotype in Whsc1-deficient mice.

Heterozygous Letm1 loss (Letm1±) Mus musculus

Heterozygous Letm1 mice show increased susceptibility to chemically induced seizures. This single-gene, provoked-seizure model supports a susceptibility role but does not reproduce spontaneous human WHS epilepsy or the multigene distal 4p deletion.

Species

Mus musculus

Genotype

Heterozygous Letm1 loss (Letm1±)

Genes

LETM1 hgnc:6556

Show evidence (1 reference)

PMID:26747863 SUPPORT Model Organism

"heterozygous Letm1± mice, as well as rats with a lentiviral-mediated Letm1 knockdown, demonstrate increased seizure susceptibility in response to kainic acid or pilocarpine seizure induction."

Documents challenge-induced seizure susceptibility in heterozygous Letm1 mice while leaving spontaneous epilepsy and multigene effects untested.

Lentiviral-mediated Letm1 knockdown Rattus norvegicus

Lentiviral Letm1 knockdown in rats increases susceptibility to chemically induced seizures. The acute single-gene perturbation and provoked endpoint limit translation to spontaneous epilepsy in a constitutional multigene 4p deletion.

Species

Rattus norvegicus

Genotype

Lentiviral-mediated Letm1 knockdown

Genes

LETM1 hgnc:6556

Show evidence (1 reference)

PMID:26747863 SUPPORT Model Organism

"heterozygous Letm1± mice, as well as rats with a lentiviral-mediated Letm1 knockdown, demonstrate increased seizure susceptibility in response to kainic acid or pilocarpine seizure induction."

Documents challenge-induced seizure susceptibility after rat Letm1 knockdown, not a constitutional human-like deletion model.

Morpholino knockdown of DrWhsc1, the zebrafish NSD2 homolog Danio rerio

DrWhsc1 morphants model acute reduction of the zebrafish NSD2 homolog. They show impaired embryonic H3K36 dimethylation with brain, cartilage, bone, and motor-neuron abnormalities. Morpholino knockdown and a single-gene perturbation are important limitations relative to a stable heterozygous multigene human deletion.

Species

Danio rerio

Genotype

Morpholino knockdown of DrWhsc1, the zebrafish NSD2 homolog

Genes

NSD2 hgnc:12766

Show evidence (2 references)

PMID:20946879 SUPPORT Model Organism

"Morpholino oligonucleotides for the DrWhsc1 gene affected early embryogenesis in zebrafish, such as endbrain enlargement, abnormal cartilage, marked reduction of bone, and incomplete motor neuron formation."

Defines the developmental phenotype of the zebrafish knockdown model.

PMID:20946879 SUPPORT Model Organism

"suppression of the DrWhsc1 gene or defect in the SET domain of DrWhsc1 resulted in impairment of di-methylation of histone H3K36 at early embryogenesis"

Links DrWhsc1 perturbation to the predicted chromatin defect.

{ }

Source YAML

click to show

name: Wolf-Hirschhorn_Syndrome
creation_date: '2026-01-07T21:37:01Z'
description: >
  Wolf-Hirschhorn syndrome (WHS) is a contiguous-gene disorder caused by a
  heterozygous deletion of distal chromosome 4p, usually including 4p16.3 and
  the Wolf-Hirschhorn syndrome critical regions. Core manifestations include a
  characteristic craniofacial gestalt, prenatal- and postnatal-onset growth
  deficiency, developmental delay or intellectual disability, hypotonia, and
  epilepsy. Deletion size and gene content modify the phenotype. NSD2/WHSC1,
  LETM1, and a distal seizure-susceptibility interval containing PIGG are among
  the best-studied contributors, but no single deleted gene reproduces the full
  syndrome; the evidence supports a multigene dosage model.
disease_term:
  preferred_term: Wolf-Hirschhorn syndrome
  term:
    id: MONDO:0008684
    label: Wolf-Hirschhorn syndrome
category: Genetic
parents:
- Chromosomal Disorder
synonyms:
- 4p- syndrome
- 4p deletion syndrome
- Pitt-Rogers-Danks syndrome
- chromosome 4p16.3 deletion syndrome
- distal deletion 4p
- distal monosomy 4p
inheritance:
- name: Predominantly sporadic 4p deletion
  inheritance_term:
    preferred_term: Sporadic
    term:
      id: HP:0003745
      label: Sporadic
  description: >-
    WHS is usually sporadic. About 50%-60% of affected individuals have a de
    novo pure 4p deletion, while about 40%-45% have an unbalanced translocation
    that may be de novo or inherited from a parent carrying a balanced
    rearrangement in the historical GeneReviews summary; cohort proportions
    vary with ascertainment. Ring chromosome 4 and other complex rearrangements
    account for the remainder.
  evidence:
  - reference: PMID:20301362
    reference_title: "Wolf-Hirschhorn Syndrome – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      About 50%-60% of individuals with WHS have a de novo pure deletion of
      4p16 and about 40%-45% have an unbalanced translocation with both a
      deletion of 4p and a partial trisomy of a different chromosome arm.
    explanation: >-
      The retired GeneReviews chapter supplies the historical distribution of
      pure deletions and unbalanced translocations; newer cohort evidence is
      used elsewhere in this entry to cross-check the chromosomal mechanisms.
  - reference: PMID:18932224
    reference_title: "Update on the clinical features and natural history of Wolf-Hirschhorn (4p-) syndrome: experience with 87 patients and recommendations for routine health supervision."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Sixty-five of 87 patients had an apparent pure, de novo, terminal deletion
    explanation: >-
      Demonstrates a higher pure-deletion proportion in one later cohort and
      therefore cautions against treating the historical percentages as fixed.
- name: Rearrangement-dependent recurrence risk
  description: >-
    Recurrence risk cannot be assigned from the WHS diagnosis alone. It is low
    after a confirmed de novo deletion but can be substantially higher when an
    unbalanced 4p deletion is inherited from a parent with a balanced
    rearrangement. Parental chromosome studies therefore determine counseling
    and prenatal-testing options.
  evidence:
  - reference: PMID:20301362
    reference_title: "Wolf-Hirschhorn Syndrome – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      These unbalanced translocations may be de novo or inherited from a parent
      with a balanced rearrangement.
    explanation: >-
      Documents the inherited balanced-rearrangement mechanism that changes
      recurrence risk.
  - reference: PMID:20301362
    reference_title: "Wolf-Hirschhorn Syndrome – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Risks to family members depend on the mechanism of origin of the deletion.
    explanation: >-
      Directly supports mechanism-specific rather than universal recurrence
      counseling.
references:
- reference: PMID:20301362
  title: "Wolf-Hirschhorn Syndrome – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY."
  tags:
  - GeneReviews
  findings:
  - statement: >-
      Archival expert summary covering phenotype, diagnosis, supportive
      management, surveillance, and genetic counseling; it is explicitly
      retired and is therefore cross-checked against newer cohorts and reviews.
    supporting_text: >-
      NOTE: THIS PUBLICATION HAS BEEN RETIRED. THIS ARCHIVAL VERSION IS FOR
      HISTORICAL REFERENCE ONLY, AND THE INFORMATION MAY BE OUT OF DATE.
    evidence:
    - reference: PMID:20301362
      reference_title: "Wolf-Hirschhorn Syndrome – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        NOTE: THIS PUBLICATION HAS BEEN RETIRED. THIS ARCHIVAL VERSION IS FOR HISTORICAL REFERENCE ONLY, AND THE INFORMATION MAY BE OUT OF DATE.
      explanation: Establishes the retirement caveat governing use of this source.
- reference: PMID:26239400
  title: "Wolf-Hirschhorn syndrome: A review and update."
  findings:
  - statement: >-
      Review framing WHS as distal 4p monosomy and identifying deletion-resolved
      genotype-phenotype correlation as the major unresolved task.
    supporting_text: >-
      Thus, the next step is to determine the precise effects of specific gene deletions.
    evidence:
    - reference: PMID:26239400
      reference_title: "Wolf-Hirschhorn syndrome: A review and update."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        Thus, the next step is to determine the precise effects of specific gene deletions.
      explanation: Directly states the review's deletion-resolved research priority.
- reference: PMID:18932224
  title: "Update on the clinical features and natural history of Wolf-Hirschhorn (4p-) syndrome: experience with 87 patients and recommendations for routine health supervision."
  findings:
  - statement: >-
      Eighty-seven-person natural-history cohort providing quantitative
      phenotype frequencies and longitudinal clinical observations.
    supporting_text: >-
      Global developmental delay of varying degrees was present in all patients.
    evidence:
    - reference: PMID:18932224
      reference_title: "Update on the clinical features and natural history of Wolf-Hirschhorn (4p-) syndrome: experience with 87 patients and recommendations for routine health supervision."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Global developmental delay of varying degrees was present in all patients.
      explanation: Example quantitative phenotype result from the natural-history cohort.
- reference: PMID:26747863
  title: "Chromosomal microarray testing identifies a 4p terminal region associated with seizures in Wolf-Hirschhorn syndrome."
  findings:
  - statement: >-
      Chromosomal-microarray mapping study refining a distal 4p seizure
      susceptibility interval while challenging a single-gene LETM1 model.
    supporting_text: >-
      Some of these deletions suggest that LETM1 deletion is neither necessary
      nor sufficient for the expression of a seizure phenotype in individuals
      with WHS
    evidence:
    - reference: PMID:26747863
      reference_title: "Chromosomal microarray testing identifies a 4p terminal region associated with seizures in Wolf-Hirschhorn syndrome."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Some of these deletions suggest that LETM1 deletion is neither necessary nor sufficient for the expression of a seizure phenotype in individuals with WHS
      explanation: Directly challenges a single-gene LETM1 explanation using human deletion mapping.
- reference: PMID:41303083
  title: "Epilepsy in Wolf-Hirschhorn Syndrome: Clinical Insights from a Pediatric Cohort and a Review of the Literature."
  findings:
  - statement: >-
      Contemporary 140-patient cohort defining epilepsy burden, status
      epilepticus frequency, treatment patterns, and age-related course.
    supporting_text: >-
      Epilepsy was observed in 92% of patients, typically beginning before 12 months of age.
    evidence:
    - reference: PMID:41303083
      reference_title: "Epilepsy in Wolf-Hirschhorn Syndrome: Clinical Insights from a Pediatric Cohort and a Review of the Literature."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Epilepsy was observed in 92% of patients, typically beginning before 12 months of age.
      explanation: Quantifies epilepsy and its typical onset in the 140-person cohort.
- reference: PMID:11584045
  title: "An epidemiological study of Wolf-Hirschhorn syndrome: life expectancy and cause of mortality."
  findings:
  - statement: >-
      UK epidemiologic cohort quantifying early mortality and the association
      between larger de novo deletions and mortality.
    supporting_text: >-
      The crude infant mortality rate was 17% (23/132) and in the first two years
      of life the mortality rate was 21% (28/132).
    evidence:
    - reference: PMID:11584045
      reference_title: "An epidemiological study of Wolf-Hirschhorn syndrome: life expectancy and cause of mortality."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        The crude infant mortality rate was 17% (23/132) and in the first two years of life the mortality rate was 21% (28/132). Cases with large de novo deletions (proximal to and including p15.2) were more likely to have died than those with smaller deletions (odds ratio=5.7, 95% CI=1.7-19.9) after adjusting for age.
      explanation: Quantifies early mortality and its association with larger de novo deletions in the UK epidemiologic cohort.
- reference: PMID:9672528
  title: Antibody deficiency in Wolf-Hirschhorn syndrome.
  findings:
  - statement: >-
      Selected infection-prone cohort documenting several forms of humoral
      antibody deficiency in WHS while retaining normal T-cell immunity.
    supporting_text: >-
      We identified antibody deficiencies in 9 of 13 infection-prone children
      with Wolf-Hirschhorn syndrome (4p-monosomy).
    evidence:
    - reference: PMID:9672528
      reference_title: Antibody deficiency in Wolf-Hirschhorn syndrome.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        We identified antibody deficiencies in 9 of 13 infection-prone children with Wolf-Hirschhorn syndrome (4p-monosomy).
      explanation: Directly documents the selected immune cohort and its antibody-deficiency yield.
prevalence:
- population: Global
  measure_type: BIRTH_PREVALENCE
  prevalence_class: BAND_1_9_PER_100000
  rate_low: 2.0
  rate_high: 5.0
  evidence:
  - reference: PMID:18932224
    reference_title: "Update on the clinical features and natural history of Wolf-Hirschhorn (4p-) syndrome: experience with 87 patients and recommendations for routine health supervision."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Its frequency is estimated as 1/50,000-1/20,000 births, with a female predilection of 2:1.
    explanation: >-
      Directly supports the curated range of 2-5 affected births per 100,000.
progression:
- phase: Onset
  age_range: Antenatal-Neonatal
  notes: Prenatal growth deficiency is a defining early manifestation.
  evidence:
  - reference: PMID:20301362
    reference_title: "Wolf-Hirschhorn Syndrome – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      All affected individuals have prenatal-onset growth deficiency followed
      by postnatal growth retardation and hypotonia with muscle underdevelopment.
    explanation: Establishes prenatal onset and persistence after birth.
- phase: Infantile epilepsy
  age_range: First year of life
  notes: >-
    Epilepsy usually begins before 12 months; status epilepticus is a major
    infantile complication.
  evidence:
  - reference: PMID:41303083
    reference_title: "Epilepsy in Wolf-Hirschhorn Syndrome: Clinical Insights from a Pediatric Cohort and a Review of the Literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Epilepsy was observed in 92% of patients, typically beginning before 12 months of age.
    explanation: Quantifies the epilepsy burden and typical first-year onset.
- phase: Childhood and later course
  age_range: Childhood-Adulthood
  notes: >-
    Developmental gains and improved seizure control may occur over time, but
    multisystem disability persists and outcome varies with deletion size and
    complications.
  evidence:
  - reference: PMID:18932224
    reference_title: "Update on the clinical features and natural history of Wolf-Hirschhorn (4p-) syndrome: experience with 87 patients and recommendations for routine health supervision."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      A global improvement was observed in all individuals, over time.
    explanation: Longitudinal cohort documents developmental improvement rather than uniform regression.
  - reference: PMID:41303083
    reference_title: "Epilepsy in Wolf-Hirschhorn Syndrome: Clinical Insights from a Pediatric Cohort and a Review of the Literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      ASM discontinuation was significantly associated with older age at evaluation, supporting improved seizure control over time.
    explanation: Supports age-related improvement in seizure control for some patients.
- phase: Early mortality risk
  age_range: Infancy-Early childhood
  notes: >-
    Mortality is concentrated in early life but is lower than historically
    reported; larger de novo deletions carry higher overall mortality risk.
  evidence:
  - reference: PMID:11584045
    reference_title: "An epidemiological study of Wolf-Hirschhorn syndrome: life expectancy and cause of mortality."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The crude infant mortality rate was 17% (23/132) and in the first two years of life the mortality rate was 21% (28/132).
    explanation: Quantifies early mortality in the UK epidemiologic cohort.
  - reference: PMID:11584045
    reference_title: "An epidemiological study of Wolf-Hirschhorn syndrome: life expectancy and cause of mortality."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The mortality rate is lower than previously reported. There is a statistically significant relationship between deletion size and overall risk of death in de novo deletion cases.
    explanation: >-
      Directly supports the comparison with historical mortality estimates and
      the deletion-size association stated in this progression phase.
pathophysiology:
- name: 4p16.3 Contiguous Gene Deletion
  description: >
    Wolf-Hirschhorn syndrome is a contiguous gene deletion disorder caused
    by hemizygous loss of distal chromosome 4 (4p16.3). Two adjacent
    "critical regions" lie ~1.8-2.0 Mb from the 4p telomere: WHSCR (a
    ~165 kb interval encompassing parts of WHSC1/NSD2 and WHSC2/NELFA)
    and WHSCR-2 (a ~300-600 kb interval that includes the 5' end of
    WHSC1/NSD2 and all of LETM1). A separate ~197 kb terminal seizure
    susceptibility region (containing PIGG, ZNF721 and ABCA11P) lies
    ~368 kb from the 4p telomere. Phenotypic severity scales broadly
    with deletion size, but individual features track more tightly with
    which dosage-sensitive genes are removed.
  evidence:
  - reference: PMID:32914558
    reference_title: "Wolf-Hirschhorn syndrome: A case series from India."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The syndrome is caused by deletion of a critical region (Wolf-Hirschhorn Syndrome Critical region-WHSCR) on chromosome 4p16.3."
    explanation: This establishes the genetic basis of Wolf-Hirschhorn syndrome as a deletion of the critical region on 4p16.3.
  - reference: PMID:26747863
    reference_title: "Chromosomal microarray testing identifies a 4p terminal region associated with seizures in Wolf-Hirschhorn syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Wolf-Hirschhorn syndrome (WHS) is a contiguous gene deletion syndrome involving variable size deletions of the 4p16.3 region."
    explanation: Establishes WHS as a contiguous gene deletion syndrome of variable size.
  - reference: PMID:26747863
    reference_title: "Chromosomal microarray testing identifies a 4p terminal region associated with seizures in Wolf-Hirschhorn syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Two adjacent regions, located approximately 1.8–2.0 Mbp from the 4p terminus, are each proposed to be the minimal region of deletion necessary to observe the core WHS features."
    explanation: Defines WHSCR/WHSCR-2 as the historically recognized critical regions for the core WHS phenotype.
  - reference: PMID:18474167
    reference_title: "Wolf-Hirschhorn syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We report a case of a rare chromosomal disorder, Wolf-Hirschhorn syndrome, caused by deletion of short arm of chromosome 4."
    explanation: This confirms that Wolf-Hirschhorn syndrome results from deletion of the short arm of chromosome 4.
  - reference: PMID:18932224
    reference_title: "Update on the clinical features and natural history of Wolf-Hirschhorn (4p-) syndrome: experience with 87 patients and recommendations for routine health supervision."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      No single gene deletions or intragenic mutations have been shown to confer the full WHS phenotype.
    explanation: >-
      Supports a contiguous multigene dosage model rather than assigning the
      complete syndrome to one deleted gene.
  downstream:
  - target: NSD2 (WHSC1) Haploinsufficiency
    description: Loss of one copy of NSD2/WHSC1 within WHSCR/WHSCR-2 reduces H3K36 dimethyltransferase dosage.
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:26747863
      reference_title: "Chromosomal microarray testing identifies a 4p terminal region associated with seizures in Wolf-Hirschhorn syndrome."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        The first critical region described was a 165 kbp interval encompassing part of the WHSC1 gene and all of the WHSC2 (NELFA) gene.
      explanation: Places NSD2/WHSC1 within a mapped WHS critical region.
  - target: LETM1 Haploinsufficiency and Mitochondrial Ion Dyshomeostasis
    description: Loss of LETM1, located in WHSCR-2, halves the mitochondrial K+/H+ and Ca2+/H+ exchanger.
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:26747863
      reference_title: "Chromosomal microarray testing identifies a 4p terminal region associated with seizures in Wolf-Hirschhorn syndrome."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        the critical region (designated WHSCR2) lies in an adjacent, 300–600 kbp interval that includes the 5′ end of WHSC1 and the entirety of LETM1, a candidate seizure gene
      explanation: Places LETM1 within the proposed WHSCR2 interval.
  - target: Telomeric 4p Seizure-Susceptibility Region Haploinsufficiency
    description: Most WHS deletions extend to the 4p terminus, removing the ~197 kb terminal region containing PIGG and ZNF721.
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:26747863
      reference_title: "Chromosomal microarray testing identifies a 4p terminal region associated with seizures in Wolf-Hirschhorn syndrome."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        There are two genes and one pseudogene in this region: ZNF721, encoding a zinc-finger containing protein of unknown function, PIGG, a member of the phosphatidylinositol glycan anchor biosynthetic pathway, and ABCA11P, a pseudogene with sequence similarity to ATP-binding cassette, subfamily A genes
      explanation: Defines the gene content of the mapped 197 kb interval.
  - target: Candidate Multigene Neuronal-Communication Dysfunction
    description: >-
      Depending on the breakpoint, the 4p deletion can remove several candidate
      epilepsy contributors nominated by computational network analysis,
      including PIGG, CPLX1, CTBP1, and LETM1.
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:35278209
      reference_title: "Distinct Epileptogenic Mechanisms Associated with Seizures in Wolf-Hirschhorn Syndrome."
      supports: SUPPORT
      evidence_source: COMPUTATIONAL
      snippet: "The proximity among the previous reported haploinsufficient candidate genes (PIGG, CPLX1, CTBP1, LETM1) and disease genes associated with epilepsy suggests not just one, but different impaired mechanisms in cellular networks responsible for the balance of neuronal activity in WHS patients, from which neuron communication is the most impaired in WHS-related seizures."
      explanation: >-
        Nominates a multigene neuronal-network model; it does not establish that
        every WHS deletion removes all four genes or prove their individual
        causal contributions.
  - target: Candidate MSX1-Dependent Odontogenesis Defect
    description: Larger 4p deletions remove MSX1, a craniofacial/odontogenic transcription factor.
    causal_link_type: DIRECT
  - target: Candidate FGFR3-Dependent Neural-Crest Signaling Defect
    description: FGFR3 lies near the WHS critical regions and may be co-deleted depending on the breakpoint.
    causal_link_type: DIRECT
  - target: Microcephaly
    description: Distal 4p gene loss can produce microcephaly through unresolved multigene developmental mechanisms.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Hypotonia
    description: Hypotonia is associated with the distal 4p deletion syndrome, but its gene-level mechanism remains unresolved.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:18932224
      reference_title: "Update on the clinical features and natural history of Wolf-Hirschhorn (4p-) syndrome: experience with 87 patients and recommendations for routine health supervision."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Hypotonia was present in virtually all patients.
      explanation: >-
        Supports the syndrome-level deletion-to-hypotonia association while
        leaving the responsible deleted gene or genes unresolved.
  - target: Status Epilepticus
    description: >-
      WHS-associated epilepsy can include status epilepticus, but available
      cohort evidence does not assign that complication to a particular distal
      interval or deleted gene.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:41303083
      reference_title: "Epilepsy in Wolf-Hirschhorn Syndrome: Clinical Insights from a Pediatric Cohort and a Review of the Literature."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Status epilepticus occurred in 58% of cases, with a high proportion requiring multiple ASMs.
      explanation: >-
        Supports a syndrome-level association while explicitly leaving the
        responsible deletion interval and mechanism unresolved.
  - target: Corpus Callosum Abnormalities
    description: Structural brain abnormalities can accompany distal 4p deletion, but the responsible dosage-sensitive genes are unresolved.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Renal Anomalies
    description: Kidney and urinary-tract anomalies occur in the deletion syndrome without a securely mapped single-gene mechanism.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Feeding Difficulties
    description: Feeding impairment is a variable multisystem consequence of the deletion syndrome.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Hearing Loss
    description: Hearing loss is a recurrent manifestation with conductive and sensorineural components and incompletely resolved gene attribution.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Ophthalmologic Abnormalities
    description: Ocular abnormalities occur in the distal 4p deletion syndrome, with the responsible gene-level mechanisms unresolved.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:29199884
      reference_title: "Congenital cavitary optic disc anomaly and Axenfeld's anomaly in Wolf-Hirschhorn syndrome: A case report and review of the literature."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        A variety of ocular manifestations may occur in up to 40% of patients.
      explanation: Supports the syndrome-level deletion-to-ocular-abnormality association without assigning a specific deleted gene.
  - target: Hepatic Neoplasia
    description: Rare reported hepatic neoplasms may be associated with the distal 4p deletion, but penetrance and gene attribution are unresolved.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:30289612
      reference_title: "Risk of hepatic neoplasms in Wolf-Hirschhorn syndrome (4p-): Four new cases and review of the literature."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        We propose that, in the context of the rarity of WHS, these seven cases suggest that hepatocellular neoplasia may be a feature of WHS.
      explanation: Supports a proposed syndrome association based on seven cumulative cases, not an established frequency or mechanism.
- name: NSD2 (WHSC1) Haploinsufficiency
  description: >
    NSD2 (also called WHSC1 or MMSET) encodes a SET-domain histone
    methyltransferase that dimethylates lysine 36 of histone H3
    (H3K36me2). NSD2 partners with cell-type-specific transcription
    factors (e.g., Sall1/Sall4/Nanog in embryonic stem cells, Nkx2-5 in
    embryonic heart) to deposit H3K36 marks at developmental gene loci,
    preventing inappropriate transcription. Hemizygous loss of NSD2 is
    included in essentially all classic WHS deletions and is a well-supported
    contributor to the craniofacial, growth, neurodevelopmental and
    cardiovascular phenotypes. NSD2 loss alone has not been shown to reproduce
    the full human contiguous-deletion syndrome.
  gene:
    preferred_term: NSD2
    term:
      id: hgnc:12766
      label: NSD2
  biological_processes:
  - preferred_term: chromatin remodeling
    term:
      id: GO:0006338
      label: chromatin remodeling
    modifier: DECREASED
  - preferred_term: regulation of transcription by RNA polymerase II
    term:
      id: GO:0006357
      label: regulation of transcription by RNA polymerase II
    modifier: DECREASED
  molecular_functions:
  - preferred_term: histone methyltransferase activity
    term:
      id: GO:0042054
      label: histone methyltransferase activity
    modifier: DECREASED
  - preferred_term: histone H3K36 dimethyltransferase activity
    term:
      id: GO:0140954
      label: histone H3K36 dimethyltransferase activity
    modifier: DECREASED
  evidence:
  - reference: PMID:25942451
    reference_title: "The NSD family of protein methyltransferases in human cancer."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "NSD2 haploinsufficiency causes Wolf-Hirschhorn syndrome"
    explanation: >-
      Cancer-biology review shorthand linking NSD2 haploinsufficiency to WHS;
      it supports a contributory role but does not establish single-gene
      sufficiency for the full contiguous-deletion syndrome.
  - reference: PMID:26092122
    reference_title: "Auditory hair cell defects as potential cause for sensorineural deafness in Wolf-Hirschhorn syndrome."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "WHSC1 is a histone methyltransferase (HMT) that catalyses the addition of methyl groups to lysine 36 on histone 3. In humans, WHSC1 haploinsufficiency is associated with all known cases of Wolf-Hirschhorn syndrome (WHS)."
    explanation: Names WHSC1/NSD2 as the histone methyltransferase whose haploinsufficiency underlies WHS.
  - reference: PMID:19483677
    reference_title: "A histone H3 lysine 36 trimethyltransferase links Nkx2-5 to Wolf-Hirschhorn syndrome."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "the H3K36me3-specific histone methyltransferase (HMTase) Wolf-Hirschhorn syndrome candidate 1 (WHSC1, also known as NSD2 or MMSET) functions in transcriptional regulation together with developmental transcription factors whose defects overlap with the human disease Wolf-Hirschhorn syndrome (WHS)"
    explanation: Identifies WHSC1/NSD2 as the H3K36 methyltransferase that partners with developmental transcription factors implicated in WHS.
  downstream:
  - target: Impaired H3K36 Dimethylation and Developmental Gene Mis-regulation
    description: >-
      DrWhsc1 suppression or SET-domain disruption impairs embryonic H3K36
      dimethylation in zebrafish; the magnitude of the effect from heterozygous
      human NSD2 loss is not quantified by this evidence.
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:20946879
      reference_title: "Functional characterization of the zebrafish WHSC1-related gene, a homolog of human NSD2."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        suppression of the DrWhsc1 gene or defect in the SET domain of DrWhsc1 resulted in impairment of di-methylation of histone H3K36 at early embryogenesis
      explanation: >-
        Directly links DrWhsc1 suppression or SET-domain disruption to impaired
        embryonic H3K36 dimethylation in zebrafish, without quantifying the
        heterozygous human effect.
  - target: Cranial Neural Crest Cell Migration Defect
    description: WHSC1/NSD2 is expressed in jaw, face and CNS tissues that depend on cranial neural crest, and its dysregulation has been linked to defective neural crest migration.
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - Loss of H3K36me2/me3 marks at neural crest target genes
    - Wnt and Twist signaling dysregulation
    evidence:
    - reference: PMID:27777068
      reference_title: "Exploring the developmental mechanisms underlying Wolf-Hirschhorn Syndrome: Evidence for defects in neural crest cell migration."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        we propose a novel characterization for WHS as a pathophysiology owing in part to defects in neural crest cell motility and migration during development.
      explanation: Supports neural-crest dysfunction as a review-level hypothesis, not a directly measured human mechanism.
  - target: Sensorineural Hearing Loss
    description: Whsc1-deficient mice develop abnormal cochlear hair-bundle morphology, supporting an NSD2 contribution to the sensorineural component of WHS hearing loss.
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:26092122
      reference_title: "Auditory hair cell defects as potential cause for sensorineural deafness in Wolf-Hirschhorn syndrome."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        Although auditory hair cells are specified normally, their stereocilia hair bundles required for sound perception fail to develop the appropriate morphology.
      explanation: Provides model-organism support for a cochlear hair-cell intermediate.
  - target: Humoral Antibody Deficiency
    description: Mouse B-cell studies make impaired NSD2-dependent class switching a candidate mechanism for the human antibody deficiencies observed in WHS.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:32862441
      reference_title: "The catalytic domain of the histone methyltransferase NSD2/MMSET is required for the generation of B1 cells in mice."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "NSD2 is required for B cell class switch recombination"
      explanation: Supports biological plausibility but does not by itself establish the mechanism in human WHS.
- name: Impaired H3K36 Dimethylation and Developmental Gene Mis-regulation
  description: >
    NSD2 is an H3K36 methyltransferase that cooperates with developmental
    transcription factors such as Nkx2-5. In zebrafish, DrWhsc1 suppression or
    SET-domain disruption impairs H3K36 dimethylation during early
    embryogenesis and produces brain, cartilage, bone, and motor-neuron
    abnormalities. Whsc1-deficient mice show growth, midline, and cardiovascular
    defects that are aggravated by Nkx2-5 heterozygosity. These models support a
    developmental chromatin mechanism, but the magnitude or global distribution
    of H3K36me2 change in human heterozygous 4p deletions is not established by
    the cited evidence.
  biological_processes:
  - preferred_term: regulation of transcription by RNA polymerase II
    term:
      id: GO:0006357
      label: regulation of transcription by RNA polymerase II
    modifier: DYSREGULATED
  - preferred_term: chromatin remodeling
    term:
      id: GO:0006338
      label: chromatin remodeling
    modifier: DECREASED
  molecular_functions:
  - preferred_term: histone H3K36 dimethyltransferase activity
    term:
      id: GO:0140954
      label: histone H3K36 dimethyltransferase activity
    modifier: DECREASED
  evidence:
  - reference: PMID:19483677
    reference_title: "A histone H3 lysine 36 trimethyltransferase links Nkx2-5 to Wolf-Hirschhorn syndrome."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Whsc1-deficient mice showed growth retardation and various WHS-like midline defects, including congenital cardiovascular anomalies."
    explanation: Mouse Whsc1 deficiency recapitulates growth retardation and midline/cardiac defects of WHS.
  - reference: PMID:19483677
    reference_title: "A histone H3 lysine 36 trimethyltransferase links Nkx2-5 to Wolf-Hirschhorn syndrome."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "The effects of Whsc1 haploinsufficiency were increased in Nkx2-5 heterozygous mutant hearts, indicating their functional link."
    explanation: Establishes the NSD2/WHSC1-Nkx2-5 transcriptional axis as a driver of WHS cardiac phenotypes.
  - reference: PMID:20946879
    reference_title: "Functional characterization of the zebrafish WHSC1-related gene, a homolog of human NSD2."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Morpholino oligonucleotides for the DrWhsc1 gene affected early embryogenesis in zebrafish, such as endbrain enlargement, abnormal cartilage, marked reduction of bone, and incomplete motor neuron formation."
    explanation: Zebrafish Whsc1 knockdown produces brain, skeletal and motor neuron phenotypes that mirror WHS features.
  - reference: PMID:20946879
    reference_title: "Functional characterization of the zebrafish WHSC1-related gene, a homolog of human NSD2."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "suppression of the DrWhsc1 gene or defect in the SET domain of DrWhsc1 resulted in impairment of di-methylation of histone H3K36 at early embryogenesis"
    explanation: Establishes WHSC1/NSD2 SET domain as required for embryonic H3K36 dimethylation.
  downstream:
  - target: Global Developmental Delay
    description: Loss of H3K36 methylation at neurodevelopmental targets is a candidate contributor to developmental delay.
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:20946879
      reference_title: "Functional characterization of the zebrafish WHSC1-related gene, a homolog of human NSD2."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        Morpholino oligonucleotides for the DrWhsc1 gene affected early embryogenesis in zebrafish, such as endbrain enlargement, abnormal cartilage, marked reduction of bone, and incomplete motor neuron formation.
      explanation: Supports neurodevelopmental consequences of Whsc1 reduction in a model, not direct causation of human delay.
  - target: Intellectual Disability
    description: Mis-regulation of neuronal differentiation and transcription is a candidate contributor to cognitive impairment.
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:20946879
      reference_title: "Functional characterization of the zebrafish WHSC1-related gene, a homolog of human NSD2."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        Morpholino oligonucleotides for the DrWhsc1 gene affected early embryogenesis in zebrafish, such as endbrain enlargement, abnormal cartilage, marked reduction of bone, and incomplete motor neuron formation.
      explanation: Provides model evidence for neural developmental effects but cannot isolate the cause of human intellectual disability.
  - target: Intrauterine Growth Retardation
    description: Whsc1-deficient mice show growth retardation phenocopying prenatal growth deficiency in WHS.
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:19483677
      reference_title: "A histone H3 lysine 36 trimethyltransferase links Nkx2-5 to Wolf-Hirschhorn syndrome."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        Whsc1-deficient mice showed growth retardation and various WHS-like midline defects, including congenital cardiovascular anomalies.
      explanation: Supports an NSD2 contribution to growth impairment in a mouse model.
  - target: Postnatal Growth Retardation
    description: Persistent NSD2-dependent transcriptional defects may contribute to ongoing growth failure after birth.
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:19483677
      reference_title: "A histone H3 lysine 36 trimethyltransferase links Nkx2-5 to Wolf-Hirschhorn syndrome."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        Whsc1-deficient mice showed growth retardation and various WHS-like midline defects, including congenital cardiovascular anomalies.
      explanation: Supports a model-organism NSD2 growth effect without establishing it as the sole human mechanism.
  - target: Congenital Heart Defects
    description: Altered H3K36 methylation at Nkx2-5 cardiac targets is a model-supported contributor to cardiovascular malformation.
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:19483677
      reference_title: "A histone H3 lysine 36 trimethyltransferase links Nkx2-5 to Wolf-Hirschhorn syndrome."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        The effects of Whsc1 haploinsufficiency were increased in Nkx2-5 heterozygous mutant hearts, indicating their functional link.
      explanation: Supports a Whsc1-Nkx2-5 cardiac interaction in mice.
  - target: Skeletal Anomalies
    description: Reduced Whsc1 activity and H3K36 dimethylation impair cartilage and bone formation in zebrafish, supporting a candidate skeletal contribution.
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:20946879
      reference_title: "Functional characterization of the zebrafish WHSC1-related gene, a homolog of human NSD2."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        Morpholino oligonucleotides for the DrWhsc1 gene affected early embryogenesis in zebrafish, such as endbrain enlargement, abnormal cartilage, marked reduction of bone, and incomplete motor neuron formation.
      explanation: Directly documents cartilage and bone phenotypes in the model.
- name: LETM1 Haploinsufficiency and Mitochondrial Ion Dyshomeostasis
  description: >
    LETM1 lies in WHSCR-2 and encodes an inner-mitochondrial-membrane
    protein that catalyses K+/H+ exchange and Ca2+/H+ antiport, and
    controls mitochondrial volume, membrane potential and OXPHOS protein
    integrity. Hemizygous loss in WHS halves LETM1 dosage, producing
    impaired mitochondrial K+ efflux and perturbed Ca2+ handling. Heterozygous
    mouse and knockdown-rat models show increased chemically induced seizure
    susceptibility.
    LETM1 has long been treated as a major candidate gene for
    WHS-associated seizures. Human deletion mapping shows seizures both when
    LETM1 is spared and absent seizures when it is deleted, indicating that
    LETM1 haploinsufficiency is neither necessary nor sufficient.
  gene:
    preferred_term: LETM1
    term:
      id: hgnc:6556
      label: LETM1
  cellular_components:
  - preferred_term: mitochondrial inner membrane
    term:
      id: GO:0005743
      label: mitochondrial inner membrane
  biological_processes:
  - preferred_term: mitochondrial calcium ion homeostasis
    term:
      id: GO:0051560
      label: mitochondrial calcium ion homeostasis
    modifier: DECREASED
  - preferred_term: potassium ion homeostasis
    term:
      id: GO:0055075
      label: potassium ion homeostasis
    modifier: DECREASED
  evidence:
  - reference: PMID:24738919
    reference_title: "Unusual 4p16.3 deletions suggest an additional chromosome region for the Wolf-Hirschhorn syndrome-associated seizures disorder."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "LETM1, encoding a mitochondrial protein playing a role in K(+) /H(+) exchange and in Ca(2+) homeostasis, is currently considered the major candidate gene."
    explanation: Establishes LETM1 as the historically major candidate gene for WHS seizures and its mitochondrial K+/H+ and Ca2+ functions.
  - reference: PMID:36055214
    reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Leucine zipper-EF-hand containing transmembrane protein 1 (LETM1) encodes an inner mitochondrial membrane protein with an osmoregulatory function controlling mitochondrial volume and ion homeostasis."
    explanation: Defines LETM1's molecular function as the inner-mitochondrial-membrane osmoregulator.
  - reference: PMID:36055214
    reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "bi-allelic LETM1 variants are associated with defective mitochondrial K+ efflux, swollen mitochondrial matrix structures, and loss of important mitochondrial oxidative phosphorylation protein components"
    explanation: Bi-allelic loss-of-function LETM1 variants confirm the cellular consequences of LETM1 loss that are partially recapitulated in WHS heterozygotes.
  - reference: PMID:23963300
    reference_title: "Deletions involving genes WHSC1 and LETM1 may be necessary, but are not sufficient to cause Wolf-Hirschhorn Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Within this region, haploinsufficiency of the genes WHSC1 and LETM1 is thought to be a major contributor to the pathogenesis of WHS."
    explanation: Genotype-phenotype analysis supports WHSC1/LETM1 haploinsufficiency as a major (but not exclusive) WHS driver.
  downstream:
  - target: Seizures
    description: Mitochondrial K+/H+ and Ca2+ dyshomeostasis may lower neuronal seizure threshold, but LETM1 loss is not sufficient or necessary in human deletion mapping.
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - Altered mitochondrial K+ efflux and volume control
    - Perturbed mitochondrial Ca2+ homeostasis
    evidence:
    - reference: PMID:26747863
      reference_title: "Chromosomal microarray testing identifies a 4p terminal region associated with seizures in Wolf-Hirschhorn syndrome."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        heterozygous Letm1± mice, as well as rats with a lentiviral-mediated Letm1 knockdown, demonstrate increased seizure susceptibility in response to kainic acid or pilocarpine seizure induction.
      explanation: Supports LETM1-dependent seizure susceptibility in models while human mapping limits a single-gene interpretation.
- name: Telomeric 4p Seizure-Susceptibility Region Haploinsufficiency
  description: >
    High-resolution chromosomal microarray mapping (n=48) proposed an
    independent seizure-susceptibility region to a ~197 kb interval
    starting ~368 kb from the 4p telomere, distal to LETM1 and
    containing PIGG, ZNF721 and the pseudogene ABCA11P. Patients with
    interstitial deletions whose distal breakpoint preserves the
    terminal 751 kb (and thus this region) lacked seizures in the mapped
    cohort, while deletion of the interval tracked with seizures in that
    cohort. This is evidence for susceptibility, not proof of a universally
    deterministic interval.
  genes:
  - preferred_term: PIGG
    term:
      id: hgnc:25985
      label: PIGG
  evidence:
  - reference: PMID:26747863
    reference_title: "Chromosomal microarray testing identifies a 4p terminal region associated with seizures in Wolf-Hirschhorn syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We identify a small terminal region of chromosome 4p that represents a seizure susceptibility region. Deletion of this region in the context of WHS is sufficient for seizure occurrence."
    explanation: >-
      Defines the terminal interval associated with seizures in the mapping
      cohort; it is retained as a susceptibility region rather than treated as
      a universally deterministic locus.
  - reference: PMID:26747863
    reference_title: "Chromosomal microarray testing identifies a 4p terminal region associated with seizures in Wolf-Hirschhorn syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Some of these deletions suggest that LETM1 deletion is neither necessary nor sufficient for the expression of a seizure phenotype in individuals with WHS"
    explanation: Refutes a single-gene LETM1 model and motivates the search for additional seizure-susceptibility genes.
  - reference: PMID:24738919
    reference_title: "Unusual 4p16.3 deletions suggest an additional chromosome region for the Wolf-Hirschhorn syndrome-associated seizures disorder."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "haploinsufficiency not limited to LETM1 but including other genes acts as a risk factor for the WHS-associated seizure disorder, according to a comorbidity model of pathogenesis"
    explanation: Supports a comorbidity/synergistic model of WHS seizures involving LETM1 and additional genes.
  downstream:
  - target: Seizures
    description: Deletion of the mapped distal interval was associated with seizures in the high-resolution mapping cohort.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:26747863
      reference_title: "Chromosomal microarray testing identifies a 4p terminal region associated with seizures in Wolf-Hirschhorn syndrome."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        The deletion of this region correlates strongly with the presence of seizures, and its preservation, as in cases of the interstitial WHS deletions we described, correlates with the absence of seizures.
      explanation: Supports a deletion-phenotype association for the distal candidate interval.
- name: Candidate Multigene Neuronal-Communication Dysfunction
  description: >-
    Computational network analysis nominates PIGG, CPLX1, CTBP1, and LETM1 as
    haploinsufficient candidate genes acting through multiple cellular networks
    that converge on impaired neuronal communication in WHS-associated
    seizures. This is a candidate multigene model rather than proof that any
    one gene, or the four-gene set, is necessary or sufficient.
  genes:
  - preferred_term: PIGG
    term:
      id: hgnc:25985
      label: PIGG
  - preferred_term: CPLX1
    term:
      id: hgnc:2309
      label: CPLX1
  - preferred_term: CTBP1
    term:
      id: hgnc:2494
      label: CTBP1
  - preferred_term: LETM1
    term:
      id: hgnc:6556
      label: LETM1
  biological_processes:
  - preferred_term: trans-synaptic signaling
    term:
      id: GO:0099537
      label: trans-synaptic signaling
    modifier: DECREASED
  evidence:
  - reference: PMID:35278209
    reference_title: "Distinct Epileptogenic Mechanisms Associated with Seizures in Wolf-Hirschhorn Syndrome."
    supports: SUPPORT
    evidence_source: COMPUTATIONAL
    snippet: "The proximity among the previous reported haploinsufficient candidate genes (PIGG, CPLX1, CTBP1, LETM1) and disease genes associated with epilepsy suggests not just one, but different impaired mechanisms in cellular networks responsible for the balance of neuronal activity in WHS patients, from which neuron communication is the most impaired in WHS-related seizures."
    explanation: >-
      Supports a candidate multigene network converging on neuronal
      communication, while remaining computational rather than experimental
      causal evidence.
  downstream:
  - target: Seizures
    description: Candidate multigene network dysfunction may disturb neuronal communication and contribute to seizure susceptibility.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:35278209
      reference_title: "Distinct Epileptogenic Mechanisms Associated with Seizures in Wolf-Hirschhorn Syndrome."
      supports: SUPPORT
      evidence_source: COMPUTATIONAL
      snippet: "The proximity among the previous reported haploinsufficient candidate genes (PIGG, CPLX1, CTBP1, LETM1) and disease genes associated with epilepsy suggests not just one, but different impaired mechanisms in cellular networks responsible for the balance of neuronal activity in WHS patients, from which neuron communication is the most impaired in WHS-related seizures."
      explanation: >-
        Provides a computational association between the nominated network and
        WHS-related seizures, not direct functional validation.
- name: Cranial Neural Crest Cell Migration Defect
  description: >
    Most of the WHS-affected midline structures (Greek-warrior-helmet
    facies, palatal clefts, cardiac outflow tract, mandibular and
    auricular cartilage, dental papilla) derive from cranial neural
    crest cells. Multiple WHS-region genes (NSD2/WHSC1, LETM1, TACC3,
    FGFR3) are enriched in migratory neural crest, and their combined
    haploinsufficiency is proposed to perturb neural crest cell motility,
    epithelial-to-mesenchymal transition (via NSD2-Twist regulation) and
    chemotactic responses to FGF8 (via FGFR1/3). This proposed mechanism could
    reduce delivery and patterning of neural crest derivatives at the face,
    ear, jaw and conotruncal heart.
  cell_types:
  - preferred_term: migratory neural crest cell
    term:
      id: CL:0000333
      label: migratory neural crest cell
  - preferred_term: migratory cardiac neural crest cell
    term:
      id: CL:2000073
      label: migratory cardiac neural crest cell
  locations:
  - preferred_term: cranial neural crest
    term:
      id: UBERON:0003099
      label: cranial neural crest
  - preferred_term: embryonic head
    term:
      id: UBERON:0008816
      label: embryonic head
  biological_processes:
  - preferred_term: neural crest cell migration
    term:
      id: GO:0001755
      label: neural crest cell migration
    modifier: DECREASED
  evidence:
  - reference: PMID:27777068
    reference_title: "Exploring the developmental mechanisms underlying Wolf-Hirschhorn Syndrome: Evidence for defects in neural crest cell migration."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "we propose a novel characterization for WHS as a pathophysiology owing in part to defects in neural crest cell motility and migration during development."
    explanation: Review proposes defective cranial neural crest migration as a unifying mechanism for WHS midline phenotypes.
  - reference: PMID:27777068
    reference_title: "Exploring the developmental mechanisms underlying Wolf-Hirschhorn Syndrome: Evidence for defects in neural crest cell migration."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "the formation of structures of the face and jaw, as well as certain glial cell populations in the brain, depend on neural crest cell migration"
    explanation: Establishes the developmental dependence of WHS-affected craniofacial structures on cranial neural crest migration.
  downstream:
  - target: Characteristic Facial Features
    description: Defective migration of cranial neural crest into the frontonasal and maxillary processes is proposed to shape the Greek-warrior-helmet facies.
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:27777068
      reference_title: "Exploring the developmental mechanisms underlying Wolf-Hirschhorn Syndrome: Evidence for defects in neural crest cell migration."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        the formation of structures of the face and jaw, as well as certain glial cell populations in the brain, depend on neural crest cell migration
      explanation: Supports the developmental plausibility of the proposed facial mechanism.
  - target: Hypertelorism
    description: Aberrant cranial-neural-crest patterning is a proposed contributor to hypertelorism.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:27777068
      reference_title: "Exploring the developmental mechanisms underlying Wolf-Hirschhorn Syndrome: Evidence for defects in neural crest cell migration."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        we propose a novel characterization for WHS as a pathophysiology owing in part to defects in neural crest cell motility and migration during development.
      explanation: Supports the general neural-crest hypothesis, not this individual facial feature specifically.
  - target: Cleft Lip or Palate
    description: Disrupted neural crest delivery to the palatal shelves is a proposed contributor to cleft palate.
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:27777068
      reference_title: "Exploring the developmental mechanisms underlying Wolf-Hirschhorn Syndrome: Evidence for defects in neural crest cell migration."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        we propose a novel characterization for WHS as a pathophysiology owing in part to defects in neural crest cell motility and migration during development.
      explanation: Supports a syndrome-level hypothesis but not a feature-specific causal assignment.
  - target: Congenital Heart Defects
    description: Reduced cardiac neural crest migration is a proposed contributor to septal and conotruncal defects.
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:27777068
      reference_title: "Exploring the developmental mechanisms underlying Wolf-Hirschhorn Syndrome: Evidence for defects in neural crest cell migration."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        FGFRs 1 and 3 have recently been implicated in the chemotactic response of cardiac neural crest cells to FGF8 in the pharyngeal ecto-and endoderm in chick embryos, operating upstream of the MAPK/ERK pathway
      explanation: Supplies model-system plausibility for altered cardiac-neural-crest chemotaxis.
- name: Candidate FGFR3-Dependent Neural-Crest Signaling Defect
  description: >
    FGFR3 lies just distal to the WHSC1/LETM1 critical regions in 4p16.3
    and is co-deleted in many WHS deletions. Together with FGFR1, FGFR3
    participates in cardiac-neural-crest chemotaxis to FGF8 in chick
    embryos. Its specific contribution to human WHS remains a candidate
    mechanism rather than an established explanation for skeletal or hearing
    phenotypes; the available WHS cochlear model instead directly tests
    Whsc1/NSD2 deficiency.
  gene:
    preferred_term: FGFR3
    term:
      id: hgnc:3690
      label: FGFR3
  cell_types:
  - preferred_term: migratory cardiac neural crest cell
    term:
      id: CL:2000073
      label: migratory cardiac neural crest cell
  biological_processes:
  - preferred_term: fibroblast growth factor receptor signaling pathway
    term:
      id: GO:0008543
      label: fibroblast growth factor receptor signaling pathway
    modifier: DECREASED
  evidence:
  - reference: PMID:27777068
    reference_title: "Exploring the developmental mechanisms underlying Wolf-Hirschhorn Syndrome: Evidence for defects in neural crest cell migration."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "FGFRs 1 and 3 have recently been implicated in the chemotactic response of cardiac neural crest cells to FGF8 in the pharyngeal ecto-and endoderm in chick embryos, operating upstream of the MAPK/ERK pathway"
    explanation: Provides mechanism by which FGFR3 haploinsufficiency may compromise cardiac neural-crest chemotaxis.
  downstream:
  - target: Congenital Heart Defects
    description: Reduced FGFR3-dependent neural-crest chemotaxis is a proposed, not yet human-validated, contributor to cardiac malformation risk.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:27777068
      reference_title: "Exploring the developmental mechanisms underlying Wolf-Hirschhorn Syndrome: Evidence for defects in neural crest cell migration."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        FGFRs 1 and 3 have recently been implicated in the chemotactic response of cardiac neural crest cells to FGF8 in the pharyngeal ecto-and endoderm in chick embryos, operating upstream of the MAPK/ERK pathway
      explanation: Supports the proposed pathway in chick embryos but does not establish the human WHS edge.
- name: Candidate MSX1-Dependent Odontogenesis Defect
  description: >
    Larger 4p deletions extend proximally to encompass MSX1, a homeobox
    transcription factor involved in odontogenesis. Heterozygous MSX1
    variants cause non-syndromic tooth agenesis; applying that evidence to
    WHS makes MSX1 haploinsufficiency a plausible contributor to hypodontia
    and abnormal tooth morphology, but the WHS-specific attribution remains
    extrapolative.
  gene:
    preferred_term: MSX1
    term:
      id: hgnc:7391
      label: MSX1
  cell_types:
  - preferred_term: odontoblast
    term:
      id: CL:0000060
      label: odontoblast
  biological_processes:
  - preferred_term: odontogenesis
    term:
      id: GO:0042476
      label: odontogenesis
    modifier: DYSREGULATED
  evidence:
  - reference: PMID:29628999
    reference_title: "A review on non-syndromic tooth agenesis associated with PAX9 mutations."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Mutation of candidate genes PAX9 and MSX1 have been identified as the main causes of hypodontia and oligodontia"
    explanation: Identifies MSX1 as a primary disease gene for tooth agenesis. Evidence is extrapolated from non-syndromic tooth agenesis literature; no WHS-specific MSX1 publication is cited here.
  downstream:
  - target: Tooth Abnormalities
    description: MSX1 haploinsufficiency is a candidate contributor to hypodontia and abnormal dental morphology in WHS.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:29628999
      reference_title: "A review on non-syndromic tooth agenesis associated with PAX9 mutations."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        Mutation of candidate genes PAX9 and MSX1 have been identified as the main causes of hypodontia and oligodontia
      explanation: Supports MSX1-related tooth agenesis outside WHS; the WHS attribution remains extrapolative.
- name: Humoral Antibody Deficiency
  description: >
    A selected series of infection-prone children with WHS documented
    common variable immunodeficiency, IgA or IgG2 subclass deficiency, and
    impaired polysaccharide responsiveness with normal T-cell immunity.
    NSD2-dependent B-cell class switching and B1-cell development in mice
    provide a plausible deleted-gene mechanism, but that attribution has not
    been established directly in human WHS.
  gene:
    preferred_term: NSD2
    term:
      id: hgnc:12766
      label: NSD2
  cell_types:
  - preferred_term: B cell
    term:
      id: CL:0000236
      label: B cell
  molecular_functions:
  - preferred_term: histone H3K36 dimethyltransferase activity
    term:
      id: GO:0140954
      label: histone H3K36 dimethyltransferase activity
    modifier: DECREASED
  evidence:
  - reference: PMID:9672528
    reference_title: Antibody deficiency in Wolf-Hirschhorn syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We identified antibody deficiencies in 9 of 13 infection-prone children with Wolf-Hirschhorn syndrome (4p-monosomy).
    explanation: >-
      Directly documents humoral antibody defects in a selected infection-prone
      WHS cohort; the selected denominator is not used as a population frequency.
  - reference: PMID:9672528
    reference_title: Antibody deficiency in Wolf-Hirschhorn syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Two of the children had common variable immunodeficiency, one had IgA and IgG2 subclass deficiency, three had IgA deficiency, and three had impaired polysaccharide responsiveness.
    explanation: Defines the spectrum of antibody defects observed in that cohort.
  - reference: PMID:32862441
    reference_title: "The catalytic domain of the histone methyltransferase NSD2/MMSET is required for the generation of B1 cells in mice."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "NSD2 is required for B cell class switch recombination"
    explanation: NSD2 is required for normal B-cell class switching, providing a mechanism for WHS-associated humoral immunodeficiency.
  - reference: PMID:32862441
    reference_title: "The catalytic domain of the histone methyltransferase NSD2/MMSET is required for the generation of B1 cells in mice."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "deletion of the catalytic domain of NSD2 in primary B cells impairs the generation of B1 lineage. Thus, NSD2, a histone H3 K36 dimethylase, is the first-in-class epigenetic regulator of a B-cell lineage in mice."
    explanation: NSD2 SET-domain loss in mouse B cells impairs B1 cell development.
  downstream:
  - target: Immunodeficiency
    description: Documented antibody-production defects constitute a humoral immunodeficiency phenotype in a subset of WHS patients.
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:9672528
      reference_title: Antibody deficiency in Wolf-Hirschhorn syndrome.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        We identified antibody deficiencies in 9 of 13 infection-prone children with Wolf-Hirschhorn syndrome (4p-monosomy).
      explanation: Directly documents the humoral immunodeficiency phenotype in a selected subgroup.
  - target: Recurrent Infections
    description: Impaired antibody quantity or vaccine-polysaccharide responsiveness increases susceptibility to recurrent infection.
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:9672528
      reference_title: Antibody deficiency in Wolf-Hirschhorn syndrome.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        We identified antibody deficiencies in 9 of 13 infection-prone children with Wolf-Hirschhorn syndrome (4p-monosomy).
      explanation: Connects recurrent-infection ascertainment with measured antibody deficiency while not estimating syndrome-wide risk.
phenotypes:
- category: Craniofacial
  name: Characteristic Facial Features
  diagnostic: true
  notes: The distinctive facies includes broad nasal bridge continuing to the forehead (Greek warrior helmet appearance), microcephaly, high forehead with prominent glabella, hypertelorism, and micrognathia.
  phenotype_term:
    preferred_term: Abnormal facial shape
    term:
      id: HP:0001999
      label: Abnormal facial shape
  evidence:
  - reference: PMID:25137600
    reference_title: "Wolf-Hirschhorn syndrome: a case study and disease overview."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The major features of this disorder include a characteristic facial appearance known as the \"Greek helmet,\" delayed growth and development; prenatally and postnatally, intellectual disabilities, and seizures."
    explanation: This establishes the characteristic Greek helmet facial appearance as a major diagnostic feature.
  - reference: PMID:32914558
    reference_title: "Wolf-Hirschhorn syndrome: A case series from India."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Its core features are typical facial gestalt, growth retardation, intellectual disability, or developmental delay and seizures."
    explanation: This identifies the typical facial gestalt as one of the core features of Wolf-Hirschhorn syndrome.
- category: Craniofacial
  name: Microcephaly
  diagnostic: true
  notes: >-
    Microcephaly is characteristic but not universal and can be absent in some
    individuals with smaller or cryptic unbalanced rearrangements.
  phenotype_term:
    preferred_term: Microcephaly
    term:
      id: HP:0000252
      label: Microcephaly
  evidence:
  - reference: PMID:18474167
    reference_title: "Wolf-Hirschhorn syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "It was characterized by well-described facial appearance, seizures, microcephaly and midline closure defects along with growth and mental retardation."
    explanation: This establishes microcephaly as a characteristic feature of Wolf-Hirschhorn syndrome.
- category: Craniofacial
  name: Hypertelorism
  diagnostic: true
  notes: Widely spaced eyes are a characteristic feature contributing to the distinctive facial appearance.
  phenotype_term:
    preferred_term: Hypertelorism
    term:
      id: HP:0000316
      label: Hypertelorism
  evidence:
  - reference: PMID:9774859
    reference_title: "Wolf-Hirschhorn syndrome: case report and review of the chromosomal aberrations associated with diaphragmatic defects."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "At the autopsy, the propositus showed microcephaly, prominent glabella, broad bridge of the nose, ocular hypertelorism, poorly differentiated and low-set ears, bilateral palatoschisis, and micrognathia."
    explanation: This case report confirms ocular hypertelorism as a characteristic craniofacial feature of Wolf-Hirschhorn syndrome.
  - reference: PMID:29199884
    reference_title: "Congenital cavitary optic disc anomaly and Axenfeld's anomaly in Wolf-Hirschhorn syndrome: A case report and review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Ocular findings included normal intraocular pressures and corneal diameters, large-angle exotropia, downward slanting of the palpebral fissures, absent eyelid creases, upper and lower eyelid retraction with shortage of the anterior eyelid lamellae, euryblepharon, lagophthalmos with poor Bell's reflex and exposure keratopathy, hypertelorism, Axenfeld's anomaly, megalopapillae, and cavitary optic disc anomaly."
    explanation: This documents hypertelorism as one of the ocular findings in Wolf-Hirschhorn syndrome.
- category: Ophthalmologic
  name: Ophthalmologic Abnormalities
  notes: >-
    Ocular manifestations are heterogeneous and may include strabismus,
    eyelid abnormalities, anterior-segment anomalies, exposure keratopathy,
    and optic-disc anomalies. The reported "up to 40%" figure is an upper bound,
    not a representative prevalence estimate, so no frequency band is assigned.
  phenotype_term:
    preferred_term: Abnormality of the eye
    term:
      id: HP:0000478
      label: Abnormality of the eye
  evidence:
  - reference: PMID:29199884
    reference_title: "Congenital cavitary optic disc anomaly and Axenfeld's anomaly in Wolf-Hirschhorn syndrome: A case report and review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      A variety of ocular manifestations may occur in up to 40% of patients.
    explanation: >-
      Documents a reported upper bound for ocular manifestations but does not
      establish a representative frequency band.
  - reference: PMID:29199884
    reference_title: "Congenital cavitary optic disc anomaly and Axenfeld's anomaly in Wolf-Hirschhorn syndrome: A case report and review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Ocular findings included normal intraocular pressures and corneal diameters, large-angle exotropia, downward slanting of the palpebral fissures, absent eyelid creases, upper and lower eyelid retraction with shortage of the anterior eyelid lamellae, euryblepharon, lagophthalmos with poor Bell's reflex and exposure keratopathy, hypertelorism, Axenfeld's anomaly, megalopapillae, and cavitary optic disc anomaly."
    explanation: Documents the heterogeneous ocular phenotype in an affected individual.
- category: Growth
  name: Intrauterine Growth Retardation
  frequency: VERY_FREQUENT
  diagnostic: true
  notes: Marked intrauterine growth retardation is a consistent prenatal finding in Wolf-Hirschhorn syndrome.
  phenotype_term:
    preferred_term: Intrauterine growth retardation
    term:
      id: HP:0001511
      label: Intrauterine growth retardation
  evidence:
  - reference: PMID:25137600
    reference_title: "Wolf-Hirschhorn syndrome: a case study and disease overview."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The major features of this disorder include a characteristic facial appearance known as the \"Greek helmet,\" delayed growth and development; prenatally and postnatally, intellectual disabilities, and seizures."
    explanation: This describes delayed growth and development both prenatally and postnatally as major features.
  - reference: PMID:20301362
    reference_title: "Wolf-Hirschhorn Syndrome – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      All affected individuals have prenatal-onset growth deficiency followed by postnatal growth retardation and hypotonia with muscle underdevelopment.
    explanation: Supports the very-frequent prenatal growth-deficiency annotation.
- category: Growth
  name: Postnatal Growth Retardation
  frequency: VERY_FREQUENT
  notes: Slow postnatal weight gain and continued growth impairment are characteristic.
  phenotype_term:
    preferred_term: Postnatal growth retardation
    term:
      id: HP:0008897
      label: Postnatal growth retardation
  evidence:
  - reference: PMID:30289612
    reference_title: "Risk of hepatic neoplasms in Wolf-Hirschhorn syndrome (4p-): Four new cases and review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Wolf-Hirschhorn syndrome (WHS) is a rare contiguous gene deletion disorder characterized by distinctive craniofacial features, prenatal/postnatal growth deficiency, intellectual disability, and seizures."
    explanation: This establishes prenatal/postnatal growth deficiency as a characteristic feature of Wolf-Hirschhorn syndrome.
  - reference: PMID:20301362
    reference_title: "Wolf-Hirschhorn Syndrome – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      All affected individuals have prenatal-onset growth deficiency followed by postnatal growth retardation and hypotonia with muscle underdevelopment.
    explanation: Supports the very-frequent postnatal growth-retardation annotation.
- category: Neurologic
  name: Intellectual Disability
  frequency: VERY_FREQUENT
  diagnostic: true
  notes: Intellectual disability is moderate to severe in most cases, rarely mild.
  phenotype_term:
    preferred_term: Intellectual disability
    term:
      id: HP:0001249
      label: Intellectual disability
  evidence:
  - reference: PMID:32914558
    reference_title: "Wolf-Hirschhorn syndrome: A case series from India."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Its core features are typical facial gestalt, growth retardation, intellectual disability, or developmental delay and seizures."
    explanation: This identifies intellectual disability as one of the core features of Wolf-Hirschhorn syndrome.
  - reference: PMID:25137600
    reference_title: "Wolf-Hirschhorn syndrome: a case study and disease overview."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The major features of this disorder include a characteristic facial appearance known as the \"Greek helmet,\" delayed growth and development; prenatally and postnatally, intellectual disabilities, and seizures."
    explanation: This establishes intellectual disabilities as a major feature of the disorder.
  - reference: PMID:18474167
    reference_title: "Wolf-Hirschhorn syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "It was characterized by well-described facial appearance, seizures, microcephaly and midline closure defects along with growth and mental retardation."
    explanation: This confirms mental retardation (intellectual disability) as a characteristic feature.
  - reference: PMID:20301362
    reference_title: "Wolf-Hirschhorn Syndrome – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Developmental delay/intellectual disability of variable degree is present in all.
    explanation: Directly supports the very-frequent intellectual-disability annotation.
- category: Neurologic
  name: Global Developmental Delay
  frequency: VERY_FREQUENT
  diagnostic: true
  notes: >-
    Global developmental delay is present in nearly all affected individuals,
    with severity varying across motor, speech, and adaptive domains.
  phenotype_term:
    preferred_term: Global developmental delay
    term:
      id: HP:0001263
      label: Global developmental delay
  evidence:
  - reference: PMID:29199884
    reference_title: "Congenital cavitary optic disc anomaly and Axenfeld's anomaly in Wolf-Hirschhorn syndrome: A case report and review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Wolf-Hirschhorn syndrome is a rare genetic syndrome caused by a heterozygous deletion on chromosome 4p16.3 and is characterized by a \"Greek warrior helmet\" facies, hypotonia, developmental delay, seizures, structural central nervous system defects, intrauterine growth restriction, sketelal anomalies, cardiac defects, abnormal tooth development, and hearing loss."
    explanation: This identifies developmental delay as one of the characteristic features of Wolf-Hirschhorn syndrome.
  - reference: PMID:40404199
    reference_title: "Clinical features, behaviour and language in Wolf-Hirschhorn syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Wolf-Hirschhorn syndrome (WHS) is associated with intellectual disability and multiple congenital anomalies."
    explanation: This confirms the association of Wolf-Hirschhorn syndrome with intellectual disability and developmental impairment.
  - reference: PMID:18932224
    reference_title: "Update on the clinical features and natural history of Wolf-Hirschhorn (4p-) syndrome: experience with 87 patients and recommendations for routine health supervision."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Global developmental delay of varying degrees was present in all patients.
    explanation: Directly supports the very-frequent global-developmental-delay annotation.
- category: Neurologic
  name: Seizures
  frequency: VERY_FREQUENT
  diagnostic: true
  notes: Seizures are a very frequent feature, occurring in the majority of patients with Wolf-Hirschhorn syndrome.
  phenotype_term:
    preferred_term: Seizure
    term:
      id: HP:0001250
      label: Seizure
  evidence:
  - reference: PMID:32914558
    reference_title: "Wolf-Hirschhorn syndrome: A case series from India."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Its core features are typical facial gestalt, growth retardation, intellectual disability, or developmental delay and seizures."
    explanation: This identifies seizures as one of the core features of Wolf-Hirschhorn syndrome.
  - reference: PMID:25137600
    reference_title: "Wolf-Hirschhorn syndrome: a case study and disease overview."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The major features of this disorder include a characteristic facial appearance known as the \"Greek helmet,\" delayed growth and development; prenatally and postnatally, intellectual disabilities, and seizures."
    explanation: This establishes seizures as a major feature of the disorder.
  - reference: PMID:18474167
    reference_title: "Wolf-Hirschhorn syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "It was characterized by well-described facial appearance, seizures, microcephaly and midline closure defects along with growth and mental retardation."
    explanation: This confirms seizures as a characteristic feature of Wolf-Hirschhorn syndrome.
  - reference: PMID:41303083
    reference_title: "Epilepsy in Wolf-Hirschhorn Syndrome: Clinical Insights from a Pediatric Cohort and a Review of the Literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Epilepsy was observed in 92% of patients, typically beginning before 12 months of age.
    explanation: Quantitatively supports the very-frequent seizure annotation.
- category: Neurologic
  name: Status Epilepticus
  frequency: FREQUENT
  notes: >
    Status epilepticus is a frequent and clinically significant
    complication of WHS-associated epilepsy, occurring in roughly 58%
    of patients in pediatric cohorts and contributing to neurological
    morbidity.
  phenotype_term:
    preferred_term: Status epilepticus
    term:
      id: HP:0002133
      label: Status epilepticus
  evidence:
  - reference: PMID:41303083
    reference_title: "Epilepsy in Wolf-Hirschhorn Syndrome: Clinical Insights from a Pediatric Cohort and a Review of the Literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Status epilepticus occurred in 58% of cases, with a high proportion requiring multiple ASMs."
    explanation: Pediatric WHS cohort directly quantifies status epilepticus prevalence at 58%.
- category: Neurologic
  name: Hypotonia
  frequency: VERY_FREQUENT
  diagnostic: true
  notes: Hypotonia with muscle underdevelopment is a characteristic feature.
  phenotype_term:
    preferred_term: Hypotonia
    term:
      id: HP:0001252
      label: Hypotonia
  evidence:
  - reference: PMID:29199884
    reference_title: "Congenital cavitary optic disc anomaly and Axenfeld's anomaly in Wolf-Hirschhorn syndrome: A case report and review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Wolf-Hirschhorn syndrome is a rare genetic syndrome caused by a heterozygous deletion on chromosome 4p16.3 and is characterized by a \"Greek warrior helmet\" facies, hypotonia, developmental delay, seizures, structural central nervous system defects, intrauterine growth restriction, sketelal anomalies, cardiac defects, abnormal tooth development, and hearing loss."
    explanation: This establishes hypotonia as one of the characteristic features of Wolf-Hirschhorn syndrome.
  - reference: PMID:18932224
    reference_title: "Update on the clinical features and natural history of Wolf-Hirschhorn (4p-) syndrome: experience with 87 patients and recommendations for routine health supervision."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Hypotonia was present in virtually all patients.
    explanation: Quantitatively supports the very-frequent hypotonia annotation.
- category: Neurologic
  name: Corpus Callosum Abnormalities
  notes: Structural central nervous system defects including corpus callosum abnormalities may occur.
  phenotype_term:
    preferred_term: Abnormal corpus callosum morphology
    term:
      id: HP:0001273
      label: Abnormal corpus callosum morphology
  evidence:
  - reference: PMID:29199884
    reference_title: "Congenital cavitary optic disc anomaly and Axenfeld's anomaly in Wolf-Hirschhorn syndrome: A case report and review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Systemic findings included \"Greek warrior helmet\" facies, hypotonia, cleft palate, neonatal tooth eruption, talipes equinovarus, bilateral clinodactyly, clitoromegaly, partial agenesis of the corpus callosum, bilateral renal hypoplasia, and two atrial septal defects."
    explanation: This case report documents partial agenesis of the corpus callosum as a structural CNS abnormality in Wolf-Hirschhorn syndrome.
  - reference: PMID:34572183
    reference_title: "Wolf-Hirschhorn Syndrome: Clinical and Genetic Study of 7 New Cases, and Mini Review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In some cases, we observed seizures, structural brain abnormalities, immunodeficiencies, and renal anomalies."
    explanation: This study identifies structural brain abnormalities as a manifestation in some cases of Wolf-Hirschhorn syndrome.
- category: Cardiac
  name: Congenital Heart Defects
  frequency: FREQUENT
  notes: Congenital heart defects occur in a substantial proportion of patients.
  phenotype_term:
    preferred_term: Congenital heart defect
    term:
      id: HP:0001627
      label: Abnormal heart morphology
  evidence:
  - reference: PMID:29199884
    reference_title: "Congenital cavitary optic disc anomaly and Axenfeld's anomaly in Wolf-Hirschhorn syndrome: A case report and review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Wolf-Hirschhorn syndrome is a rare genetic syndrome caused by a heterozygous deletion on chromosome 4p16.3 and is characterized by a \"Greek warrior helmet\" facies, hypotonia, developmental delay, seizures, structural central nervous system defects, intrauterine growth restriction, sketelal anomalies, cardiac defects, abnormal tooth development, and hearing loss."
    explanation: This identifies cardiac defects as one of the characteristic features of Wolf-Hirschhorn syndrome.
  - reference: PMID:33599186
    reference_title: "An unusual ophthalmic presentation of Wolf-Hirschhorn syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The infant had multiple congenital anomalies; a cleft palate, microcephalia, micrognathia, renal pelvicalyceal ectasia, atrial septal defect, transvers arcus hypoplasia, patent ductus arteriosus, hypospadias and undescended testicle."  # codespell:ignore-line
    explanation: This case report documents specific cardiac defects (atrial septal defect, patent ductus arteriosus) in Wolf-Hirschhorn syndrome.
  - reference: PMID:18932224
    reference_title: "Update on the clinical features and natural history of Wolf-Hirschhorn (4p-) syndrome: experience with 87 patients and recommendations for routine health supervision."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      60% had skeletal anomalies; 50% had heart lesions; 50% had abnormal tooth development
    explanation: Quantitatively supports the frequent congenital-heart-defect annotation.
- category: Skeletal
  name: Skeletal Anomalies
  frequency: FREQUENT
  notes: Skeletal anomalies may include kyphosis, scoliosis, vertebral malformations, and limb abnormalities.
  phenotype_term:
    preferred_term: Abnormality of the skeletal system
    term:
      id: HP:0000924
      label: Abnormality of the skeletal system
  evidence:
  - reference: PMID:29199884
    reference_title: "Congenital cavitary optic disc anomaly and Axenfeld's anomaly in Wolf-Hirschhorn syndrome: A case report and review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Wolf-Hirschhorn syndrome is a rare genetic syndrome caused by a heterozygous deletion on chromosome 4p16.3 and is characterized by a \"Greek warrior helmet\" facies, hypotonia, developmental delay, seizures, structural central nervous system defects, intrauterine growth restriction, sketelal anomalies, cardiac defects, abnormal tooth development, and hearing loss."
    explanation: This identifies skeletal anomalies as one of the characteristic features of Wolf-Hirschhorn syndrome.
  - reference: PMID:9774859
    reference_title: "Wolf-Hirschhorn syndrome: case report and review of the chromosomal aberrations associated with diaphragmatic defects."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Midline closure defects of the cervical spine bodies, lower jaw, and skull base were seen at postmortem radiography."
    explanation: This case report documents specific skeletal abnormalities including cervical spine defects in Wolf-Hirschhorn syndrome.
  - reference: PMID:18932224
    reference_title: "Update on the clinical features and natural history of Wolf-Hirschhorn (4p-) syndrome: experience with 87 patients and recommendations for routine health supervision."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      slow weight gain; 60% had skeletal anomalies; 50% had heart lesions
    explanation: Quantitatively supports the frequent skeletal-anomaly annotation.
- category: Genitourinary
  name: Renal Anomalies
  frequency: OCCASIONAL
  notes: >
    Renal/urological anomalies including renal hypoplasia and
    oligomeganephronia occur in a minority of WHS patients and warrant
    routine renal surveillance. The archival GeneReviews summary reports
    urinary-tract malformations in 25%.
  phenotype_term:
    preferred_term: Abnormality of the kidney
    term:
      id: HP:0000077
      label: Abnormality of the kidney
  evidence:
  - reference: PMID:34572183
    reference_title: "Wolf-Hirschhorn Syndrome: Clinical and Genetic Study of 7 New Cases, and Mini Review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In some cases, we observed seizures, structural brain abnormalities, immunodeficiencies, and renal anomalies."
    explanation: This study identifies renal anomalies as a manifestation in some cases of Wolf-Hirschhorn syndrome.
  - reference: PMID:41225980
    reference_title: "Renal Hypoplasia and Oligomeganephronia in a Fetus with Wolf-Hirschhorn Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "It is characterized by intrauterine growth restriction (IUGR), developmental delay, epilepsy, distinctive facial features, and urinary tract anomalies, particularly renal hypoplasia."
    explanation: This identifies renal hypoplasia as a characteristic urinary tract anomaly in Wolf-Hirschhorn syndrome.
  - reference: PMID:29199884
    reference_title: "Congenital cavitary optic disc anomaly and Axenfeld's anomaly in Wolf-Hirschhorn syndrome: A case report and review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Systemic findings included \"Greek warrior helmet\" facies, hypotonia, cleft palate, neonatal tooth eruption, talipes equinovarus, bilateral clinodactyly, clitoromegaly, partial agenesis of the corpus callosum, bilateral renal hypoplasia, and two atrial septal defects."
    explanation: This case report documents bilateral renal hypoplasia as a systemic finding in Wolf-Hirschhorn syndrome.
  - reference: PMID:20301362
    reference_title: "Wolf-Hirschhorn Syndrome – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Other findings include skeletal anomalies (60%-70%), congenital heart defects (~50%), hearing loss (mostly conductive) (>40%), urinary tract malformations (25%), and structural brain abnormalities (33%).
    explanation: Quantitatively supports the occasional urinary-tract-anomaly annotation.
- category: Hepatic
  name: Hepatic Neoplasia
  notes: >-
    Hepatocellular neoplasia has been proposed as a rare WHS manifestation from
    seven cumulative reported cases. No population frequency or causal deleted
    gene has been established.
  phenotype_term:
    preferred_term: Neoplasm of the liver
    term:
      id: HP:0002896
      label: Neoplasm of the liver
  evidence:
  - reference: PMID:30289612
    reference_title: "Risk of hepatic neoplasms in Wolf-Hirschhorn syndrome (4p-): Four new cases and review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We propose that, in the context of the rarity of WHS, these seven cases suggest that hepatocellular neoplasia may be a feature of WHS.
    explanation: >-
      Supports a proposed association while avoiding a frequency assignment
      from a small cumulative case series.
- category: Immunologic
  name: Immunodeficiency
  notes: >-
    Humoral immune defects include common variable immunodeficiency, IgA or
    IgG2 subclass deficiency, and impaired polysaccharide responsiveness. The
    available 9/13 proportion comes from a selected infection-prone cohort and
    is not treated as a population frequency.
  phenotype_term:
    preferred_term: Immunodeficiency
    term:
      id: HP:0002721
      label: Immunodeficiency
  evidence:
  - reference: PMID:34572183
    reference_title: "Wolf-Hirschhorn Syndrome: Clinical and Genetic Study of 7 New Cases, and Mini Review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In some cases, we observed seizures, structural brain abnormalities, immunodeficiencies, and renal anomalies."
    explanation: This study identifies immunodeficiencies as a rare manifestation that should be looked for in Wolf-Hirschhorn syndrome.
  - reference: PMID:9672528
    reference_title: Antibody deficiency in Wolf-Hirschhorn syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We identified antibody deficiencies in 9 of 13 infection-prone children with Wolf-Hirschhorn syndrome (4p-monosomy).
    explanation: >-
      Establishes antibody deficiency in a clinically selected WHS subgroup
      without supporting a syndrome-wide frequency estimate.
- category: Immunologic
  name: Recurrent Infections
  notes: >-
    Recurrent or clinically important infections should prompt evaluation for
    humoral antibody deficiency; published immune testing focused specifically
    on infection-prone children.
  phenotype_term:
    preferred_term: Recurrent infections
    term:
      id: HP:0002719
      label: Recurrent infections
  evidence:
  - reference: PMID:9672528
    reference_title: Antibody deficiency in Wolf-Hirschhorn syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We identified antibody deficiencies in 9 of 13 infection-prone children with Wolf-Hirschhorn syndrome (4p-monosomy).
    explanation: >-
      The infection-prone ascertainment documents the clinically relevant
      infection phenotype while precluding a population frequency estimate.
- category: Craniofacial
  name: Cleft Lip or Palate
  notes: Cleft lip/palate may occur in some cases.
  phenotype_term:
    preferred_term: Cleft palate
    term:
      id: HP:0000175
      label: Cleft palate
  evidence:
  - reference: PMID:33599186
    reference_title: "An unusual ophthalmic presentation of Wolf-Hirschhorn syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The infant had multiple congenital anomalies; a cleft palate, microcephalia, micrognathia, renal pelvicalyceal ectasia, atrial septal defect, transvers arcus hypoplasia, patent ductus arteriosus, hypospadias and undescended testicle."  # codespell:ignore-line
    explanation: This case report documents cleft palate as one of the congenital anomalies in Wolf-Hirschhorn syndrome.
- category: Gastrointestinal
  name: Feeding Difficulties
  notes: >
    Feeding difficulties are highly variable and may require special feeding
    techniques, gavage feeding, or gastrostomy, while contributing to postnatal
    growth failure. No quantitative frequency is assigned from the available
    evidence.
  phenotype_term:
    preferred_term: Feeding difficulties
    term:
      id: HP:0011968
      label: Feeding difficulties
  evidence:
  - reference: PMID:26747863
    reference_title: "Chromosomal microarray testing identifies a 4p terminal region associated with seizures in Wolf-Hirschhorn syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "additional highly variable clinical features of WHS include, but are not limited to, feeding difficulties, congenital heart defects, hearing loss, skeletal anomalies, kidney and urinary tract malformations, and ophthalmological and dental abnormalities."
    explanation: WHS clinical-genetic literature lists feeding difficulties among the recurrent variable features.
- category: Auditory
  name: Hearing Loss
  frequency: FREQUENT
  notes: >-
    Hearing loss affects about 40% or more of reported cohorts and is
    predominantly conductive, although a sensorineural component is also
    recognized.
  phenotype_term:
    preferred_term: Hearing impairment
    term:
      id: HP:0000365
      label: Hearing impairment
  evidence:
  - reference: PMID:18932224
    reference_title: "Update on the clinical features and natural history of Wolf-Hirschhorn (4p-) syndrome: experience with 87 patients and recommendations for routine health supervision."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      50% had abnormal tooth development; and 40% had hearing loss.
    explanation: Quantitatively supports the frequent hearing-loss annotation.
  - reference: PMID:20301362
    reference_title: "Wolf-Hirschhorn Syndrome – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      hearing loss (mostly conductive) (>40%)
    explanation: Supports both the frequency range and predominant conductive type.
- category: Auditory
  name: Sensorineural Hearing Loss
  frequency: OCCASIONAL
  notes: >
    Sensorineural hearing loss is reported in approximately 15% of individuals
    with WHS. Whsc1-deficient mice provide a candidate cochlear hair-cell
    mechanism; the model does not establish that all human sensorineural loss
    has this cause.
  phenotype_term:
    preferred_term: Sensorineural hearing impairment
    term:
      id: HP:0000407
      label: Sensorineural hearing impairment
  evidence:
  - reference: PMID:26092122
    reference_title: "Auditory hair cell defects as potential cause for sensorineural deafness in Wolf-Hirschhorn syndrome."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "The cardinal feature of WHS is a craniofacial dysmorphism, which is accompanied by sensorineural hearing loss in 15% of individuals with WHS."
    explanation: Quantitatively supports the occasional sensorineural-hearing-loss annotation; model findings are curated separately.
- category: Dental
  name: Tooth Abnormalities
  frequency: FREQUENT
  notes: >
    Dental abnormalities including hypodontia, abnormal tooth morphology,
    delayed eruption and neonatal teeth are recurrent in WHS, consistent
    with co-deletion of MSX1 in larger 4p deletions and broader cranial
    neural-crest dysfunction.
  phenotype_term:
    preferred_term: Abnormality of the dentition
    term:
      id: HP:0000164
      label: Abnormality of the dentition
  evidence:
  - reference: PMID:29199884
    reference_title: "Congenital cavitary optic disc anomaly and Axenfeld's anomaly in Wolf-Hirschhorn syndrome: A case report and review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Wolf-Hirschhorn syndrome is a rare genetic syndrome caused by a heterozygous deletion on chromosome 4p16.3 and is characterized by a \"Greek warrior helmet\" facies, hypotonia, developmental delay, seizures, structural central nervous system defects, intrauterine growth restriction, sketelal anomalies, cardiac defects, abnormal tooth development, and hearing loss."
    explanation: Lists abnormal tooth development among the characteristic WHS features.
  - reference: PMID:29199884
    reference_title: "Congenital cavitary optic disc anomaly and Axenfeld's anomaly in Wolf-Hirschhorn syndrome: A case report and review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Systemic findings included \"Greek warrior helmet\" facies, hypotonia, cleft palate, neonatal tooth eruption, talipes equinovarus, bilateral clinodactyly, clitoromegaly, partial agenesis of the corpus callosum, bilateral renal hypoplasia, and two atrial septal defects."
    explanation: Documents neonatal tooth eruption as a specific dental abnormality observed in WHS.
  - reference: PMID:18932224
    reference_title: "Update on the clinical features and natural history of Wolf-Hirschhorn (4p-) syndrome: experience with 87 patients and recommendations for routine health supervision."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      50% had abnormal tooth development
    explanation: Quantitatively supports the frequent dental-abnormality annotation.
genetic:
- name: Chromosome 4p16.3 Deletion
  association: Causal
  notes: >
    The defining lesion is a heterozygous distal 4p deletion. It may be a de
    novo pure deletion, the deleted component of an unbalanced translocation,
    or part of a ring or other complex rearrangement. Deletion size and gene
    content modify phenotype and mortality.
  evidence:
  - reference: PMID:32914558
    reference_title: "Wolf-Hirschhorn syndrome: A case series from India."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Less than half of the patients can be identified by conventional cytogenetics and molecular cytogenetic testing should be offered for diagnosis. Karyotyping of the parents should always be offered in a child with WHS."
    explanation: This provides important diagnostic guidance regarding the need for molecular cytogenetic testing and parental karyotyping.
  - reference: PMID:11584045
    reference_title: "An epidemiological study of Wolf-Hirschhorn syndrome: life expectancy and cause of mortality."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Cases with large de novo deletions (proximal to and including p15.2) were more likely to have died than those with smaller deletions (odds ratio=5.7, 95% CI=1.7-19.9) after adjusting for age."
    explanation: Larger 4p deletions carry a 5.7-fold increased mortality, consistent with the contiguous-gene-deletion model where more haploinsufficient genes drive worse outcomes.
  - reference: PMID:41303083
    reference_title: "Epilepsy in Wolf-Hirschhorn Syndrome: Clinical Insights from a Pediatric Cohort and a Review of the Literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Patients with more severe epilepsy tended to have larger deletions (>9 Mb) and poorer developmental outcomes.
    explanation: >-
      Records a cohort-level association between deletions above 9 Mb, epilepsy
      severity, and developmental outcome without treating the threshold as
      deterministically predictive for an individual.
  - reference: PMID:20301362
    reference_title: "Wolf-Hirschhorn Syndrome – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      WHS is caused by deletion of the WHSCR of chromosome 4p16.3 by one of several genetic mechanisms.
    explanation: Establishes the defining deletion and its mechanistic heterogeneity.
- name: NSD2 (WHSC1) Haploinsufficiency
  association: Contributory
  relationship_type: SUSCEPTIBILITY
  gene_term:
    preferred_term: NSD2
    term:
      id: hgnc:12766
      label: NSD2
  notes: >
    NSD2/WHSC1 is the H3K36 dimethyltransferase whose hemizygous loss is
    included in essentially all classic WHS deletions. Model-organism data
    support an epigenetic contribution to craniofacial, growth, cardiac, and
    cochlear phenotypes, but NSD2 loss alone has not been shown to cause the
    full contiguous-deletion syndrome.
  evidence:
  - reference: PMID:25942451
    reference_title: "The NSD family of protein methyltransferases in human cancer."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "NSD2 haploinsufficiency causes Wolf-Hirschhorn syndrome"
    explanation: >-
      Cancer-biology review shorthand linking NSD2 haploinsufficiency to WHS;
      the evidence supports this contributory genetic entry but not single-gene
      sufficiency for the full syndrome.
- name: LETM1 Haploinsufficiency
  association: Contributory
  relationship_type: SUSCEPTIBILITY
  gene_term:
    preferred_term: LETM1
    term:
      id: hgnc:6556
      label: LETM1
  notes: >
    LETM1, encoding the inner-mitochondrial-membrane K+/H+ and Ca2+/H+
    exchanger, lies in WHSCR-2 and is deleted in most WHS patients. It
    has long been considered the major candidate gene for WHS-associated
    seizures, but human deletion mapping indicates that LETM1
    haploinsufficiency is neither necessary nor sufficient.
  evidence:
  - reference: PMID:24738919
    reference_title: "Unusual 4p16.3 deletions suggest an additional chromosome region for the Wolf-Hirschhorn syndrome-associated seizures disorder."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "LETM1, encoding a mitochondrial protein playing a role in K(+) /H(+) exchange and in Ca(2+) homeostasis, is currently considered the major candidate gene."
    explanation: Establishes LETM1 as the historical major candidate seizure gene.
- name: PIGG Haploinsufficiency
  association: Candidate contributor
  relationship_type: SUSCEPTIBILITY
  gene_term:
    preferred_term: PIGG
    term:
      id: hgnc:25985
      label: PIGG
  notes: >
    PIGG lies within the refined 197 kb terminal 4p seizure-susceptibility
    region. Its haploinsufficiency, alongside CPLX1 and CTBP1, is
    nominated as a contributor to WHS-associated epilepsy by interval mapping
    and network analyses; those data do not isolate PIGG from neighboring
    deleted genes.
  evidence:
  - reference: PMID:26747863
    reference_title: "Chromosomal microarray testing identifies a 4p terminal region associated with seizures in Wolf-Hirschhorn syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We identify a small terminal region of chromosome 4p that represents a seizure susceptibility region. Deletion of this region in the context of WHS is sufficient for seizure occurrence."
    explanation: >-
      Supports the candidate interval containing PIGG but does not isolate PIGG
      from ZNF721 or other co-deleted genes.
- name: CPLX1 Haploinsufficiency
  association: Candidate contributor
  relationship_type: SUSCEPTIBILITY
  gene_term:
    preferred_term: CPLX1
    term:
      id: hgnc:2309
      label: CPLX1
  notes: >
    CPLX1 encodes Complexin-1, a SNARE-binding regulator of synaptic
    vesicle exocytosis. Computational network analysis nominates its
    haploinsufficiency, together with LETM1, PIGG, and CTBP1, as a candidate
    contributor to the seizure phenotype.
  evidence:
  - reference: PMID:35278209
    reference_title: "Distinct Epileptogenic Mechanisms Associated with Seizures in Wolf-Hirschhorn Syndrome."
    supports: SUPPORT
    evidence_source: COMPUTATIONAL
    snippet: "The proximity among the previous reported haploinsufficient candidate genes (PIGG, CPLX1, CTBP1, LETM1) and disease genes associated with epilepsy suggests not just one, but different impaired mechanisms in cellular networks responsible for the balance of neuronal activity in WHS patients, from which neuron communication is the most impaired in WHS-related seizures."
    explanation: Network analysis groups CPLX1 with PIGG/CTBP1/LETM1 as a synergistic seizure-susceptibility module.
- name: CTBP1 Haploinsufficiency
  association: Candidate contributor
  relationship_type: SUSCEPTIBILITY
  gene_term:
    preferred_term: CTBP1
    term:
      id: hgnc:2494
      label: CTBP1
  notes: >
    CTBP1 (C-terminal-binding protein 1) is a transcriptional corepressor
    expressed in brain. Its haploinsufficiency in WHS is implicated in
    seizure susceptibility and may be a pharmacologic target for future
    seizure therapy.
  evidence:
  - reference: PMID:35278209
    reference_title: "Distinct Epileptogenic Mechanisms Associated with Seizures in Wolf-Hirschhorn Syndrome."
    supports: SUPPORT
    evidence_source: COMPUTATIONAL
    snippet: "CTBP1 obtained the largest number of drug associations, reinforcing its importance for adaptations of brain circuits and its putative use as a pharmacological target for treating seizures/epilepsy in patients with WHS."
    explanation: Identifies CTBP1 as a candidate drug-targetable haploinsufficient gene in WHS.
- name: FGFR3 Haploinsufficiency
  association: Candidate contributor
  relationship_type: SUSCEPTIBILITY
  gene_term:
    preferred_term: FGFR3
    term:
      id: hgnc:3690
      label: FGFR3
  notes: >
    FGFR3 lies near the WHS critical regions and is co-deleted in many cases.
    Chick-embryo neural-crest biology makes reduced FGFR3 signaling a candidate
    developmental contributor, but the cited evidence does not establish a
    specific human WHS skeletal or cochlear effect.
  evidence:
  - reference: PMID:27777068
    reference_title: "Exploring the developmental mechanisms underlying Wolf-Hirschhorn Syndrome: Evidence for defects in neural crest cell migration."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "FGFRs 1 and 3 have recently been implicated in the chemotactic response of cardiac neural crest cells to FGF8 in the pharyngeal ecto-and endoderm in chick embryos, operating upstream of the MAPK/ERK pathway"
    explanation: FGFR3 haploinsufficiency may compromise cardiac neural-crest chemotaxis upstream of MAPK/ERK.
- name: MSX1 Haploinsufficiency
  association: Candidate contributor
  relationship_type: SUSCEPTIBILITY
  gene_term:
    preferred_term: MSX1
    term:
      id: hgnc:7391
      label: MSX1
  notes: >
    MSX1 is a homeobox transcription factor implicated in non-syndromic tooth
    agenesis. When co-deleted in larger 4p deletions it is a plausible dental
    contributor, but this assignment is extrapolated rather than directly
    demonstrated in WHS.
  evidence:
  - reference: PMID:29628999
    reference_title: "A review on non-syndromic tooth agenesis associated with PAX9 mutations."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Mutation of candidate genes PAX9 and MSX1 have been identified as the main causes of hypodontia and oligodontia"
    explanation: Identifies MSX1 as a primary tooth-agenesis disease gene; mechanistic role in WHS dental phenotypes is extrapolated from this non-syndromic literature.
diagnosis:
- name: Chromosomal microarray confirmation and deletion definition
  description: >-
    Chromosomal microarray is used to establish the distal 4p deletion, define
    its breakpoints and gene content, and detect additional copy-number changes
    from an unbalanced translocation. A heterozygous deletion including the
    WHS critical region establishes the molecular diagnosis in the appropriate
    clinical setting.
  diagnosis_term:
    preferred_term: chromosomal microarray analysis
    term:
      id: NCIT:C18477
      label: Microarray Analysis
  results: Heterozygous distal 4p16.3 deletion including the WHS critical region.
  evidence:
  - reference: PMID:20301362
    reference_title: "Wolf-Hirschhorn Syndrome – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The diagnosis of WHS is established by the finding of a heterozygous deletion of the Wolf-Hirschhorn syndrome critical region (WHSCR) on chromosome 4p16.3 by chromosomal microarray (CMA), conventional G-banded cytogenetic analysis, or fluorescence in situ hybridization (FISH).
    explanation: Defines the diagnostic lesion and accepted cytogenetic methods.
  - reference: PMID:18932224
    reference_title: "Update on the clinical features and natural history of Wolf-Hirschhorn (4p-) syndrome: experience with 87 patients and recommendations for routine health supervision."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Array-CGH analysis at 1 Mb resolution was performed in 34/87 patients, and, in 15/34 (44%), showed an unbalanced translocation leading to both a 4p monosomy and a partial trisomy for another chromosome arm.
    explanation: Shows why genome-wide copy-number definition matters beyond a targeted deletion call.
- name: Karyotype and targeted FISH assessment
  description: >-
    Conventional karyotyping can identify larger 4p deletions, rings, and
    translocations, while targeted FISH can confirm a suspected deletion not
    visible by routine chromosome analysis. Once WHS is diagnosed, parental
    karyotyping is important to determine whether a balanced rearrangement
    changes recurrence risk.
  diagnosis_term:
    preferred_term: karyotyping
    term:
      id: NCIT:C16768
      label: Karyotyping
  results: Defines visible structural rearrangements and parental balanced-rearrangement status.
  evidence:
  - reference: PMID:18932224
    reference_title: "Update on the clinical features and natural history of Wolf-Hirschhorn (4p-) syndrome: experience with 87 patients and recommendations for routine health supervision."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Deletion was detected by standard cytogenetics in 44/87 (50.5%) patients, whereas FISH was necessary in the other 43 (49.5%).
    explanation: Documents complementary diagnostic yield of standard cytogenetics and targeted FISH in the cohort.
  - reference: PMID:32914558
    reference_title: "Wolf-Hirschhorn syndrome: A case series from India."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Karyotyping of the parents should always be offered in a child with WHS.
    explanation: Supports parental chromosome analysis for recurrence-risk assessment.
differential_diagnoses:
- name: Cri-du-chat syndrome
  disease_term:
    preferred_term: Cri-du-chat syndrome
    term:
      id: MONDO:0007404
      label: cri du chat syndrome
  description: >-
    Cri-du-chat syndrome is another terminal autosomal deletion disorder with
    prenatal or postnatal growth impairment, microcephaly, craniofacial
    dysmorphism, developmental delay, and possible cardiac, neurologic, and
    renal malformations. Cytogenetic testing distinguishes its 5p deletion from
    the distal 4p deletion of WHS.
  distinguishing_features:
  - A high-pitched monochromatic cat-like cry and a chromosome 5p deletion favor Cri-du-chat syndrome.
  - A Greek-warrior-helmet facial gestalt with a distal 4p16.3 deletion favors Wolf-Hirschhorn syndrome.
  evidence:
  - reference: PMID:16953888
    reference_title: Cri du Chat syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The Cri du Chat syndrome (CdCS) is a genetic disease resulting from a deletion of variable size occurring on the short arm of chromosome 5 (5p-).
    explanation: Establishes the alternative chromosomal lesion.
  - reference: PMID:16953888
    reference_title: Cri du Chat syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The main clinical features are a high-pitched monochromatic cry, microcephaly, broad nasal bridge, epicanthal folds, micrognathia, abnormal dermatoglyphics, and severe psychomotor and mental retardation.
    explanation: Documents the overlapping phenotype and the characteristic cry that helps distinguish Cri-du-chat syndrome.
- name: Dravet syndrome
  disease_term:
    preferred_term: Dravet syndrome
    term:
      id: MONDO:0100135
      label: Dravet syndrome
  description: >-
    WHS epilepsy can resemble Dravet syndrome through infantile onset,
    fever-associated prolonged clonic or tonic-clonic seizures, atypical
    absences, and later developmental impairment. Children with subtle WHS
    dysmorphism may initially undergo SCN1A testing. Chromosomal microarray
    showing distal 4p deletion favors WHS, whereas a pathogenic SCN1A variant
    without the WHS deletion supports Dravet syndrome.
  distinguishing_features:
  - The characteristic WHS facial gestalt, congenital anomalies, and distal 4p deletion favor Wolf-Hirschhorn syndrome.
  - A pathogenic SCN1A variant in the appropriate electroclinical setting favors Dravet syndrome.
  evidence:
  - reference: PMID:26747863
    reference_title: "Chromosomal microarray testing identifies a 4p terminal region associated with seizures in Wolf-Hirschhorn syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Individuals with WHS display a distinctive electroclinical pattern resembling the severe myoclonic epilepsy of infancy or Dravet syndrome.
    explanation: Directly establishes the electroclinical overlap.
  - reference: PMID:26747863
    reference_title: "Chromosomal microarray testing identifies a 4p terminal region associated with seizures in Wolf-Hirschhorn syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      some patients with a milder presentation of WHS-related dysmorphologies are sometimes first suspected of having Dravet syndrome
    explanation: Documents the real-world diagnostic confusion in mildly dysmorphic WHS.
treatments:
- name: Seizure Management with Levetiracetam
  description: >-
    Levetiracetam is commonly used for WHS-associated epilepsy and was rated
    the most effective antiseizure medication in one retrospective study.
  action_category: THERAPEUTIC
  therapeutic_modality: SMALL_MOLECULE
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
    therapeutic_agent:
    - preferred_term: levetiracetam
      term:
        id: CHEBI:6437
        label: levetiracetam
  target_phenotypes:
  - preferred_term: Seizure
    term:
      id: HP:0001250
      label: Seizure
  evidence:
  - reference: PMID:37075791
    reference_title: "Efficacy of Antiseizure Medications in Wolf-Hirschhorn Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The most effective ASM was levetiracetam. Although WHS-associated epilepsy is intractable with frequent SE occurrence during infancy, improvement in seizure control is expected with age. Levetiracetam may be a novel ASM for WHS."
    explanation: This study found levetiracetam to be the most effective antiseizure medication for Wolf-Hirschhorn syndrome.
  - reference: PMID:41303083
    reference_title: "Epilepsy in Wolf-Hirschhorn Syndrome: Clinical Insights from a Pediatric Cohort and a Review of the Literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Valproic acid and levetiracetam were the most commonly used treatments."
    explanation: This cohort study confirms that levetiracetam is one of the most commonly used antiseizure medications for WHS.
- name: Seizure Management with Valproic Acid
  description: >-
    Valproic acid is commonly used for WHS-associated epilepsy and the archival
    GeneReviews chapter specifically recommends it for atypical absence
    seizures. Carbamazepine may worsen atypical absence seizures and should be
    avoided for that seizure type.
  action_category: THERAPEUTIC
  therapeutic_modality: SMALL_MOLECULE
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
    therapeutic_agent:
    - preferred_term: valproic acid
      term:
        id: CHEBI:39867
        label: valproic acid
  target_phenotypes:
  - preferred_term: Seizure
    term:
      id: HP:0001250
      label: Seizure
  evidence:
  - reference: PMID:41303083
    reference_title: "Epilepsy in Wolf-Hirschhorn Syndrome: Clinical Insights from a Pediatric Cohort and a Review of the Literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Valproic acid and levetiracetam were the most commonly used treatments."
    explanation: This large cohort study indicates valproic acid is one of the most frequently prescribed antiseizure medications for WHS.
  - reference: PMID:20301362
    reference_title: "Wolf-Hirschhorn Syndrome – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      valproic acid for atypical absence seizures; benzodiazepines for status epilepticus
    explanation: >-
      Supplies the archival seizure-type-specific valproate recommendation and
      is retained only with the chapter's retirement caveat.
  - reference: PMID:20301362
    reference_title: "Wolf-Hirschhorn Syndrome – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Agents/circumstances to avoid: Carbamazepine may worsen atypical absence seizures.
    explanation: Records the seizure-type-specific medication-safety warning.
- name: Growth Hormone Therapy
  description: >-
    Recombinant human growth hormone may be considered only for an individual
    with documented growth hormone deficiency. The available WHS evidence is a
    single long-term case and does not support routine use for syndrome-related
    growth failure alone.
  action_category: THERAPEUTIC
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
  target_phenotypes:
  - preferred_term: Postnatal growth retardation
    term:
      id: HP:0008897
      label: Postnatal growth retardation
  evidence:
  - reference: PMID:41017003
    reference_title: "Wolf-Hirschhorn syndrome with growth hormone deficiency: long-term response to RhGH therapy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Across 11 years of rhGH, height improved from ~ - 4.2 to ~ - 1.3 SDS with normalized height velocity and a prolonged but uneventful pubertal course. No major adverse effects were observed. Muscle tone improvement was also noted with treatment initiation."
    explanation: >-
      Single-case evidence supports a possible response in the specific context
      of confirmed growth hormone deficiency, not a general WHS indication.
- name: Benzodiazepines for Status Epilepticus
  description: >-
    Acute status epilepticus requires prompt protocol-based treatment; the
    archival GeneReviews chapter specifically lists benzodiazepines for status
    epilepticus in WHS.
  action_category: THERAPEUTIC
  therapeutic_modality: SMALL_MOLECULE
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
  target_phenotypes:
  - preferred_term: Status epilepticus
    term:
      id: HP:0002133
      label: Status epilepticus
  evidence:
  - reference: PMID:20301362
    reference_title: "Wolf-Hirschhorn Syndrome – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      valproic acid for atypical absence seizures; benzodiazepines for status epilepticus
    explanation: Directly supports benzodiazepine use for this acute complication.
- name: Multidisciplinary Rehabilitation Therapy
  description: >
    Multidisciplinary rehabilitation including physical therapy, speech and
    communication therapy, sign language, and occupational therapy is the
    standard of care to address the developmental delay, hypotonia, and
    motor/communication impairments seen in WHS.
  action_category: THERAPEUTIC
  therapeutic_modality: BEHAVIORAL
  treatment_term:
    preferred_term: physical therapy
    term:
      id: NCIT:C15302
      label: Physical Therapy
  target_phenotypes:
  - preferred_term: Global developmental delay
    term:
      id: HP:0001263
      label: Global developmental delay
  - preferred_term: Hypotonia
    term:
      id: HP:0001252
      label: Hypotonia
  evidence:
  - reference: PMID:20301362
    reference_title: "Wolf-Hirschhorn Syndrome – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Treatment includes: rehabilitation, speech/communication therapy and sign language"
    explanation: GeneReviews lists rehabilitation and speech/communication therapy as core management for WHS.
- name: Feeding Support
  description: >
    Special feeding techniques, gavage feeding, and gastrostomy placement
    are recommended for the feeding difficulties common in WHS, which
    contribute to postnatal growth deficiency.
  action_category: THERAPEUTIC
  therapeutic_modality: BEHAVIORAL
  treatment_term:
    preferred_term: dietary intervention
    term:
      id: NCIT:C15447
      label: Dietary Intervention
  target_phenotypes:
  - preferred_term: Feeding difficulties
    term:
      id: HP:0011968
      label: Feeding difficulties
  evidence:
  - reference: PMID:20301362
    reference_title: "Wolf-Hirschhorn Syndrome – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "special feeding techniques, gavage feeding, and/or gastrostomy for feeding difficulties"
    explanation: GeneReviews recommends graduated feeding support for the WHS feeding-difficulty phenotype.
- name: Genetic Counseling
  description: >
    Genetic counseling incorporates the proband's deletion mechanism and
    parental chromosome findings. A confirmed parental balanced rearrangement
    changes recurrence risk and enables targeted prenatal testing.
  action_category: COUNSELING_INFORMATIONAL
  treatment_term:
    preferred_term: Genetic Counseling
    term:
      id: NCIT:C15240
      label: Genetic Counseling
  evidence:
  - reference: PMID:20301362
    reference_title: "Wolf-Hirschhorn Syndrome – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Risks to family members depend on the mechanism of origin of the deletion. Prenatal testing is possible for families in which one parent is known to be a carrier of a chromosome rearrangement involving 4p16.3."
    explanation: GeneReviews establishes the indication for genetic counseling and prenatal testing in WHS families.
- name: Immunoglobulin Replacement for Documented Antibody Deficiency
  description: >-
    IVIG may be used for selected individuals with documented antibody
    deficiency and clinically important infections; continuous antibiotic
    prophylaxis is another option described in the archival management summary.
    This is not universal treatment for all individuals with WHS.
  action_category: THERAPEUTIC
  treatment_term:
    preferred_term: intravenous immunoglobulin therapy
    term:
      id: NCIT:C62710
      label: Immunoglobulin Therapy
  target_phenotypes:
  - preferred_term: Immunodeficiency
    term:
      id: HP:0002721
      label: Immunodeficiency
  - preferred_term: Recurrent infections
    term:
      id: HP:0002719
      label: Recurrent infections
  evidence:
  - reference: PMID:20301362
    reference_title: "Wolf-Hirschhorn Syndrome – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      IVIG infusions or continuous antibiotics for those with antibody deficiencies.
    explanation: Bounds immune-directed management to patients with documented antibody deficiency.
- name: Multisystem Surveillance
  description: >-
    Longitudinal follow-up should monitor developmental therapies and known
    complications. The archival GeneReviews summary specifies annual complete
    blood count and renal-function testing and consideration of routine liver
    ultrasonography, with standard specialty care for skeletal, ophthalmologic,
    cardiac, hearing, sleep, and hepatic manifestations. Because the chapter is
    retired, schedules should be individualized with current specialist input.
  action_category: MONITORING
  treatment_term:
    preferred_term: Supportive Care
    term:
      id: NCIT:C15747
      label: Supportive Care
  evidence:
  - reference: PMID:20301362
    reference_title: "Wolf-Hirschhorn Syndrome – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Surveillance: Systematic follow up to monitor rehabilitation and treatment as needed; annual complete blood count and renal function testing; consideration of routine liver ultrasounds.
    explanation: Provides the explicit historical surveillance schedule, retained with a retirement caveat.
  - reference: PMID:20301362
    reference_title: "Wolf-Hirschhorn Syndrome – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Standard care is recommended for skeletal anomalies, ophthalmologic abnormalities, congenital heart defects, hearing loss, sleep disturbance, and hepatic adenomas.
    explanation: Supports coordinated specialty follow-up across recurrent WHS complications.
animal_models:
- species: Mus musculus
  genotype: Whsc1/Nsd2 deficiency, including haploinsufficient and deficient mouse embryos
  genes:
  - preferred_term: NSD2
    term:
      id: hgnc:12766
      label: NSD2
  description: >-
    Whsc1-deficient mice model one deleted gene rather than the full human 4p
    contiguous deletion. They show growth retardation and WHS-like midline and
    cardiovascular defects, with genetic interaction between Whsc1 and Nkx2-5.
    A complementary cochlear study found disorganized hair cells and abnormal
    stereocilia bundles, supporting an NSD2-dependent sensorineural-hearing
    mechanism. The single-gene model cannot assign the remaining human
    deletion phenotypes.
  associated_phenotypes:
  - Growth retardation
  - Midline defects
  - Congenital cardiovascular anomalies
  - Cochlear hair-cell and stereocilia abnormalities
  evidence:
  - reference: PMID:19483677
    reference_title: "A histone H3 lysine 36 trimethyltransferase links Nkx2-5 to Wolf-Hirschhorn syndrome."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Whsc1-deficient mice showed growth retardation and various WHS-like midline defects, including congenital cardiovascular anomalies.
    explanation: Documents WHS-relevant growth, midline, and cardiac phenotypes in the mouse model.
  - reference: PMID:19483677
    reference_title: "A histone H3 lysine 36 trimethyltransferase links Nkx2-5 to Wolf-Hirschhorn syndrome."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      The effects of Whsc1 haploinsufficiency were increased in Nkx2-5 heterozygous mutant hearts, indicating their functional link.
    explanation: Supports a Whsc1-Nkx2-5 developmental interaction in the cardiac phenotype.
  - reference: PMID:26092122
    reference_title: "Auditory hair cell defects as potential cause for sensorineural deafness in Wolf-Hirschhorn syndrome."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Although auditory hair cells are specified normally, their stereocilia hair bundles required for sound perception fail to develop the appropriate morphology.
    explanation: Documents the cochlear hair-bundle phenotype in Whsc1-deficient mice.
- species: Mus musculus
  genotype: Heterozygous Letm1 loss (Letm1±)
  genes:
  - preferred_term: LETM1
    term:
      id: hgnc:6556
      label: LETM1
  description: >-
    Heterozygous Letm1 mice show increased susceptibility to chemically induced
    seizures. This single-gene, provoked-seizure model supports a susceptibility
    role but does not reproduce spontaneous human WHS epilepsy or the multigene
    distal 4p deletion.
  associated_phenotypes:
  - Increased chemically induced seizure susceptibility
  evidence:
  - reference: PMID:26747863
    reference_title: "Chromosomal microarray testing identifies a 4p terminal region associated with seizures in Wolf-Hirschhorn syndrome."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      heterozygous Letm1± mice, as well as rats with a lentiviral-mediated Letm1 knockdown, demonstrate increased seizure susceptibility in response to kainic acid or pilocarpine seizure induction.
    explanation: >-
      Documents challenge-induced seizure susceptibility in heterozygous Letm1
      mice while leaving spontaneous epilepsy and multigene effects untested.
- species: Rattus norvegicus
  genotype: Lentiviral-mediated Letm1 knockdown
  genes:
  - preferred_term: LETM1
    term:
      id: hgnc:6556
      label: LETM1
  description: >-
    Lentiviral Letm1 knockdown in rats increases susceptibility to chemically
    induced seizures. The acute single-gene perturbation and provoked endpoint
    limit translation to spontaneous epilepsy in a constitutional multigene 4p
    deletion.
  associated_phenotypes:
  - Increased chemically induced seizure susceptibility
  evidence:
  - reference: PMID:26747863
    reference_title: "Chromosomal microarray testing identifies a 4p terminal region associated with seizures in Wolf-Hirschhorn syndrome."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      heterozygous Letm1± mice, as well as rats with a lentiviral-mediated Letm1 knockdown, demonstrate increased seizure susceptibility in response to kainic acid or pilocarpine seizure induction.
    explanation: >-
      Documents challenge-induced seizure susceptibility after rat Letm1
      knockdown, not a constitutional human-like deletion model.
- species: Danio rerio
  genotype: Morpholino knockdown of DrWhsc1, the zebrafish NSD2 homolog
  genes:
  - preferred_term: NSD2
    term:
      id: hgnc:12766
      label: NSD2
  description: >-
    DrWhsc1 morphants model acute reduction of the zebrafish NSD2 homolog.
    They show impaired embryonic H3K36 dimethylation with brain, cartilage,
    bone, and motor-neuron abnormalities. Morpholino knockdown and a single-gene
    perturbation are important limitations relative to a stable heterozygous
    multigene human deletion.
  associated_phenotypes:
  - Endbrain enlargement
  - Abnormal cartilage
  - Reduced bone
  - Incomplete motor-neuron formation
  evidence:
  - reference: PMID:20946879
    reference_title: "Functional characterization of the zebrafish WHSC1-related gene, a homolog of human NSD2."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Morpholino oligonucleotides for the DrWhsc1 gene affected early embryogenesis in zebrafish, such as endbrain enlargement, abnormal cartilage, marked reduction of bone, and incomplete motor neuron formation.
    explanation: Defines the developmental phenotype of the zebrafish knockdown model.
  - reference: PMID:20946879
    reference_title: "Functional characterization of the zebrafish WHSC1-related gene, a homolog of human NSD2."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      suppression of the DrWhsc1 gene or defect in the SET domain of DrWhsc1 resulted in impairment of di-methylation of histone H3K36 at early embryogenesis
    explanation: Links DrWhsc1 perturbation to the predicted chromatin defect.
discussions:
- discussion_id: gap_whs_deletion_resolved_causality
  prompt: >-
    Which distal 4p genes and gene combinations are necessary for each major WHS
    phenotype, and how do deletion size, breakpoint, and additional duplicated
    material alter penetrance?
  kind: KNOWLEDGE_GAP
  status: OPEN
  attaches_to:
  - pathophysiology#4p16.3 Contiguous Gene Deletion
  - pathophysiology#NSD2 (WHSC1) Haploinsufficiency
  - pathophysiology#Telomeric 4p Seizure-Susceptibility Region Haploinsufficiency
  - pathophysiology#Candidate Multigene Neuronal-Communication Dysfunction
  rationale: >-
    Human deletion mapping supports a multigene syndrome and identifies
    candidate intervals, but most individual-gene assignments remain
    correlational or extrapolated. Resolving this gap is necessary for
    genotype-specific prognosis and for distinguishing causal drivers from
    passengers in differently sized deletions.
  proposed_experiments:
  - experiment_id: exp_whs_isogenic_4p_dosage_series
    name: Isogenic distal-4p deletion and gene-restoration series
    description: >-
      Engineer matched human iPSC lines carrying nested heterozygous distal-4p
      deletions, then restore NSD2, LETM1, PIGG, or defined gene combinations.
      Differentiate cortical, neural-crest, cardiac, renal, and cochlear lineages
      and compare chromatin, mitochondrial, electrophysiologic, migration, and
      morphogenesis readouts.
    decision_criterion: >-
      Reproducible rescue by one restored gene would assign that dosage
      component to the affected lineage; rescue only after defined multigene
      restoration would support a synergistic contiguous-deletion mechanism.
    evidence:
    - reference: PMID:26239400
      reference_title: "Wolf-Hirschhorn syndrome: A review and update."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        Thus, the next step is to determine the precise effects of specific gene deletions.
      explanation: Motivates an isogenic experiment that separates the effects of specific deleted genes.
  evidence:
  - reference: PMID:26239400
    reference_title: "Wolf-Hirschhorn syndrome: A review and update."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Thus, the next step is to determine the precise effects of specific gene deletions.
    explanation: The review explicitly identifies gene-resolved dosage effects as the next mechanistic task.
  - reference: PMID:26239400
    reference_title: "Wolf-Hirschhorn syndrome: A review and update."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      our focus will continue to be on the establishment of robust genotype-phenotype correlations and the penetrance of these phenotypes.
    explanation: Supports the need for deletion-resolved penetrance estimates.
- discussion_id: gap_whs_human_model_translation
  prompt: >-
    How faithfully do current NSD2 developmental models and LETM1
    seizure-susceptibility models represent a human heterozygous multigene 4p
    deletion?
  kind: HUMAN_MODEL_MISMATCH
  status: OPEN
  attaches_to:
  - pathophysiology#Impaired H3K36 Dimethylation and Developmental Gene Mis-regulation
  - pathophysiology#LETM1 Haploinsufficiency and Mitochondrial Ion Dyshomeostasis
  - pathophysiology#Candidate FGFR3-Dependent Neural-Crest Signaling Defect
  - pathophysiology#Humoral Antibody Deficiency
  rationale: >-
    Existing models establish important NSD2- and LETM1-dependent biology but
    perturb one gene; some use homozygous deficiency, transient knockdown, or
    pharmacologically triggered seizures. They cannot by themselves validate
    the human effects of heterozygous dosage loss across multiple neighboring
    genes or interactions with unbalanced-translocation trisomic material.
  proposed_experiments:
  - experiment_id: exp_whs_model_benchmark
    name: Cross-model benchmark against deletion-resolved human cells
    description: >-
      Compare matched molecular and developmental readouts across nested-deletion
      human iPSC lineages, stable heterozygous Nsd2 mouse cells, and stable
      heterozygous zebrafish mutants. In a parallel neuronal/seizure arm, compare
      human deletion-derived neurons with heterozygous Letm1 mice and
      lentiviral-mediated Letm1-knockdown rats at baseline and under matched
      kainic-acid or pilocarpine challenge. Separate conserved single-gene
      effects from phenotypes that require additional 4p dosage loss.
    decision_criterion: >-
      Translational conservation requires concordant lineage-specific NSD2
      signatures across heterozygous human and animal models and concordant
      LETM1-related neuronal or seizure-threshold effects across human cells,
      heterozygous mice, and rat knockdown. Effects confined to homozygous,
      morpholino, knockdown, or provoked-seizure conditions would limit their
      relevance to human WHS haploinsufficiency.
    evidence:
    - reference: PMID:26239400
      reference_title: "Wolf-Hirschhorn syndrome: A review and update."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        New animal models will also be developed to further our understanding of the effects of hemizygosity as well as to serve as models for treatment development.
      explanation: Motivates a cross-model benchmark centered on human hemizygosity.
    - reference: PMID:26747863
      reference_title: "Chromosomal microarray testing identifies a 4p terminal region associated with seizures in Wolf-Hirschhorn syndrome."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        heterozygous Letm1± mice, as well as rats with a lentiviral-mediated Letm1 knockdown, demonstrate increased seizure susceptibility in response to kainic acid or pilocarpine seizure induction.
      explanation: >-
        Supplies the permitted evidence for the explicit LETM1 mouse/rat
        comparison arm while underscoring that the existing endpoint is
        challenge-induced seizure susceptibility.
  evidence:
  - reference: PMID:26239400
    reference_title: "Wolf-Hirschhorn syndrome: A review and update."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      New animal models will also be developed to further our understanding of the effects of hemizygosity as well as to serve as models for treatment development.
    explanation: The review explicitly calls for models that address hemizygosity and treatment translation.
review_notes: >-
  The GeneReviews chapter available for WHS is retired and explicitly warns that
  it may be out of date. This review retains it as a clearly tagged historical
  baseline for diagnosis, management, surveillance, and counseling, and
  cross-checks phenotype frequencies, natural history, epilepsy, mortality,
  genotype mapping, and immune findings against later primary cohorts and
  reviews.

📚

References & Deep Research

References

7

PMID:20301362

Wolf-Hirschhorn Syndrome – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY.

1 finding

Archival expert summary covering phenotype, diagnosis, supportive management, surveillance, and genetic counseling; it is explicitly retired and is therefore cross-checked against newer cohorts and reviews.

"NOTE: THIS PUBLICATION HAS BEEN RETIRED. THIS ARCHIVAL VERSION IS FOR HISTORICAL REFERENCE ONLY, AND THE INFORMATION MAY BE OUT OF DATE."

Show evidence (1 reference)

PMID:20301362 SUPPORT Other

"NOTE: THIS PUBLICATION HAS BEEN RETIRED. THIS ARCHIVAL VERSION IS FOR HISTORICAL REFERENCE ONLY, AND THE INFORMATION MAY BE OUT OF DATE."

Establishes the retirement caveat governing use of this source.

PMID:26239400

Wolf-Hirschhorn syndrome: A review and update.

1 finding

Review framing WHS as distal 4p monosomy and identifying deletion-resolved genotype-phenotype correlation as the major unresolved task.

"Thus, the next step is to determine the precise effects of specific gene deletions."

Show evidence (1 reference)

PMID:26239400 SUPPORT Other

"Thus, the next step is to determine the precise effects of specific gene deletions."

Directly states the review's deletion-resolved research priority.

PMID:18932224

Update on the clinical features and natural history of Wolf-Hirschhorn (4p-) syndrome: experience with 87 patients and recommendations for routine health supervision.

1 finding

Eighty-seven-person natural-history cohort providing quantitative phenotype frequencies and longitudinal clinical observations.

"Global developmental delay of varying degrees was present in all patients."

Show evidence (1 reference)

PMID:18932224 SUPPORT Human Clinical

"Global developmental delay of varying degrees was present in all patients."

Example quantitative phenotype result from the natural-history cohort.

PMID:26747863

Chromosomal microarray testing identifies a 4p terminal region associated with seizures in Wolf-Hirschhorn syndrome.

1 finding

Chromosomal-microarray mapping study refining a distal 4p seizure susceptibility interval while challenging a single-gene LETM1 model.

"Some of these deletions suggest that LETM1 deletion is neither necessary nor sufficient for the expression of a seizure phenotype in individuals with WHS"

Show evidence (1 reference)

PMID:26747863 SUPPORT Human Clinical

"Some of these deletions suggest that LETM1 deletion is neither necessary nor sufficient for the expression of a seizure phenotype in individuals with WHS"

Directly challenges a single-gene LETM1 explanation using human deletion mapping.

PMID:41303083

Epilepsy in Wolf-Hirschhorn Syndrome: Clinical Insights from a Pediatric Cohort and a Review of the Literature.

1 finding

Contemporary 140-patient cohort defining epilepsy burden, status epilepticus frequency, treatment patterns, and age-related course.

"Epilepsy was observed in 92% of patients, typically beginning before 12 months of age."

Show evidence (1 reference)

PMID:41303083 SUPPORT Human Clinical

"Epilepsy was observed in 92% of patients, typically beginning before 12 months of age."

Quantifies epilepsy and its typical onset in the 140-person cohort.

PMID:11584045

An epidemiological study of Wolf-Hirschhorn syndrome: life expectancy and cause of mortality.

1 finding

UK epidemiologic cohort quantifying early mortality and the association between larger de novo deletions and mortality.

"The crude infant mortality rate was 17% (23/132) and in the first two years of life the mortality rate was 21% (28/132)."

Show evidence (1 reference)

PMID:11584045 SUPPORT Human Clinical

"The crude infant mortality rate was 17% (23/132) and in the first two years of life the mortality rate was 21% (28/132). Cases with large de novo deletions (proximal to and including p15.2) were more likely to have died than those with smaller deletions (odds ratio=5.7, 95% CI=1.7-19.9) after..."

Quantifies early mortality and its association with larger de novo deletions in the UK epidemiologic cohort.

PMID:9672528

Antibody deficiency in Wolf-Hirschhorn syndrome.

1 finding

Selected infection-prone cohort documenting several forms of humoral antibody deficiency in WHS while retaining normal T-cell immunity.

"We identified antibody deficiencies in 9 of 13 infection-prone children with Wolf-Hirschhorn syndrome (4p-monosomy)."

Show evidence (1 reference)

PMID:9672528 SUPPORT Human Clinical

"We identified antibody deficiencies in 9 of 13 infection-prone children with Wolf-Hirschhorn syndrome (4p-monosomy)."

Directly documents the selected immune cohort and its antibody-deficiency yield.

Deep Research

1

Falcon ▸

Wolf–Hirschhorn syndrome (WHS): Disease Characteristics Research Report

Edison Scientific Literature 46 citations 2026-04-26T20:22:58.757876

Wolf–Hirschhorn syndrome (WHS): Disease Characteristics Research Report

Target disease: Wolf–Hirschhorn syndrome (genetic contiguous gene deletion disorder; distal 4p deletion). (nevado2020internationalmeetingon pages 3-4, zollino2008onthenosology pages 1-2)

Executive summary (current understanding)

Wolf–Hirschhorn syndrome (WHS) is a contiguous gene deletion syndrome caused by loss of genetic material from the distal short arm of chromosome 4 (4p16.3). It is clinically characterized by a recognizable core phenotype comprising typical craniofacial dysmorphism (“Greek warrior helmet” gestalt), prenatal/postnatal growth deficiency, developmental delay/intellectual disability, and seizures/EEG abnormalities. (nevado2020internationalmeetingon pages 3-4, berrocoso2020copingwithwolfhirschhorna pages 1-2, zollino2008onthenosology pages 1-2)

Recent large-cohort work (Spain/Latin America, n=140; collected 2013–2023) underscores that epilepsy is highly prevalent (92%), begins in infancy (mean onset ~9.8 months), and is frequently severe (status epilepticus 58.4%), with substantial treatment burden (polytherapy common). (blancolago2025epilepsyinwolf–hirschhorn pages 2-4, blancolago2025epilepsyinwolf–hirschhorn pages 1-2)

A major mechanistic advance over the last decade is the refinement of a terminal 4p seizure susceptibility region to an ~197 kb interval near the telomere (hg19/GRCh37 chr4:367,691–564,593), containing PIGG and ZNF721 (and ABCA11P), suggesting that seizure risk is driven by haploinsufficiency of telomeric genes beyond the historically emphasized LETM1 region in at least some individuals. (ho2016chromosomalmicroarraytesting pages 1-1, ho2016chromosomalmicroarraytesting media f15f4c0a)

1. Disease information

1.1 Definition/overview

WHS is a chromosomal disorder caused by distal 4p deletions (usually 4p16.3), producing a multisystem developmental syndrome with characteristic facial features, growth delay, intellectual disability/developmental delay, and seizures. (nevado2020internationalmeetingon pages 3-4, zollino2008onthenosology pages 1-2)

1.2 Key identifiers

OMIM: #194190 (explicitly stated in WHS nosology/meeting proceedings). (nevado2020internationalmeetingon pages 2-2)
MONDO / MeSH / ICD-10 / ICD-11 / Orphanet ORPHAcode: Not retrievable from the tool-accessible full-text corpus in this run. (see Limitations).

1.3 Common synonyms / alternative names

“4p- syndrome”, “deletion 4p”, “terminal 4p deletion” (terminology used across prenatal and clinical genetics literature). (sifakis2012prenataldiagnosisof pages 1-2, nevado2020internationalmeetingon pages 3-4)

1.4 Source type (individual vs aggregated)

Evidence in this report derives from: - Aggregated cohorts and registries (e.g., epidemiology cohort n=159; epilepsy cohort n=140; prenatal cohort n=18). (shannon2001anepidemiologicalstudy pages 1-2, blancolago2025epilepsyinwolf–hirschhorn pages 2-4, simonini2022prenatalsonographicfindings pages 1-2) - Curated clinical genetics guidance (clinical utility gene card). (battaglia2011clinicalutilitygene pages 1-2) - Model organism and developmental biology studies/reviews supporting mechanistic hypotheses. (, )

2. Etiology

2.1 Disease causal factors

Primary cause: hemizygous deletion of the distal short arm of chromosome 4 (4p16.3), with variable deletion size and complexity, producing a contiguous gene haploinsufficiency syndrome. (zollino2008onthenosology pages 1-2, nevado2020internationalmeetingon pages 3-4)

Rearrangement classes reported include: - terminal deletions (most common), - interstitial 4p deletions, - unbalanced translocations (including recurrent 4p;8p events), - ring chromosome 4, - inverted duplications/complex rearrangements. (ho2016chromosomalmicroarraytesting pages 1-1, nevado2020internationalmeetingon pages 4-4, simonini2022prenatalsonographicfindings pages 5-7)

2.2 Risk factors

Genetic risk factors: Presence of a parental balanced translocation involving 4p can raise recurrence risk for offspring with an unbalanced rearrangement; thus parental cytogenetic testing is relevant for counseling. (simonini2022prenatalsonographicfindings pages 5-7, xing2018prenataldiagnosisof pages 5-7)

Environmental risk factors: Not supported in the retrieved evidence; WHS is primarily genetic due to structural chromosome abnormalities. (nevado2020internationalmeetingon pages 3-4, zollino2008onthenosology pages 1-2)

2.3 Protective factors

No validated genetic or environmental protective factors were identified in the retrieved literature.

2.4 Gene–environment interactions

No WHS-specific gene–environment interactions were identified in the retrieved literature.

3. Phenotypes (clinical spectrum)

3.1 Core phenotype (postnatal)

The consensus “core WHS phenotype” includes typical facial dysmorphism, growth delay, intellectual disability/developmental delay, and seizures (or EEG abnormalities). (nevado2020internationalmeetingon pages 3-4)

A large cohort (n=140) quantified high frequencies of major features: - Psychomotor developmental delay: ~98.9% - Craniofacial features: ~97.8% - Hypotonia: ~89% - IUGR/postnatal growth restriction: ~94.2% - Cardiac defects: ~44.5% - Renal/urological anomalies: ~53% (these are cohort-derived rates reported in the epilepsy-focused cohort paper). (blancolago2025epilepsyinwolf–hirschhorn pages 1-2)

3.2 Epilepsy phenotype (key quantitative data)

In the same n=140 cohort, epilepsy burden was high and early-onset: - Epilepsy prevalence: 92% (126/137) - Mean seizure onset: 9.8 months (range 3 days–36 months) - Seizure types (proportions): generalized tonic-clonic 55.9%, absence/atypical absence 51.8%, focal 26.9%, tonic 24.3%, myoclonic 20.4%, epileptic spasms 12.4% - Status epilepticus: 58.4% - Febrile-triggered seizures: 68.6% - Treatment burden: 85.9% treated with antiseizure medications; 42.2% had used ≥3 ASMs; commonly used ASMs were valproic acid and levetiracetam - Genotype–phenotype: larger deletions (>9 Mb) associated with more severe epilepsy and poorer developmental outcomes (pediatric cohort with standardized caregiver questionnaires). (blancolago2025epilepsyinwolf–hirschhorn pages 2-4, blancolago2025epilepsyinwolf–hirschhorn pages 1-2)

Suggested HPO terms (examples): - Seizures HP:0001250; Epileptic spasms HP:0011097; Status epilepticus HP:0002133; Febrile seizures HP:0002373; Developmental delay HP:0001263; Intellectual disability HP:0001249; Hypotonia HP:0001252; Intrauterine growth restriction HP:0001511; Failure to thrive HP:0001508; Microcephaly HP:0000252; Congenital heart defect HP:0001627; Renal anomaly HP:0000077.

3.3 Prenatal phenotype (ultrasound; frequencies)

In a retrospective prenatal cohort of 18 confirmed WHS cases (3 tertiary centers in Germany), the most frequent ultrasound findings were: - Facial abnormalities: 94.4% (17/18) - Symmetric IUGR: 83.3% (15/18) - Microcephaly: 72.2% (13/18) - Cardiac anomalies: 50.0% (9/18) A particularly characteristic combination was microcephaly + hypoplastic nasal bone; growth restriction was present in all fetuses assessed after 20 weeks. (simonini2022prenatalsonographicfindings pages 1-2, simonini2022prenatalsonographicfindings pages 5-7)

A broader prenatal review (10 new + 37 literature cases) reported severe IUGR 97.7% and typical facial appearance 82.9%, with cardiac malformations 29.8% and renal hypoplasia 36.2%. (xing2018prenataldiagnosisof pages 1-2)

Suggested prenatal HPO terms (examples): IUGR HP:0001511; Hypoplastic nasal bone HP:0012745; Abnormal facial shape HP:0001999; Micrognathia HP:0000347.

3.4 Quality of life impact

A study of 22 Spanish caregivers evaluated psychosocial profile and caregiver quality of life (QoL) and found that the syndrome’s severe, lifelong care needs (growth issues, seizures, developmental disability) can impact parental QoL; problem-focused coping and social support were associated with improved psychological QoL. (berrocoso2020copingwithwolfhirschhorna pages 1-2)

4. Genetic / molecular information

4.1 Causal genomic lesion and critical regions

WHS is caused by deletions of 4p16.3 with broad size variation; meeting proceedings and genotype–phenotype analyses emphasize variability from <2 Mb up to ~30 Mb or more. (nevado2020internationalmeetingon pages 3-4)

Historically defined WHS “critical regions” include: - WHSCR: a ~165 kb interval ~2 Mb from the telomere, containing WHSC1/NSD2 and WHSC2/NELFA. (nevado2020internationalmeetingon pages 4-4) - WHSCR-2: an adjacent 300–600 kb interval including LETM1 (a long-discussed seizure candidate) and part of WHSC1/NSD2. (ho2016chromosomalmicroarraytesting pages 1-1)

4.2 Genotype–phenotype correlations (deletion size)

Multiple sources define broad severity bands: - Mild: deletions ≤3.5 Mb - Typical/classic: ~5–18 Mb - Severe: ~22–25 Mb or more (Prenatal and postnatal sources concordantly report this pattern). (zollino2008onthenosology pages 1-2, luo2023prenataldiagnosisand pages 2-3, simonini2022prenatalsonographicfindings pages 5-7)

4.3 Seizure susceptibility region (recent mapping)

A chromosomal microarray mapping study (n=48) identified a strong association between interstitial deletions that exclude the distal terminal segment and absence of seizures, and refined a terminal seizure susceptibility region to ~197 kb beginning ~368 kb from the 4p terminus. (ho2016chromosomalmicroarraytesting pages 1-1)

Figure-based coordinates and genes in this interval (hg19/GRCh37 chr4:367,691–564,593) include PIGG and ZNF721 (and ABCA11P). (ho2016chromosomalmicroarraytesting media f15f4c0a)

4.4 Inheritance and origin

WHS rearrangements are often de novo, but familial recurrence can occur via parental balanced translocations. In a UK epidemiologic cohort (n=159): 72.3% de novo deletions, 20.1% translocations, 7.5% other rearrangements. (shannon2001anepidemiologicalstudy pages 1-2)

In the prenatal literature, approximate etiologic fractions are described as ~55% de novo deletions, ~40–45% unbalanced translocations, and ~5% complex rearrangements. (simonini2022prenatalsonographicfindings pages 5-7)

4.5 Epigenetics / modifiers

Phenotypic severity is not strictly linear with deletion size; meeting proceedings discuss that LETM1 haploinsufficiency alone is not sufficient for seizures, implying additional telomeric dosage-sensitive genes and/or modifier effects. (nevado2020internationalmeetingon pages 4-5)

5. Environmental information

No WHS-specific environmental toxins, lifestyle risk factors, or infectious triggers causing WHS were identified in retrieved evidence. WHS is primarily a structural genomic disorder. (nevado2020internationalmeetingon pages 3-4, zollino2008onthenosology pages 1-2)

6. Mechanism / pathophysiology

6.1 Causal chain (conceptual)

Upstream trigger: hemizygous deletion of distal 4p (4p16.3) → haploinsufficiency of multiple developmental genes (including NSD2/WHSC1, NELFA/WHSC2, LETM1, and telomeric genes such as PIGG/ZNF721) → disruption of transcriptional regulation, neuronal excitability balance and developmental programs → downstream neurodevelopmental impairment, growth delay, craniofacial malformations, congenital anomalies, and epilepsy (often early-onset and severe). (zollino2008onthenosology pages 1-2, ho2016chromosomalmicroarraytesting pages 1-1, nevado2020internationalmeetingon pages 4-5)

6.2 Seizure biology (regional genetics)

The CMA mapping work supports a model in which deletion of a small terminal region can be sufficient for seizure susceptibility in WHS, refining the mechanistic focus beyond LETM1 alone. (ho2016chromosomalmicroarraytesting pages 1-1, ho2016chromosomalmicroarraytesting media f15f4c0a)

6.3 Developmental mechanisms: neural crest hypothesis (model-organism evidence)

A Xenopus-focused primary study supports the hypothesis that WHS craniofacial and related defects may arise from perturbation of cranial neural crest biology: WHS-associated genes (whsc1, whsc2, letm1, tacc3) show enrichment in migratory neural crest and influence craniofacial patterning/cartilage formation and neural crest motility when depleted. ()

Suggested GO Biological Process terms (examples): - cranial neural crest cell migration (GO:0002302), - regulation of transcription, DNA-templated (GO:0006355), - nervous system development (GO:0007399), - synaptic signaling (GO:0099536), - mitochondrial calcium ion homeostasis (candidate for LETM1-related mechanisms).

Suggested CL cell-type terms (examples): - neural crest cell (CL:0000134), - excitatory neuron (CL:0000127), - inhibitory interneuron (CL:0000099).

7. Anatomical structures affected

Based on the multisystem phenotype described in cohorts: - Nervous system: epilepsy, developmental delay (UBERON:0001016 “nervous system”; brain UBERON:0000955). (blancolago2025epilepsyinwolf–hirschhorn pages 2-4) - Craniofacial structures: characteristic facial gestalt; craniofacial developmental defects (UBERON:0001136 “facial skeleton”). (berrocoso2020copingwithwolfhirschhorna pages 1-2) - Cardiovascular system: congenital heart defects (~44.5% in a large cohort; 50% in prenatal series). (blancolago2025epilepsyinwolf–hirschhorn pages 1-2, simonini2022prenatalsonographicfindings pages 1-2) - Urinary system/kidney: renal/urologic anomalies (~53% in large cohort; renal hypoplasia often reported prenatally). (blancolago2025epilepsyinwolf–hirschhorn pages 1-2, xing2018prenataldiagnosisof pages 1-2)

8. Temporal development

Onset: congenital; many features are prenatal (IUGR, microcephaly, facial anomalies) and postnatal developmental delay is universal/near-universal in cohorts. (simonini2022prenatalsonographicfindings pages 1-2, blancolago2025epilepsyinwolf–hirschhorn pages 1-2)
Epilepsy onset: typically within the first year; mean onset ~9.8 months. (blancolago2025epilepsyinwolf–hirschhorn pages 2-4)
Course: high early-childhood morbidity and mortality; survival improves after age 2, with some individuals surviving into adulthood (documented up to mid-30s in UK cohort, and to 55 years in adult natural history series). (shannon2001anepidemiologicalstudy pages 1-2, shannon2001anepidemiologicalstudy pages 1-1)

9. Inheritance and population

9.1 Epidemiology

Minimum UK birth incidence (1989–1998): 1 in 95,896. (shannon2001anepidemiologicalstudy pages 1-2, shannon2001anepidemiologicalstudy pages 1-1)
Commonly cited incidence/prevalence in clinical literature: ~1/20,000–1/50,000 births, with female predominance ~2:1. (berrocoso2020copingwithwolfhirschhorna pages 1-2, nevado2025clinicianbasedfunctionalscoring pages 1-2)

9.2 Inheritance pattern

WHS is typically sporadic/de novo as a chromosomal deletion syndrome; familial recurrence risk depends on parental chromosomal rearrangements (balanced translocation carriers). (shannon2001anepidemiologicalstudy pages 1-2, simonini2022prenatalsonographicfindings pages 5-7)

10. Diagnostics

10.1 Clinical suspicion

Prenatal: symmetric IUGR + microcephaly + hypoplastic nasal bone + facial anomalies should raise suspicion. (simonini2022prenatalsonographicfindings pages 1-2)
Postnatal: characteristic facial gestalt + growth restriction + neurodevelopmental delay + seizures/EEG abnormalities. (nevado2020internationalmeetingon pages 3-4, berrocoso2020copingwithwolfhirschhorna pages 1-2)

10.2 Genetic testing strategy (real-world implementation)

Chromosomal microarray (CMA) is highlighted as the method of choice for diagnosis, particularly to detect small deletions (<3 Mb) and complex rearrangements. (simonini2022prenatalsonographicfindings pages 1-2, simonini2022prenatalsonographicfindings pages 5-7)
Routine karyotype detection ~50–60%; FISH sensitivity ~95% in prenatal review. (simonini2022prenatalsonographicfindings pages 1-2)
Clinical utility gene card: appropriately designed FISH or genomic microarray targeting at least portions of LETM1 and WHSC1 should yield >99% clinical sensitivity; standard chromosome studies may have only ~50–60% sensitivity and can miss microdeletions. (battaglia2011clinicalutilitygene pages 1-2)

10.3 Differential diagnosis

A formal differential diagnosis list was not available in retrieved full texts. In practice, WHS overlaps with other chromosomal deletion syndromes presenting with growth restriction, dysmorphism, and epilepsy; confirmation requires molecular cytogenetics (CMA/FISH/karyotype). (battaglia2011clinicalutilitygene pages 1-2, nevado2020internationalmeetingon pages 3-4)

11. Outcomes / prognosis

11.1 Survival and mortality (key statistics)

In the UK epidemiologic cohort: - Infant mortality: 17.4% (23/132) - Two-year mortality: 21% (28/132) - Timing: 63.9% of deaths in the first year; 77.8% within the first two years - Deletion size prognostic factor: large deletions had 51.5% deaths vs 9.7% for small deletions; adjusted OR 5.7 (95% CI 1.7–19.9) (published Oct 2001). (shannon2001anepidemiologicalstudy pages 3-4)

Among deaths with known cause (n=32): - lower respiratory tract infection 25% (8/32), - multiple congenital anomalies 15.6% (5/32), - sudden unexplained death 15.6% (5/32), - congenital heart disease 15.6% (5/32). (published Oct 2001). (shannon2001anepidemiologicalstudy pages 4-5)

11.2 Prognostic factors

Deletion size and complexity (large deletions, complex rearrangements). (shannon2001anepidemiologicalstudy pages 3-4)
Epilepsy severity and seizure pattern, emphasized as major determinants of neurodevelopmental outcome. (nevado2020internationalmeetingon pages 3-4, blancolago2025epilepsyinwolf–hirschhorn pages 2-4)

12. Treatment

12.1 Pharmacotherapy (epilepsy)

In a large WHS cohort, commonly used antiseizure medications were valproic acid and levetiracetam, and many individuals required polytherapy; status epilepticus was frequent and likely contributes to developmental burden. (blancolago2025epilepsyinwolf–hirschhorn pages 1-2, blancolago2025epilepsyinwolf–hirschhorn pages 2-4)

Suggested MAXO terms (examples): - antiseizure therapy (MAXO:0000474), - status epilepticus management (MAXO term to map under emergency seizure management), - chromosomal microarray analysis (diagnostic procedure term), - genetic counseling (MAXO:0000072), - early intervention therapy / neurodevelopmental therapy (MAXO mapping under rehabilitation).

12.2 Supportive / rehabilitative care

Consensus and cohort interpretations emphasize multidisciplinary management (developmental therapies, monitoring for comorbidities such as cardiac/renal problems, and family support). (berrocoso2020copingwithwolfhirschhorna pages 1-2, shannon2001anepidemiologicalstudy pages 6-6)

12.3 Experimental / trials

A precise ClinicalTrials.gov condition search for “Wolf-Hirschhorn syndrome” did not retrieve disease-specific interventional trials in this tool run; earlier broad “WHS” queries primarily matched unrelated acronym uses (e.g., Women’s Health Study). (nevado2020internationalmeetingon pages 11-11)

13. Prevention

Primary “prevention” for WHS is reproductive/genetic: - Genetic counseling for affected families, - Prenatal diagnosis using ultrasound plus confirmatory CMA/karyotype/FISH, - Parental karyotyping to detect balanced translocations that elevate recurrence risk. (simonini2022prenatalsonographicfindings pages 5-7, battaglia2011clinicalutilitygene pages 1-2)

14. Other species / natural disease

No naturally occurring veterinary analogs were identified in retrieved evidence.

15. Model organisms

Mechanistic studies in vertebrate models support developmental hypotheses: - Xenopus laevis: WHS-associated genes are enriched in migratory neural crest cells; depletion affects craniofacial development and neural crest motility. () - Additional vertebrate resources were retrieved for zebrafish WHSC1/NSD2 homolog biology, supporting in vivo functional studies of WHS candidate genes. ()

Recent developments (prioritizing 2023–2024 where available)

2024: A familial terminal 4p16.3 microdeletion not causing classical WHS supports refinement of critical regions and highlights interpretive complexity for small telomeric CNVs. (Osundiji 2024; publication date Nov 2024; Chromosome Research). (osundiji2024afamilialchromosome pages 7-8)
2024: Basic mechanistic enzymology work expanded the substrate landscape of NSD2 (WHSC1), relevant to understanding pleiotropy of NSD2 haploinsufficiency in development and disease (not WHS-specific clinical study, but mechanistically relevant). (Weirich 2024; Communications Biology; Jun 2024). ()

Key quantitative findings (quick reference)

Topic	Key findings (with numbers)	Source (first author year)	URL/DOI
Birth incidence / prevalence and sex ratio	Minimum UK birth incidence 1 in 95,896; broader literature estimates 1 in 50,000 births and ~1 in 20,000–1 in 50,000 births; female predominance about 2:1; 2025 WHS cohort female proportion 67.9% (Blanco-Lago cohort) (shannon2001anepidemiologicalstudy pages 1-2, shannon2001anepidemiologicalstudy pages 1-1, berrocoso2020copingwithwolfhirschhorna pages 1-2, blancolago2025epilepsyinwolf–hirschhorn pages 2-4)	Shannon 2001; Berrocoso 2020; Corrêa 2018; Blanco-Lago 2025	https://doi.org/10.1136/jmg.38.10.674; https://doi.org/10.1186/s13023-020-01476-8; https://doi.org/10.1155/2018/5436187; https://doi.org/10.3390/jcm14228044
Mortality rates and leading causes of death	Among 132 live births, infant mortality 17.4% (23/132) and 2-year mortality 21% (28/132); 63.9% of deaths in first year and 77.8% within first 2 years; large deletions had 51.5% deaths vs 9.7% for small deletions (age-adjusted OR 5.7, 95% CI 1.7–19.9); leading causes among known causes: lower respiratory tract infection 25% (8/32), multiple congenital anomalies 15.6% (5/32), sudden unexplained death 15.6% (5/32), congenital heart disease 15.6% (5/32) (shannon2001anepidemiologicalstudy pages 3-4, shannon2001anepidemiologicalstudy pages 4-5, shannon2001anepidemiologicalstudy pages 5-6)	Shannon 2001	https://doi.org/10.1136/jmg.38.10.674
Epilepsy burden	Epilepsy in 92% (126/137); mean seizure onset 9.8 months (range 3 days–36 months), typically before 12 months; seizure frequencies: generalized tonic-clonic 55.9%, absence/atypical absence 51.8%, focal 26.9%, tonic 24.3%, myoclonic 20.4%, epileptic spasms 12.4%; status epilepticus 58.4%; febrile-triggered seizures 68.6%; 85.9% on ASMs, 42.2% had used ≥3 ASMs; common ASMs valproic acid and levetiracetam; larger deletions (>9 Mb) associated with more severe epilepsy/poorer outcomes (blancolago2025epilepsyinwolf–hirschhorn pages 2-4, blancolago2025epilepsyinwolf–hirschhorn pages 1-2, blancolago2025epilepsyinwolf–hirschhorn pages 9-11)	Blanco-Lago 2025	https://doi.org/10.3390/jcm14228044
Prenatal ultrasound frequencies and diagnostic recommendations	In 18 confirmed prenatal cases: facial abnormalities 94.4% (17/18), symmetric IUGR 83.3% (15/18), microcephaly 72.2% (13/18), cardiac anomalies 50.0% (9/18); growth restriction present in all fetuses examined after 20 weeks; characteristic combination: microcephaly + hypoplastic nasal bone; pooled review data: severe IUGR 97.7% and typical facial appearance 82.9%, cardiac malformations 29.8%; CMA/SNP-array strongly recommended when WHS is suspected prenatally (simonini2022prenatalsonographicfindings pages 1-2, simonini2022prenatalsonographicfindings pages 5-7, xing2018prenataldiagnosisof pages 1-2, xing2018prenataldiagnosisof pages 3-5)	Simonini 2022; Xing 2018	https://doi.org/10.1186/s12884-022-04665-4; https://doi.org/10.1007/s00404-018-4798-1
Genetic testing sensitivity guidance	Routine karyotype detects ~50–60% of cases; FISH sensitivity reported ~95%; gene card states appropriately designed FISH or genomic microarray targeting LETM1/WHSC1 region should provide >99% clinical sensitivity; CMA is current method of choice because small deletions (<3 Mb) and complex rearrangements may be missed by karyotype/FISH; parental studies recommended when translocation suspected (battaglia2011clinicalutilitygene pages 1-2, simonini2022prenatalsonographicfindings pages 1-2, simonini2022prenatalsonographicfindings pages 5-7, xing2018prenataldiagnosisof pages 5-7)	Battaglia 2011; Simonini 2022	https://doi.org/10.1038/ejhg.2010.186; https://doi.org/10.1186/s12884-022-04665-4
Seizure susceptibility region coordinates / genes	CMA study mapped terminal seizure susceptibility region to ~197 kb starting ~368 kb from 4p terminus; figure-based coordinates hg19/GRCh37 chr4:367,691–564,593; region contains PIGG, ZNF721, and pseudogene ABCA11P; lack of inclusion of distal terminal 751 kb associated with absence of seizures in several interstitial deletion cases (ho2016chromosomalmicroarraytesting pages 1-1, ho2016chromosomalmicroarraytesting media 365127d8, ho2016chromosomalmicroarraytesting media f15f4c0a)	Ho 2016	https://doi.org/10.1136/jmedgenet-2015-103626

Table: This table compiles the most implementation-relevant quantitative findings for Wolf-Hirschhorn syndrome, including epidemiology, mortality, epilepsy burden, prenatal detection, testing performance, and the mapped seizure-susceptibility region. It is designed for quick reference in clinical or knowledge-base curation workflows.

Visual evidence (genotype–seizure mapping)

The seizure susceptibility region on terminal 4p and the gene content of the refined ~197 kb interval are illustrated in the CMA mapping figures (Figure 2/3) from Ho et al. 2016. (ho2016chromosomalmicroarraytesting media 365127d8, ho2016chromosomalmicroarraytesting media f15f4c0a)

Limitations of this report (tooling constraints)

The tool-accessible corpus did not yield primary sources explicitly listing MONDO ID, Orphanet ORPHAcode, MeSH descriptor ID, or ICD-10/ICD-11 codes for WHS; therefore these identifiers are not asserted here.
Several clinically important areas (formal differential diagnosis lists; standardized QoL instruments for affected individuals) were not available in retrieved texts and may require additional targeted retrieval beyond the current run.

References

(nevado2020internationalmeetingon pages 3-4): Julián Nevado, Karen S. Ho, Marcella Zollino, Raquel Blanco, César Cobaleda, Christelle Golzio, Isabelle Beaudry‐Bellefeuille, Sarah Berrocoso, Jacobo Limeres, Pilar Barrúz, Candela Serrano‐Martín, Concetta Cafiero, Ignacio Málaga, Giuseppe Marangi, Elena Campos‐Sánchez, Tania Moriyón‐Iglesias, Sorangui Márquez, Leah Markham, Hope Twede, Amanda Lortz, Lenora Olson, Xiaoming Sheng, Cindy Weng, Edward Robert Wassman, Tara Newcomb, Edward Robert Wassman, John C. Carey, Agatino Battaglia, Eduardo López‐Granados, Damien Douglas, and Pablo Lapunzina. International meeting on wolf‐hirschhorn syndrome: update on the nosology and new insights on the pathogenic mechanisms for seizures and growth delay. American Journal of Medical Genetics Part A, 182:257-267, Nov 2020. URL: https://doi.org/10.1002/ajmg.a.61406, doi:10.1002/ajmg.a.61406. This article has 31 citations.
(zollino2008onthenosology pages 1-2): Marcella Zollino, Marina Murdolo, Giuseppe Marangi, Vanna Pecile, Cinzia Galasso, Laura Mazzanti, and Giovanni Neri. On the nosology and pathogenesis of wolf–hirschhorn syndrome: genotype–phenotype correlation analysis of 80 patients and literature review. American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 148C:257-269, Nov 2008. URL: https://doi.org/10.1002/ajmg.c.30190, doi:10.1002/ajmg.c.30190. This article has 216 citations.
(berrocoso2020copingwithwolfhirschhorna pages 1-2): Sarah Berrocoso, Imanol Amayra, Esther Lázaro, Oscar Martínez, Juan Francisco López-Paz, Maitane García, Manuel Pérez, Mohammad Al-Rashaida, Alicia Aurora Rodríguez, Paula Maria Luna, Paula Pérez-Núñez, Raquel Blanco, and Julián Nevado. Coping with wolf-hirschhorn syndrome: quality of life and psychosocial features of family carers. Orphanet Journal of Rare Diseases, Oct 2020. URL: https://doi.org/10.1186/s13023-020-01476-8, doi:10.1186/s13023-020-01476-8. This article has 29 citations and is from a peer-reviewed journal.
(blancolago2025epilepsyinwolf–hirschhorn pages 2-4): Raquel Blanco-Lago, Ignacio Málaga, Jair Antonio Tenorio-Castaño, Nelly Álvarez-Álvarez, Pablo Lapunzina, and Julián Nevado. Epilepsy in wolf–hirschhorn syndrome: clinical insights from a pediatric cohort and a review of the literature. Journal of Clinical Medicine, 14:8044, Nov 2025. URL: https://doi.org/10.3390/jcm14228044, doi:10.3390/jcm14228044. This article has 0 citations.
(blancolago2025epilepsyinwolf–hirschhorn pages 1-2): Raquel Blanco-Lago, Ignacio Málaga, Jair Antonio Tenorio-Castaño, Nelly Álvarez-Álvarez, Pablo Lapunzina, and Julián Nevado. Epilepsy in wolf–hirschhorn syndrome: clinical insights from a pediatric cohort and a review of the literature. Journal of Clinical Medicine, 14:8044, Nov 2025. URL: https://doi.org/10.3390/jcm14228044, doi:10.3390/jcm14228044. This article has 0 citations.
(ho2016chromosomalmicroarraytesting pages 1-1): Karen S Ho, Sarah T South, Amanda Lortz, Charles H Hensel, Mallory R Sdano, Rena J Vanzo, Megan M Martin, Andreas Peiffer, Christophe G Lambert, Amy Calhoun, John C Carey, and Agatino Battaglia. Chromosomal microarray testing identifies a 4p terminal region associated with seizures in wolf–hirschhorn syndrome. Journal of Medical Genetics, 53:256-263, Jan 2016. URL: https://doi.org/10.1136/jmedgenet-2015-103626, doi:10.1136/jmedgenet-2015-103626. This article has 59 citations and is from a domain leading peer-reviewed journal.
(ho2016chromosomalmicroarraytesting media f15f4c0a): Karen S Ho, Sarah T South, Amanda Lortz, Charles H Hensel, Mallory R Sdano, Rena J Vanzo, Megan M Martin, Andreas Peiffer, Christophe G Lambert, Amy Calhoun, John C Carey, and Agatino Battaglia. Chromosomal microarray testing identifies a 4p terminal region associated with seizures in wolf–hirschhorn syndrome. Journal of Medical Genetics, 53:256-263, Jan 2016. URL: https://doi.org/10.1136/jmedgenet-2015-103626, doi:10.1136/jmedgenet-2015-103626. This article has 59 citations and is from a domain leading peer-reviewed journal.
(nevado2020internationalmeetingon pages 2-2): Julián Nevado, Karen S. Ho, Marcella Zollino, Raquel Blanco, César Cobaleda, Christelle Golzio, Isabelle Beaudry‐Bellefeuille, Sarah Berrocoso, Jacobo Limeres, Pilar Barrúz, Candela Serrano‐Martín, Concetta Cafiero, Ignacio Málaga, Giuseppe Marangi, Elena Campos‐Sánchez, Tania Moriyón‐Iglesias, Sorangui Márquez, Leah Markham, Hope Twede, Amanda Lortz, Lenora Olson, Xiaoming Sheng, Cindy Weng, Edward Robert Wassman, Tara Newcomb, Edward Robert Wassman, John C. Carey, Agatino Battaglia, Eduardo López‐Granados, Damien Douglas, and Pablo Lapunzina. International meeting on wolf‐hirschhorn syndrome: update on the nosology and new insights on the pathogenic mechanisms for seizures and growth delay. American Journal of Medical Genetics Part A, 182:257-267, Nov 2020. URL: https://doi.org/10.1002/ajmg.a.61406, doi:10.1002/ajmg.a.61406. This article has 31 citations.
(sifakis2012prenataldiagnosisof pages 1-2): Stavros Sifakis, Emmanouil Manolakos, Annalisa Vetro, Dimitra Kappou, Panagiotis Peitsidis, Maria Kontodiou, Antonios Garas, Nikolaos Vrachnis, Anastasia Konstandinidou, Orsetta Zuffardi, Sandro Orru, and Ioannis Papoulidis. Prenatal diagnosis of wolf-hirschhorn syndrome confirmed by comparative genomic hybridization array: report of two cases and review of the literature. Molecular Cytogenetics, 5:12-12, Feb 2012. URL: https://doi.org/10.1186/1755-8166-5-12, doi:10.1186/1755-8166-5-12. This article has 35 citations and is from a peer-reviewed journal.
(shannon2001anepidemiologicalstudy pages 1-2): N. Shannon, E. Maltby, A. Rigby, and O. Quarrell. An epidemiological study of wolf-hirschhorn syndrome: life expectancy and cause of mortality. Journal of Medical Genetics, 38:674-679, Oct 2001. URL: https://doi.org/10.1136/jmg.38.10.674, doi:10.1136/jmg.38.10.674. This article has 138 citations and is from a domain leading peer-reviewed journal.
(simonini2022prenatalsonographicfindings pages 1-2): Corinna Simonini, Markus Hoopmann, Karl Oliver Kagan, Torsten Schröder, Ulrich Gembruch, and Annegret Geipel. Prenatal sonographic findings in confirmed cases of wolf-hirschhorn syndrome. BMC Pregnancy and Childbirth, Apr 2022. URL: https://doi.org/10.1186/s12884-022-04665-4, doi:10.1186/s12884-022-04665-4. This article has 13 citations and is from a peer-reviewed journal.
(battaglia2011clinicalutilitygene pages 1-2): Agatino Battaglia, Sarah South, and John C Carey. Clinical utility gene card for: wolf–hirschhorn (4p-) syndrome. European Journal of Human Genetics, 19:-, Apr 2011. URL: https://doi.org/10.1038/ejhg.2010.186, doi:10.1038/ejhg.2010.186. This article has 23 citations and is from a domain leading peer-reviewed journal.
(nevado2020internationalmeetingon pages 4-4): Julián Nevado, Karen S. Ho, Marcella Zollino, Raquel Blanco, César Cobaleda, Christelle Golzio, Isabelle Beaudry‐Bellefeuille, Sarah Berrocoso, Jacobo Limeres, Pilar Barrúz, Candela Serrano‐Martín, Concetta Cafiero, Ignacio Málaga, Giuseppe Marangi, Elena Campos‐Sánchez, Tania Moriyón‐Iglesias, Sorangui Márquez, Leah Markham, Hope Twede, Amanda Lortz, Lenora Olson, Xiaoming Sheng, Cindy Weng, Edward Robert Wassman, Tara Newcomb, Edward Robert Wassman, John C. Carey, Agatino Battaglia, Eduardo López‐Granados, Damien Douglas, and Pablo Lapunzina. International meeting on wolf‐hirschhorn syndrome: update on the nosology and new insights on the pathogenic mechanisms for seizures and growth delay. American Journal of Medical Genetics Part A, 182:257-267, Nov 2020. URL: https://doi.org/10.1002/ajmg.a.61406, doi:10.1002/ajmg.a.61406. This article has 31 citations.
(simonini2022prenatalsonographicfindings pages 5-7): Corinna Simonini, Markus Hoopmann, Karl Oliver Kagan, Torsten Schröder, Ulrich Gembruch, and Annegret Geipel. Prenatal sonographic findings in confirmed cases of wolf-hirschhorn syndrome. BMC Pregnancy and Childbirth, Apr 2022. URL: https://doi.org/10.1186/s12884-022-04665-4, doi:10.1186/s12884-022-04665-4. This article has 13 citations and is from a peer-reviewed journal.
(xing2018prenataldiagnosisof pages 5-7): Ya Xing, Jimmy Lloyd Holder, Yong Liu, Meizhen Yuan, Qi Sun, Xiaoxing Qu, Linbei Deng, Jia Zhou, Yingjun Yang, Ming Guo, Sau-Wai Cheung, and Luming Sun. Prenatal diagnosis of wolf–hirschhorn syndrome: from ultrasound findings, diagnostic technology to genetic counseling. Archives of Gynecology and Obstetrics, 298:289-295, May 2018. URL: https://doi.org/10.1007/s00404-018-4798-1, doi:10.1007/s00404-018-4798-1. This article has 36 citations and is from a peer-reviewed journal.
(xing2018prenataldiagnosisof pages 1-2): Ya Xing, Jimmy Lloyd Holder, Yong Liu, Meizhen Yuan, Qi Sun, Xiaoxing Qu, Linbei Deng, Jia Zhou, Yingjun Yang, Ming Guo, Sau-Wai Cheung, and Luming Sun. Prenatal diagnosis of wolf–hirschhorn syndrome: from ultrasound findings, diagnostic technology to genetic counseling. Archives of Gynecology and Obstetrics, 298:289-295, May 2018. URL: https://doi.org/10.1007/s00404-018-4798-1, doi:10.1007/s00404-018-4798-1. This article has 36 citations and is from a peer-reviewed journal.
(luo2023prenataldiagnosisand pages 2-3): H Luo, R Chang, F Liu, and X Gao. Prenatal diagnosis and molecular cytogenetic analyses of a de novo deletion on chromosome 4p16. 3p15. 33. Unknown journal, 2023.
(nevado2020internationalmeetingon pages 4-5): Julián Nevado, Karen S. Ho, Marcella Zollino, Raquel Blanco, César Cobaleda, Christelle Golzio, Isabelle Beaudry‐Bellefeuille, Sarah Berrocoso, Jacobo Limeres, Pilar Barrúz, Candela Serrano‐Martín, Concetta Cafiero, Ignacio Málaga, Giuseppe Marangi, Elena Campos‐Sánchez, Tania Moriyón‐Iglesias, Sorangui Márquez, Leah Markham, Hope Twede, Amanda Lortz, Lenora Olson, Xiaoming Sheng, Cindy Weng, Edward Robert Wassman, Tara Newcomb, Edward Robert Wassman, John C. Carey, Agatino Battaglia, Eduardo López‐Granados, Damien Douglas, and Pablo Lapunzina. International meeting on wolf‐hirschhorn syndrome: update on the nosology and new insights on the pathogenic mechanisms for seizures and growth delay. American Journal of Medical Genetics Part A, 182:257-267, Nov 2020. URL: https://doi.org/10.1002/ajmg.a.61406, doi:10.1002/ajmg.a.61406. This article has 31 citations.
(shannon2001anepidemiologicalstudy pages 1-1): N. Shannon, E. Maltby, A. Rigby, and O. Quarrell. An epidemiological study of wolf-hirschhorn syndrome: life expectancy and cause of mortality. Journal of Medical Genetics, 38:674-679, Oct 2001. URL: https://doi.org/10.1136/jmg.38.10.674, doi:10.1136/jmg.38.10.674. This article has 138 citations and is from a domain leading peer-reviewed journal.
(nevado2025clinicianbasedfunctionalscoring pages 1-2): Julián Nevado, Raquel Blanco-Lago, Cristina Bel-Fenellós, Adolfo Hernández, María A. Mori-Álvarez, Chantal Biencinto-López, Ignacio Málaga, Harry Pachajoa, Elena Mansilla, Fe A. García-Santiago, Pilar Barrúz, Jair A. Tenorio-Castaño, Yolanda Muñoz-GªPorrero, Isabel Vallcorba, and Pablo Lapunzina. Clinician-based functional scoring and genomic insights for prognostic stratification in wolf–hirschhorn syndrome. Genes, 16:820, Jul 2025. URL: https://doi.org/10.3390/genes16070820, doi:10.3390/genes16070820. This article has 1 citations.
(shannon2001anepidemiologicalstudy pages 3-4): N. Shannon, E. Maltby, A. Rigby, and O. Quarrell. An epidemiological study of wolf-hirschhorn syndrome: life expectancy and cause of mortality. Journal of Medical Genetics, 38:674-679, Oct 2001. URL: https://doi.org/10.1136/jmg.38.10.674, doi:10.1136/jmg.38.10.674. This article has 138 citations and is from a domain leading peer-reviewed journal.
(shannon2001anepidemiologicalstudy pages 4-5): N. Shannon, E. Maltby, A. Rigby, and O. Quarrell. An epidemiological study of wolf-hirschhorn syndrome: life expectancy and cause of mortality. Journal of Medical Genetics, 38:674-679, Oct 2001. URL: https://doi.org/10.1136/jmg.38.10.674, doi:10.1136/jmg.38.10.674. This article has 138 citations and is from a domain leading peer-reviewed journal.
(shannon2001anepidemiologicalstudy pages 6-6): N. Shannon, E. Maltby, A. Rigby, and O. Quarrell. An epidemiological study of wolf-hirschhorn syndrome: life expectancy and cause of mortality. Journal of Medical Genetics, 38:674-679, Oct 2001. URL: https://doi.org/10.1136/jmg.38.10.674, doi:10.1136/jmg.38.10.674. This article has 138 citations and is from a domain leading peer-reviewed journal.
(nevado2020internationalmeetingon pages 11-11): Julián Nevado, Karen S. Ho, Marcella Zollino, Raquel Blanco, César Cobaleda, Christelle Golzio, Isabelle Beaudry‐Bellefeuille, Sarah Berrocoso, Jacobo Limeres, Pilar Barrúz, Candela Serrano‐Martín, Concetta Cafiero, Ignacio Málaga, Giuseppe Marangi, Elena Campos‐Sánchez, Tania Moriyón‐Iglesias, Sorangui Márquez, Leah Markham, Hope Twede, Amanda Lortz, Lenora Olson, Xiaoming Sheng, Cindy Weng, Edward Robert Wassman, Tara Newcomb, Edward Robert Wassman, John C. Carey, Agatino Battaglia, Eduardo López‐Granados, Damien Douglas, and Pablo Lapunzina. International meeting on wolf‐hirschhorn syndrome: update on the nosology and new insights on the pathogenic mechanisms for seizures and growth delay. American Journal of Medical Genetics Part A, 182:257-267, Nov 2020. URL: https://doi.org/10.1002/ajmg.a.61406, doi:10.1002/ajmg.a.61406. This article has 31 citations.
(osundiji2024afamilialchromosome pages 7-8): Mayowa Azeez Osundiji, Eva Kahn, and Brendan Lanpher. A familial chromosome 4p16.3 terminal microdeletion that does not cause wolf-hirschhorn (4p-) syndrome. Chromosome research : an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology, 32 4:13, Nov 2024. URL: https://doi.org/10.1007/s10577-024-09757-9, doi:10.1007/s10577-024-09757-9. This article has 0 citations.
(shannon2001anepidemiologicalstudy pages 5-6): N. Shannon, E. Maltby, A. Rigby, and O. Quarrell. An epidemiological study of wolf-hirschhorn syndrome: life expectancy and cause of mortality. Journal of Medical Genetics, 38:674-679, Oct 2001. URL: https://doi.org/10.1136/jmg.38.10.674, doi:10.1136/jmg.38.10.674. This article has 138 citations and is from a domain leading peer-reviewed journal.
(blancolago2025epilepsyinwolf–hirschhorn pages 9-11): Raquel Blanco-Lago, Ignacio Málaga, Jair Antonio Tenorio-Castaño, Nelly Álvarez-Álvarez, Pablo Lapunzina, and Julián Nevado. Epilepsy in wolf–hirschhorn syndrome: clinical insights from a pediatric cohort and a review of the literature. Journal of Clinical Medicine, 14:8044, Nov 2025. URL: https://doi.org/10.3390/jcm14228044, doi:10.3390/jcm14228044. This article has 0 citations.
(xing2018prenataldiagnosisof pages 3-5): Ya Xing, Jimmy Lloyd Holder, Yong Liu, Meizhen Yuan, Qi Sun, Xiaoxing Qu, Linbei Deng, Jia Zhou, Yingjun Yang, Ming Guo, Sau-Wai Cheung, and Luming Sun. Prenatal diagnosis of wolf–hirschhorn syndrome: from ultrasound findings, diagnostic technology to genetic counseling. Archives of Gynecology and Obstetrics, 298:289-295, May 2018. URL: https://doi.org/10.1007/s00404-018-4798-1, doi:10.1007/s00404-018-4798-1. This article has 36 citations and is from a peer-reviewed journal.
(ho2016chromosomalmicroarraytesting media 365127d8): Karen S Ho, Sarah T South, Amanda Lortz, Charles H Hensel, Mallory R Sdano, Rena J Vanzo, Megan M Martin, Andreas Peiffer, Christophe G Lambert, Amy Calhoun, John C Carey, and Agatino Battaglia. Chromosomal microarray testing identifies a 4p terminal region associated with seizures in wolf–hirschhorn syndrome. Journal of Medical Genetics, 53:256-263, Jan 2016. URL: https://doi.org/10.1136/jmedgenet-2015-103626, doi:10.1136/jmedgenet-2015-103626. This article has 59 citations and is from a domain leading peer-reviewed journal.

Ask OpenScientist

OpenScientist Report

Inheritance

Discussions and Knowledge Gaps

Pathophysiology

Pathograph

Phenotypes

Genetic Associations

Medical Actions

Diagnosis

Progression

Prevalence

Differential Diagnoses

Animal Models

Source YAML

References & Deep Research

References

Deep Research

Wolf–Hirschhorn syndrome (WHS): Disease Characteristics Research Report

Executive summary (current understanding)

1. Disease information

1.1 Definition/overview

1.2 Key identifiers

1.3 Common synonyms / alternative names

1.4 Source type (individual vs aggregated)

2. Etiology

2.1 Disease causal factors

2.2 Risk factors

2.3 Protective factors

2.4 Gene–environment interactions

3. Phenotypes (clinical spectrum)

3.1 Core phenotype (postnatal)

3.2 Epilepsy phenotype (key quantitative data)

3.3 Prenatal phenotype (ultrasound; frequencies)

3.4 Quality of life impact

4. Genetic / molecular information

4.1 Causal genomic lesion and critical regions

4.2 Genotype–phenotype correlations (deletion size)

4.3 Seizure susceptibility region (recent mapping)

4.4 Inheritance and origin

4.5 Epigenetics / modifiers

5. Environmental information

6. Mechanism / pathophysiology

6.1 Causal chain (conceptual)

6.2 Seizure biology (regional genetics)

6.3 Developmental mechanisms: neural crest hypothesis (model-organism evidence)

7. Anatomical structures affected

8. Temporal development

9. Inheritance and population

9.1 Epidemiology

9.2 Inheritance pattern

10. Diagnostics

10.1 Clinical suspicion

10.2 Genetic testing strategy (real-world implementation)

10.3 Differential diagnosis

11. Outcomes / prognosis

11.1 Survival and mortality (key statistics)

11.2 Prognostic factors

12. Treatment

12.1 Pharmacotherapy (epilepsy)

12.2 Supportive / rehabilitative care

12.3 Experimental / trials

13. Prevention

14. Other species / natural disease

15. Model organisms

Recent developments (prioritizing 2023–2024 where available)

Key quantitative findings (quick reference)

Visual evidence (genotype–seizure mapping)

Limitations of this report (tooling constraints)